Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,39093,0.0680241348481713,0.00386883993703813,0.0604412085715766,0.075607061124766,1.5907118535589e-68
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,39023,0.132592455789617,0.0078857937776555,0.117136299985412,0.148048611593822,7.13760495975124e-63
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36420,0.0627176736612653,0.00386950822443832,0.0551334375413662,0.0703019097811644,1.72895115264367e-58
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39253,-0.169083008751828,0.0109473824276701,-0.190539878310061,-0.147626139193595,2.04879738299977e-53
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,36796,-0.0724761404894327,0.00474177054051983,-0.0817700107488516,-0.0631822702300139,2.77037898916006e-52
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,38727,0.161246291886042,0.0108566666191487,0.13996722531251,0.182525358459573,1.52299216690497e-49
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),36552,-0.22868432475952,0.0156305443280161,-0.259320191642431,-0.198048457876608,4.4109961543437e-48
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,36391,0.119563895080684,0.00822682044859989,0.103439327001428,0.13568846315994,1.80915816779084e-47
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39255,0.047936189812107,0.00330847090969258,0.0414515868291096,0.0544207927951045,2.91276322460316e-47
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,36796,-0.0550418002717733,0.00424198730893026,-0.0633560953972766,-0.0467275051462699,2.92006333449773e-38
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,38886,-0.0608240099810648,0.0047978910649663,-0.0702278764683988,-0.0514201434937309,1.21791353436646e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,36743,0.0776911162477313,0.00640252839613926,0.0651421605912984,0.0902400719041643,1.05934319931119e-33
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36430,0.129877224045611,0.0107420771379171,0.108822752855293,0.150931695235928,1.81776087292928e-33
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,36806,0.0747181618598625,0.00640990115684472,0.0621547555924469,0.0872815681272782,3.03865834175632e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39147,-0.0329144412846637,0.00285449395543879,-0.0385092494373237,-0.0273196331320036,1.23623518868004e-30
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,36500,0.0537576784176513,0.00469630579763796,0.0445529190542809,0.0629624377810216,3.4360107813849e-30
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,39118,-0.0196756548894725,0.00173589465877877,-0.0230780084206789,-0.0162733013582661,1.16220042750149e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,39095,0.08075114049957,0.00713776201091944,0.0667611269581679,0.0947411540409721,1.48058292508182e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,39086,-0.180375772255491,0.0160913928443481,-0.211914902230414,-0.148836642280569,4.76150045741197e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,36796,-0.0255368527908292,0.0022848914863882,-0.0300152401041501,-0.0210584654775084,7.21386341949654e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39165,-0.0380774529874994,0.0034277066965092,-0.0447957581126574,-0.0313591478623413,1.46293440300154e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,39064,0.0984232901318838,0.00892862149815525,0.0809231919954995,0.115923388268268,3.76932117198987e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,38987,0.0566447279501698,0.00525717599481903,0.0463406630003245,0.066948792900015,5.67590071663599e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,36791,0.0385479017788441,0.00358002540084559,0.0315310519931867,0.0455647515645014,6.3747379556392e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,38864,0.0279991311658753,0.0026074854907397,0.0228884596040255,0.0331098027277252,8.44700339531114e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,39178,0.0297762497207176,0.00277611324283039,0.02433506776477,0.0352174316766651,9.57612673886324e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,36500,0.031368698630321,0.00292876712485138,0.0256283150656123,0.0371090821950297,1.18170711697731e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39106,0.0304088856164405,0.00293942104077805,0.0246476203765155,0.0361701508563655,5.32317290895442e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,36420,0.0552522169793365,0.00538024855272667,0.0447069298159922,0.0657975041426808,1.21079221937126e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,39291,0.0253741724230338,0.00247350300525968,0.0205261065327248,0.0302222383133427,1.30149801433444e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39023,0.0324499998302231,0.00317891412327129,0.0262193281486114,0.0386806715118348,2.1920446739058e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,36792,0.0235447699813609,0.00232678390444125,0.018984273528656,0.0281052664340657,5.58774145777766e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,38960,0.0463905032537512,0.0045918669454135,0.0373904440407407,0.0553905624667616,6.39876995537688e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,36792,0.0735921490401483,0.00739227510497168,0.0591032898344038,0.0880810082458928,2.89985407362991e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,39106,0.0548036503406065,0.00553701318694771,0.043951104494189,0.065656196187024,4.9985020627808e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,36791,0.0277254480537577,0.00283763870432441,0.0221636761932818,0.0332872199142335,1.8005927743336e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,36747,-0.0318314021971035,0.00325972197003543,-0.0382204572583729,-0.0254423471358341,1.90214075604552e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,39099,0.0344395916835852,0.00355601509471086,0.0274698020979519,0.0414093812692184,4.04885753148915e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,39255,0.0214218689124031,0.00221842537697729,0.0170737551735276,0.0257699826512786,5.33450569134186e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,36796,-0.0441174071906158,0.00460199479829853,-0.0531373169952809,-0.0350974973859506,1.07489305965154e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,36806,0.0301445083045644,0.00314590196074586,0.0239785404615025,0.0363104761476263,1.1215639289523e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39147,0.0209864916401756,0.00223822099301885,0.0165995784938587,0.0253734047864926,7.76335572708739e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,39291,0.0328292850979433,0.00350810205232438,0.0259534050753875,0.0397051651204991,9.21113507695668e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,39093,-0.0237050979002769,0.00254663609336478,-0.0286965046432719,-0.0187136911572819,1.47140164185553e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,38625,0.0823223790884947,0.00891072170218257,0.0648573645522169,0.0997873936247725,2.83269438840162e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,38672,0.0451736115400659,0.0048941137650739,0.035581148560521,0.0547660745196107,3.06083362886716e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,38714,0.0483116012014202,0.00526984988192796,0.0379826954328414,0.058640506969999,5.46273156154265e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,38987,0.0572733297649444,0.00630523534008272,0.0449150684983823,0.0696315910315066,1.17976574883693e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36420,0.0291327860451242,0.00321686526252488,0.0228277301305754,0.0354378419596729,1.54743680621572e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,36791,0.0431487143382528,0.00478958824433986,0.0337611213793467,0.052536307297159,2.37104561844556e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,38832,0.0404274719299722,0.00449261793294817,0.0316219407813938,0.0492330030785507,2.55547229625477e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,39093,0.0289947475068154,0.00323203720658476,0.0226599545819092,0.0353295404317215,3.27393739979282e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39093,0.0419161443889857,0.0047110738036531,0.0326824397338256,0.0511498490441458,6.35238774356543e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,39131,0.0350384507865603,0.00399821068434679,0.0272019578452406,0.04287494372788,2.08860023818984e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,36500,-0.02787024176086,0.00322501263402457,-0.0341912665235482,-0.0215492169981719,6.18870793038142e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39140,-0.0346129457047252,0.00401721218017059,-0.0424866815778596,-0.0267392098315909,7.59305242959758e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39023,-0.0312760154457026,0.00363038918402577,-0.0383915782463931,-0.0241604526450121,7.6715357844409e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,39099,-0.0350677862708248,0.00410560505655413,-0.0431147721816709,-0.0270208003599787,1.44956061636798e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39093,-0.0251599467505151,0.00296760348342351,-0.0309764495780252,-0.0193434439230051,2.49452306648067e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,38007,0.0297020407653944,0.00351695554092523,0.022808807905181,0.0365952736256079,3.32282171523646e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,39237,0.0900528670091673,0.0106911938966572,0.0690981269717192,0.111007607046615,3.98771113169223e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,39189,0.0258673491172679,0.00307794965625321,0.0198345677910116,0.0319001304435242,4.68712839336634e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,39147,0.030284262118225,0.00360605929902333,0.0232163858921393,0.0373521383443107,4.92969841219473e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,36731,0.0282559882546033,0.00336739909860271,0.021655886021342,0.0348560904878647,5.31810722422881e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39165,-0.0432286587662699,0.00515766385644453,-0.0533376799249012,-0.0331196376076386,5.67874350996433e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,36693,-0.0258875597704433,0.00309357018788413,-0.0319509573386962,-0.0198241622021904,6.45311643626845e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,36806,-0.0404715685013511,0.00484696701884464,-0.0499716238582866,-0.0309715131444156,7.5235869654681e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,39106,-0.0338809256294768,0.00406634361559203,-0.0418509591160372,-0.0259108921429165,8.61715168153217e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,36806,-0.0193729939635628,0.00232921559444083,-0.0239382565286668,-0.0148077313984588,9.88571092584838e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39246,-0.0461308117488999,0.00555060038204389,-0.0570099884977059,-0.0352516350000939,1.02788486985438e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,38750,0.0364829051787355,0.00439094133166114,0.0278766601686797,0.0450891501887913,1.05053535219508e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39224,0.0222720143554678,0.00269646908359115,0.0169869349516291,0.0275570937593064,1.5784612821982e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,39023,0.0262699993398115,0.00318169958451931,0.0200338681541536,0.0325061305254693,1.62149376293175e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,39145,-0.017385000582413,0.0021211580090849,-0.0215424702802194,-0.0132275308846066,2.68090421797937e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,36747,0.0851741485957028,0.0104122100768042,0.0647662168451666,0.105582080346239,3.09746180445304e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39291,-0.0183964144341598,0.00225427070263308,-0.0228147850113207,-0.013978043856999,3.58612162072417e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,38741,0.0366392525747971,0.00452704994062317,0.0277662346911757,0.0455122704584185,6.24787292961833e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,36806,-0.018433760993341,0.00227779521014477,-0.0228982396052248,-0.0139692823814573,6.34807935856274e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39057,-0.0339679771624004,0.00422072999377923,-0.0422406079502077,-0.0256953463745931,9.04238044466245e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,38795,0.0538990097369121,0.00671482415865194,0.0407379543859543,0.0670600650878699,1.07395749169466e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39086,0.0348250617218046,0.004353440126361,0.026292319074137,0.0433578043694721,1.33937495764098e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,36628,-0.0295142845680607,0.00368982886440642,-0.0367463491422973,-0.0222822199938241,1.36399854068161e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,39077,-0.033999017563214,0.00426908276165977,-0.0423664197760672,-0.0256316153503609,1.78266419126607e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39283,-0.0202741154799574,0.0025506107411404,-0.0252733125325925,-0.0152749184273222,2.01403010559607e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,38630,-0.0257376673753258,0.00326151900870705,-0.0321302446323916,-0.0193450901182599,3.19918253871281e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,39283,0.0350177443722785,0.0044439866459313,0.0263075305462532,0.0437279581983039,3.49678051508569e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39023,0.0303408116274374,0.00386799560896179,0.0227595402338723,0.0379220830210025,4.6513905357826e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,36792,0.02567583491211,0.00327823075105849,0.0192505026400353,0.0321011671841846,5.16580066652274e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39162,-0.0196440145304515,0.00252176009669581,-0.0245866643199753,-0.0147013647409277,7.14039308925982e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,39166,0.044598876277954,0.0057505777395625,0.0333277439084115,0.0558700086474965,9.34854266064913e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,39117,0.0205299426169401,0.00265319784293583,0.0153296748447859,0.0257302103890943,1.0745479329656e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,39099,0.022496211415598,0.00291073864371631,0.0167911636739141,0.028201259157282,1.15410690061246e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,38741,0.0244779666294555,0.00317021547513692,0.0182643442981871,0.0306915889607238,1.22523717791077e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,39031,-0.0277539693389632,0.00361784106494972,-0.0348449378262647,-0.0206630008516618,1.80416433810074e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,39023,0.0538118933189669,0.0070502269079539,0.0399934485793772,0.0676303380585565,2.43646398939489e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,39106,-0.025288093286015,0.00332608962543055,-0.0318072289518589,-0.0187689576201711,3.06289807773183e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39093,-0.0379727812206868,0.00500565162081687,-0.0477838583974879,-0.0281617040438857,3.49014788827652e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,36728,0.0574678963798414,0.00757699650943927,0.0426169832213405,0.0723188095383424,3.56594679166474e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36500,0.0152092957040983,0.00201349647316593,0.011262842616693,0.0191557487915035,4.52214608652765e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39099,0.0272413148017981,0.0036088182420592,0.0201680310473621,0.0343145985562342,4.65038160695533e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,39241,0.0161132090430003,0.00214715354189691,0.0119047881008824,0.0203216299851183,6.50595233157223e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39093,-0.0162253967440743,0.00217477781519313,-0.0204879612618529,-0.0119628322262958,9.06960743438122e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,39205,0.0359855357466577,0.00482396350158541,0.0265305672835503,0.0454405042097651,9.1328919268992e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,39241,-0.0199701947178812,0.00267986201350137,-0.0252227242643439,-0.0147176651714185,9.68600833115367e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,39147,-0.0257882406414058,0.00347480914268749,-0.0325988665610732,-0.0189776147217383,1.21908682720443e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36500,0.0504209292265533,0.00680200817816201,0.0370889931973557,0.0637528652557508,1.31675247382009e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,38951,0.0475239095402593,0.00641826652158455,0.0349441071579536,0.0601037119225651,1.38623017879747e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,39099,-0.0206061449303799,0.00278492859706469,-0.0260646049806267,-0.0151476848801331,1.4419039740074e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,39255,-0.0297081954370092,0.00402488861202013,-0.0375969771165687,-0.0218194137574498,1.64981628147331e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,39062,-0.0173013365719691,0.00235206574389497,-0.0219113854300032,-0.0126912877139349,1.99469306773535e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,39039,0.0263974432024388,0.00359172193707983,0.0193576682057624,0.0334372181991153,2.09051745899208e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36490,0.0312019407278451,0.00426894488922462,0.0228348087449648,0.0395690727107254,2.85220098540732e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,36747,0.0454588356790369,0.00630381194656984,0.03310336426376,0.0578143070943138,5.85031303352316e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,39106,0.0426320125901471,0.00592701332358336,0.0310150664759237,0.0542489587043705,6.64132340106998e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36420,0.0367784548690055,0.00513102617930991,0.0267216435575581,0.046835266180453,8.04425155709054e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39211,-0.0217651407287945,0.00303807925444268,-0.0277197760675022,-0.0158105053900869,8.18515801073497e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,36792,0.0189082641040027,0.00264085259362906,0.0137321930204897,0.0240843351875156,8.50935151926081e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39059,-0.0208611024873828,0.0029230251653141,-0.0265902318113984,-0.0151319731633671,9.98352723023694e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,36806,-0.0117504045247417,0.00165185685176437,-0.0149880439541999,-0.00851276509528356,1.19127368036953e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,38832,0.0232458938011738,0.0032734605291048,0.0168299111641284,0.0296618764382192,1.29133076574821e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,36791,0.0170294466740047,0.00240018535686809,0.0123250833745432,0.0217338099734661,1.36037274573733e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39291,-0.0163160044781959,0.00231372920301074,-0.020850913716097,-0.0117810952402949,1.84087212147747e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39083,-0.0197054620108189,0.00280728764983145,-0.0252077458044886,-0.0142031782171493,2.32245700416789e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36500,0.030772662880133,0.00439280535620885,0.0221627643819636,0.0393825613783023,2.59053160359446e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,39093,-0.0484173386129291,0.00691759680333221,-0.0619758283474602,-0.0348588488783979,2.68257656961688e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,39241,-0.0228161934917837,0.00327071207327687,-0.0292267891554064,-0.0164055978281611,3.16291459589685e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,39255,0.0266769856921793,0.00382777742617245,0.0191745419368813,0.0341794294474773,3.31417065456014e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36500,0.024050753315739,0.00346756402727351,0.0172543278222829,0.0308471788091951,4.23229928618959e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",36792,0.0422283985485849,0.00611359088081777,0.030245760422182,0.0542110366749877,5.17078742785045e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,36796,-0.0156281649992858,0.00226286223344094,-0.02006337497683,-0.0111929550217415,5.20451846306322e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",36743,-0.0638101104346213,0.00924211611467213,-0.0819246580193786,-0.0456955628498639,5.28262363376735e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39255,-0.0359306758983307,0.00523877523674562,-0.0461986753623521,-0.0256626764343093,7.21854770801267e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,36731,0.0338235636189479,0.00494796824659609,0.0241255458556195,0.0435215813822762,8.5196815521389e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39114,0.0390501033971231,0.00571578721921916,0.0278471604474536,0.0502530463467927,8.69244115319554e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39139,-0.0301027113738565,0.00440788973331879,-0.0387421752511613,-0.0214632474965516,8.85614842397874e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,39106,0.0342123957949991,0.00502026865368244,0.0243726692337815,0.0440521223562167,9.78972533636732e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,39042,0.0185619103267538,0.00272779159425109,0.0132154388020216,0.0239083818514859,1.05021309697257e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39162,-0.0122462377389777,0.00180240005570687,-0.0157789418481632,-0.00871353362979225,1.12773436822825e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,36785,-0.0116303219258471,0.00171706668688408,-0.0149957726321399,-0.00826487121955434,1.31265442863644e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,38727,0.0378645608878171,0.00559140155912893,0.0269054138319244,0.0488237079437098,1.31844524633176e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39079,0.0589878559615671,0.00873193922439357,0.0418732550817557,0.0761024568413785,1.47594500433733e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,39103,0.0187223481695566,0.00277243936229518,0.0132883670194581,0.0241563293196552,1.50031092877573e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39131,0.0211217094088198,0.00313297757656297,0.0149810733587563,0.0272623454588832,1.62115642070666e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,38727,0.0460389558656491,0.00684946859987822,0.0326139974098877,0.0594639143214104,1.86363764510882e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,38990,-0.0136805991254192,0.00204417516491752,-0.0176871824486576,-0.00967401580218089,2.27134017131956e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,36792,0.0156277166346009,0.00233591159606804,0.0110493299063076,0.0202061033628943,2.32041856917073e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,39079,-0.0303085507423167,0.00453556807223501,-0.0391982641638973,-0.0214188373207361,2.43198707651935e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39255,0.0166944730484411,0.00250176949899832,0.0117910048304044,0.0215979412664778,2.59065820900491e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39063,0.0117102844108801,0.00175499228540614,0.00827049953148403,0.0151500692902761,2.60075339193391e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,38960,0.0271881032017471,0.00408856596382211,0.0191745139126558,0.0352016924908385,3.03590203916001e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39291,-0.0171239551036663,0.00257636650972478,-0.0221736334627269,-0.0120742767446058,3.10095722718152e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,36791,-0.034476779040749,0.00519248254454619,-0.0446540448280596,-0.0242995132534385,3.26772797723168e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,39182,-0.0164568323856426,0.00248142067626998,-0.0213204169111317,-0.0115932478601534,3.42206409250308e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,36791,0.0276034442014526,0.00417738385511362,0.0194157718454299,0.0357911165574753,4.05278361302668e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,38987,-0.0207275247466764,0.00314119250123327,-0.0268842620490936,-0.0145707874442592,4.28805716600702e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,36763,-0.0423569193633256,0.00641839810423706,-0.0549369796476303,-0.029776859079021,4.29254070227292e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,36792,0.0197110677555579,0.00299335667973557,0.0138440886632762,0.0255780468478397,4.72665559809456e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,38987,-0.0337522075613974,0.00513257343700588,-0.0438120514979289,-0.0236923636248659,4.98853453926457e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,36420,0.0163755729190584,0.00250040729440542,0.0114747746220237,0.021276371216093,6.01151593372114e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39099,-0.0226819459847133,0.00347045590771822,-0.029484039563841,-0.0158798524055856,6.53123763481016e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,38973,0.0194553823028766,0.00299112443345874,0.0135927784132975,0.0253179861924557,8.04706466743123e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39283,-0.0124550692097803,0.00191778945829171,-0.0162139365480321,-0.00869620187152858,8.58628010973267e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,39023,-0.0442612034379215,0.00681662343759359,-0.0576217853756049,-0.030900621500238,8.6687360082092e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39241,-0.0451222249842982,0.00695317687068538,-0.0587504516508415,-0.0314939983177549,8.87910485258991e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39068,-0.0220262925634523,0.00339960978483552,-0.02868952774173,-0.0153630573851747,9.51300650571527e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,39255,0.0264847840830136,0.00409235894672633,0.01846376054743,0.0345058076185972,9.97929731695497e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39093,-0.027608480769681,0.00426672026105212,-0.0359712524813432,-0.0192457090580189,1.00557488816945e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36500,0.0238798790444193,0.00369629320325869,0.0166351443660322,0.0311246137228063,1.08188623303939e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39147,-0.0227949681250542,0.00353512620618009,-0.0297238154891672,-0.0158661207609413,1.16633288174795e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39283,0.014189433341966,0.00221080472310308,0.00985625608468398,0.018522610599248,1.41901342637312e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39062,0.0285917396956373,0.00446736235625037,0.0198357094773866,0.037347769913888,1.59783430991244e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39095,0.0229601171505412,0.0035880346697859,0.0159275691977608,0.0299926651033216,1.60883423761266e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39093,-0.017463254674379,0.00272914861257492,-0.0228123859550258,-0.0121141233937322,1.61185678247723e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",36767,-0.0522129073368448,0.00815918158191367,-0.0682049032373956,-0.036220911436294,1.61504732513565e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39117,-0.0181481421458587,0.00284234826522071,-0.0237191447456913,-0.0125771395460261,1.76455431257718e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,36420,0.0173019084947406,0.00271236846745302,0.0119856662985327,0.0226181506909485,1.84631025629114e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,39255,0.0215362732974292,0.00337959302342846,0.0149122709715095,0.028160275623349,1.91326552022973e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,38832,0.0481541097253516,0.00756758925261778,0.0333216347902208,0.0629865846604824,2.03334128230504e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39283,-0.0164197123270374,0.0025882120298796,-0.0214926079056014,-0.0113468167484734,2.30061915592265e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,38741,0.0343410374713166,0.00543276667948309,0.0236928147795298,0.0449892601631035,2.67116803333017e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,39162,0.0431139362571473,0.00686329178391698,0.02966188436067,0.0565659881536246,3.43686179427856e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,39093,-0.0215456705050415,0.00343616420243571,-0.0282805523418155,-0.0148107886682675,3.70143319547978e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",39255,-0.0411085313032582,0.00656479400899727,-0.0539755275608929,-0.0282415350456236,3.90234248995543e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,39147,0.0188962525151684,0.00302287648017666,0.0129714146140222,0.0248210904163147,4.18432669682972e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39079,0.0476591290146653,0.00762823911860896,0.0327077803421918,0.0626104776871389,4.27556733862152e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",36743,-0.0490139545180418,0.00784667046809947,-0.0643934286355167,-0.0336344804005668,4.33055643433649e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,39283,-0.0130591709864155,0.00209111344081096,-0.017157753330405,-0.00896058864242601,4.34681331827341e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39093,-0.019450377303737,0.00312913252477706,-0.0255834770523,-0.013317277555174,5.23601648878179e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39099,0.01527411974041,0.00246931451942435,0.0104342632823383,0.0201139761984818,6.3458336125075e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36420,-0.0505859732217332,0.00817938883632754,-0.0666175753409352,-0.0345543711025312,6.42061554828416e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,38841,0.0164166887228878,0.00265564911150811,0.0112116164643319,0.0216217609814437,6.50178577929839e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,36420,0.0401588696628301,0.00650329914124509,0.0274124033459898,0.0529053359796705,6.81384317394162e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39283,-0.0139396462517516,0.00226538685024649,-0.0183798044782347,-0.00949948802526846,7.7753552637692e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,36792,0.0354314805576128,0.00576196436365035,0.0241380304048581,0.0467249307103675,8.01678231234282e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,36747,0.0230031287889346,0.00374236782620289,0.0156680878495769,0.0303381697282922,8.14577957602404e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,39255,0.0248163467534373,0.00406383524875875,0.0168512296658702,0.0327814638410045,1.04200228406921e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,36792,0.0503949738729033,0.00826042061718221,0.0342045494632262,0.0665853982825804,1.08568499258853e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39255,-0.0346827872093188,0.00569657996362746,-0.0458480839380286,-0.023517490480609,1.16787113162138e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39106,0.0226152768607662,0.00373533842365403,0.0152940135504043,0.0299365401711281,1.44237368864198e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39147,-0.0149178632932511,0.00246532608509042,-0.0197499024200283,-0.0100858241664738,1.4724447316605e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39128,-0.0121750009722797,0.0020125122613193,-0.0161195250044656,-0.00823047694009392,1.48547414094664e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39117,0.0143582567467425,0.00237787593912921,0.00969761990604923,0.0190188935874357,1.59388308080059e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,39106,-0.0182159866327389,0.00301770767982285,-0.0241306936851917,-0.0123012795802862,1.61277942461027e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,38841,-0.0214922878111349,0.0035705069396724,-0.0284904814128928,-0.014494094209377,1.79156693617951e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,38475,0.0202730473566622,0.00337044993001371,0.0136669654938353,0.026879129219489,1.84248594985446e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39023,0.0184551107259824,0.00306902155547971,0.0124398284772422,0.0244703929747227,1.85897129018872e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,36743,0.0425087314515016,0.00708600225759536,0.0286201670266147,0.0563972958763885,2.03895386095563e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,36791,0.0124149035045978,0.00207225036934718,0.00835329278067737,0.0164765142285183,2.1406479210335e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,36478,0.0303533842242775,0.00507304086526551,0.0204102241283571,0.0402965443201979,2.24626874385541e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39237,0.02285232282227,0.0038250360086433,0.0153552522453291,0.0303493933992108,2.36024222736253e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,36779,0.0198399520638788,0.00332726337383234,0.0133185158511674,0.0263613882765902,2.54358162048951e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,39147,-0.0151466055546066,0.00254281422873385,-0.020130521442925,-0.0101626896662883,2.63140277758158e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39283,0.0156530768053937,0.00262834624253394,0.0105015181700272,0.0208046354407602,2.64935636492395e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,38832,0.027437755633992,0.00463855672015038,0.0183461844624973,0.0365293268054868,3.38802273132307e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,38727,-0.024457277478976,0.00415115193551266,-0.0325935352725808,-0.0163210196853712,3.905406571294e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,38987,0.0120741961922727,0.00205237936476974,0.00805153263732405,0.0160968597472214,4.11344660435293e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36430,0.023555409037534,0.00400618482039846,0.015703286789553,0.031407531285515,4.21295949469852e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,36608,0.0320284673322231,0.00544817082635733,0.0213500525125627,0.0427068821518835,4.23705905409771e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39071,-0.0185773118470627,0.00316525864074257,-0.0247812187829182,-0.0123734049112073,4.47203882892272e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,36616,0.0276726961554395,0.00471735999413992,0.0184266705669252,0.0369187217439537,4.57118212847798e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,39147,0.0283245392735543,0.00483387051043352,0.0188501530731046,0.0377989254740041,4.7353135599072e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39092,-0.0496342879440161,0.00848938123831215,-0.0662734751711079,-0.0329951007169243,5.11890625230402e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,38996,0.0269848175839088,0.00461655955736979,0.017936360851464,0.0360332743163535,5.1630048978434e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,36747,0.0163682914835614,0.00280712720330207,0.0108663221650893,0.0218702608020335,5.64250098465707e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39241,-0.0232208877180355,0.00398460745493132,-0.0310307183297009,-0.0154110571063701,5.73388019809592e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,38805,-0.0198474026852757,0.00340639334361191,-0.026523933638755,-0.0131708717317963,5.77614377653326e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,36500,-0.0257127508170989,0.00441360203705905,-0.0343634108097346,-0.0170620908244632,5.82251658511766e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,38841,0.0269902051194387,0.00463346278359368,0.0179086180635951,0.0360717921752823,5.82625338150064e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39197,-0.0217203592113071,0.00372960120776284,-0.0290303775785223,-0.014410340844092,5.86842866952841e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,39291,-0.0404544238144431,0.00695898592515217,-0.0540940362277414,-0.0268148114011449,6.24761669772387e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,39140,-0.0303485502776407,0.00523414343733578,-0.0406074714148188,-0.0200896291404625,6.83585578805995e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,36500,0.0140384638135051,0.00242504068870568,0.00928538406364192,0.0187915435633682,7.2506208528634e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39106,-0.040122215288572,0.00694923386637751,-0.0537427136666719,-0.026501716910472,7.9097541334424e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,36806,0.00980053490933883,0.00169861481335679,0.00647124987515952,0.0131298199435181,8.12200690390055e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,39291,0.0195440321563238,0.00339375503844916,0.0128922722809634,0.0261957920316841,8.6314938978661e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39093,-0.0123827075395678,0.00215257718902522,-0.0166017588300573,-0.00816365624907841,8.96197287408595e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,39255,-0.0138438105113168,0.00240782998109604,-0.018563157274265,-0.00912446374836854,9.12063040775282e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,36792,0.0144904977522165,0.002522799742622,0.00954581025667737,0.0194351852477556,9.46503508975088e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,36762,-0.00740263168872471,0.00129101049810515,-0.0099330122650108,-0.00487225111243861,1.00298353082227e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,39255,0.0158234505718848,0.00276530441491839,0.0104034539186448,0.0212434472251249,1.07149602158094e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,36538,0.0276015127810132,0.00482338791897635,0.0181476724598195,0.0370553531022068,1.07386355504249e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,39131,-0.019188051727309,0.00336470996723978,-0.025782883263099,-0.012593220191519,1.2008197290472e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,38841,0.0277916018994212,0.00487991512084842,0.0182269682625583,0.0373562355362841,1.25614601789435e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39291,-0.0376081066262238,0.00661389865739239,-0.0505713479947129,-0.0246448652577347,1.32231333929353e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,38905,0.019032848403973,0.00336630274139054,0.0124348950308475,0.0256308017770984,1.59666827295951e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,38832,-0.0254188809014233,0.00449680102803625,-0.0342326109163744,-0.0166051508864723,1.60866679903704e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39211,-0.0366655522074402,0.00648942389430662,-0.0493848230402811,-0.0239462813745992,1.6325159486768e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39283,-0.0123416132391585,0.0021873467751573,-0.0166288129184668,-0.00805441355985019,1.70766838849611e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,38987,0.0212636842964368,0.00376966928982999,0.01387513248837,0.0286522361045036,1.72362968602166e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,39092,-0.0158642240424442,0.00281571249326406,-0.0213830205292418,-0.0103454275556467,1.79008860283293e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39099,-0.0201905608863621,0.00358481019072689,-0.0272167888601868,-0.0131643329125374,1.81012016779986e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,38741,0.0221613109607029,0.00394084717550748,0.0144372504967082,0.0298853714246975,1.90504303590455e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36391,0.0282190235123616,0.00501771670857639,0.0183842987635518,0.0380537482611713,1.90712808440759e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,36743,-0.0573833145894272,0.0102153527543696,-0.0774054059879916,-0.0373612231908627,1.97912656935362e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,36791,0.0179597103343449,0.00320426664749844,0.0116793477052479,0.0242400729634418,2.12592814311471e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,36747,0.0230036583900614,0.00411424596154671,0.0149397363054299,0.0310675804746929,2.30061966584324e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,39241,-0.0143671463466822,0.00257267567354083,-0.0194095906668222,-0.00932470202654218,2.38320409990283e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,39283,0.0278510464163724,0.00500030169278516,0.0180504550985135,0.0376516377342313,2.59184595861909e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39079,-0.030194232522344,0.00542304277587679,-0.0408233963630625,-0.0195650686816255,2.62389563896025e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,39071,-0.0441809154227887,0.00794131591230359,-0.0597458946109038,-0.0286159362346737,2.68992700005941e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39283,0.0135833602879191,0.00244217195040283,0.00879670326512957,0.0183700173107086,2.71132351826446e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36500,0.0107654474448254,0.00193685395469798,0.00696921369361737,0.0145616811960335,2.78070286836867e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,39093,0.0126737349257261,0.00229953303245857,0.0081666501821073,0.0171808196693449,3.61691528126541e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36391,0.0301811151108893,0.00547836859455454,0.0194435126655625,0.0409187175562162,3.67701030925511e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,38736,0.0207396424905198,0.0037663501120216,0.0133575962709575,0.0281216887100822,3.71971591728856e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39099,-0.0162994478877627,0.00296645341141426,-0.0221136965741346,-0.0104851992013907,3.97897581658902e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,36796,-0.0260861517568308,0.00475957149448256,-0.0354149118860166,-0.016757391627645,4.31392169527943e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39117,-0.0144001939865505,0.00262765438283034,-0.019550396576898,-0.00924999139620305,4.3146770214559e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39099,-0.0406351393509116,0.00742988587996816,-0.0551977156756492,-0.026072563026174,4.59327910329393e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,38788,0.0289967123028661,0.00530544543686912,0.0185980392466026,0.0393953853591296,4.69106063216465e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39165,-0.0210463934891419,0.00385583311153396,-0.0286038263877485,-0.0134889605905354,4.88123736961135e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,39264,-0.0198035963741328,0.00362858163508485,-0.026915616378899,-0.0126915763693665,4.89881141423614e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36420,0.018049676842652,0.00332122345667608,0.0115400788675669,0.0245592748177372,5.59299603942428e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,36420,0.0111028372458797,0.00204400465335166,0.0070965881253104,0.0151090863664489,5.67946383222581e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,36420,0.0250892988465486,0.00464190806193978,0.0159911590451466,0.0341874386479505,6.60095474780223e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36420,0.0116543544300312,0.00216030135768052,0.00742016376897736,0.015888545091085,6.98512514512305e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,38699,0.0574790686839878,0.0106644396575863,0.0365767669551186,0.078381370412857,7.16186635376839e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,36421,0.0384797563558141,0.00714141846775654,0.0244825761590113,0.0524769365526169,7.24308261919396e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39100,0.0458554002404911,0.00851956844087878,0.0291570460963687,0.0625537543846135,7.46024356532822e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39073,0.035129938273086,0.0065349818768902,0.0223213737943812,0.0479385027517908,7.74216788166095e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,36792,0.0140973005467069,0.00262484774502242,0.00895259896646292,0.0192420021269508,7.97838531368557e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,36747,0.012852007378955,0.00239723497010159,0.0081534268375559,0.0175505879203541,8.41063208717536e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,36743,-0.0548369552236085,0.0102524609945233,-0.0749317787728741,-0.0347421316743428,9.01214238452736e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39147,-0.0164630366337661,0.00308516598561324,-0.0225099619655681,-0.0104161113019642,9.62728731352802e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,36791,0.0236409588332525,0.00443192512818815,0.0149543855820037,0.0323275320845012,9.75618798472078e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39162,-0.0124889344515378,0.00234423812502805,-0.0170836411765928,-0.00789422772648284,1.00982139748326e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,39255,-0.0167283943744177,0.00314069261274671,-0.0228841518954012,-0.0105726368534342,1.01620839197231e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39071,0.040387149470112,0.00759538098571642,0.0255002027381078,0.0552740962021162,1.06789486726685e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,38741,0.0269197389461333,0.00506898965801723,0.0169845192164196,0.0368549586758471,1.10792909565298e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39140,-0.0424721303720285,0.0080197202256566,-0.0581907820143154,-0.0267534787297416,1.2003192962969e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,38987,0.01330004871867,0.00251171307131321,0.00837709109889611,0.0182230063384439,1.20542379918613e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,39023,-0.0137454894828326,0.00260235872197199,-0.0188461125778977,-0.00864486638776751,1.29592921597239e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,39291,0.0247902426791697,0.00469471546876201,0.0155886003603961,0.0339918849979432,1.30609776349518e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39099,0.0333547271659465,0.00634739282729799,0.0209138372244424,0.0457956171074505,1.50124966607754e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39119,-0.0245471601453995,0.00467608098299019,-0.0337122788720602,-0.0153820414187387,1.54544026959383e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39093,-0.0557788506495301,0.0106318877811428,-0.0766173507005699,-0.0349403505984903,1.57200797887253e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39023,0.0256857087181323,0.00489673384683368,0.0160881103783383,0.0352833070579263,1.57974481046008e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36500,0.0351631418399786,0.00671242093944853,0.0220067967986595,0.0483194868812977,1.64471914893416e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39023,-0.00925716259848313,0.00176972968404608,-0.0127258327792135,-0.00578849241775281,1.70991985421726e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,39255,0.0305715280330974,0.00585755688462688,0.0190907165392288,0.0420523395269661,1.82071008862822e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,39145,-0.0120208862255547,0.00230790889209486,-0.0165443876540606,-0.00749738479704878,1.92780347338612e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39023,0.038043685425254,0.00732122812305538,0.0236940783040654,0.0523932925464425,2.05871634455155e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39023,-0.0400726192857,0.0077354839072496,-0.0552341677439092,-0.0249110708274907,2.24291261402768e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39162,-0.0556873762607996,0.0107782125579738,-0.0768126728744283,-0.034562079647171,2.41306840465012e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,38700,0.0130735202979091,0.00253072843265883,0.0081132925698978,0.0180337480259204,2.42368364087221e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36420,0.0277500613228327,0.00537140923424745,0.0172220992237077,0.0382780234219577,2.4249220147113e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39255,-0.0147114186317551,0.00285249724536771,-0.0203023132326758,-0.00912052403083438,2.53532190926714e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,39191,0.0153537178740889,0.00298641984874003,0.00950033497055846,0.0212071007776194,2.76379404885763e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39099,0.0112036697547474,0.00218014716381189,0.00693058131367606,0.0154767581958187,2.79690210810104e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,36806,0.0151349782087417,0.00294732311623434,0.00935822490092237,0.020911731516561,2.85995262306355e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,39291,-0.0205132179238109,0.00399960501827231,-0.0283524437596246,-0.0126739920879972,2.95108844291265e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,36792,0.0269658598754659,0.00526146853215387,0.0166533815524443,0.0372783381984875,3.0157546864847e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39099,0.0226944312050615,0.0044350841601515,0.0140016662511646,0.0313871961589584,3.14166900856479e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,38951,0.0107119044031052,0.00209720774558686,0.0066013772217549,0.0148224315844554,3.30081029226814e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,38741,0.0230605732420648,0.00451547167508223,0.0142102487589037,0.031910897725226,3.313340803735e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,36747,0.0172627652544933,0.00339434414148064,0.0106098507371913,0.0239156797717954,3.71331277669897e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,39099,0.020826028486285,0.0040978246623818,0.0127942921480167,0.0288577648245533,3.77473070896516e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,39093,0.0292756264688626,0.00576213570364381,0.0179818404897207,0.0405694124480045,3.80513625597228e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,36743,0.0502762329766015,0.00990421825250574,0.0308639652016902,0.0696885007515127,3.90337805619205e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,38727,0.01979556759652,0.00390262772377865,0.0121464172579138,0.0274447179351261,3.97625188297719e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,36538,0.019662975919508,0.00387882910236217,0.0120604708788782,0.0272654809601379,4.04896443654678e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,36743,0.0377252443886693,0.00746254197459029,0.0230986621184723,0.0523518266588663,4.35657278634441e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,39222,-0.0169758217309003,0.00336113756670633,-0.0235636513616447,-0.0103879921001559,4.45429897064593e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36420,-0.0351138053524624,0.00695493232983649,-0.0487454727189419,-0.0214821379859829,4.50910331682041e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39147,0.0129196818388528,0.00255923974348022,0.00790357194163156,0.017935791736074,4.51001237321811e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",36767,0.0186063628682808,0.00370272560128422,0.0113490206897638,0.0258637050467979,5.10051555423648e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39241,-0.02004301316326,0.00398962477650962,-0.0278626777252188,-0.0122233486013011,5.12312409564655e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39075,-0.0430791205202322,0.00858507795968894,-0.0599058733212225,-0.0262523677192419,5.28269421447278e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,39221,-0.017214041669044,0.00343784590096457,-0.0239522196349346,-0.0104758637031534,5.58346269022892e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39283,-0.019172612220297,0.00382983873264131,-0.026679096136274,-0.01166612830432,5.61522288319957e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,38789,-0.0224716363854354,0.0044919003670057,-0.0312757611047665,-0.0136675116661042,5.71750163512401e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36500,-0.0173930042752894,0.00347963115153181,-0.0242130813322918,-0.0105729272182871,5.85458398971459e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,39093,-0.0105886891481252,0.0021251477149051,-0.0147539786693391,-0.00642339962691117,6.34345695236848e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,36767,0.0196410453037313,0.00394272801695888,0.0119132983904919,0.0273687922169707,6.38808884403922e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39149,-0.0133441420935766,0.00269514819806218,-0.0186266325617785,-0.00806165162537472,7.45543417126958e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39106,0.00776631915334268,0.00157050475224479,0.0046881298389429,0.0108445084677425,7.6910546382701e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,39253,0.0266151881021322,0.00538650157304626,0.0160576450189616,0.0371727311853029,7.85032499937082e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39093,0.0188738570187122,0.00382597637996081,0.011374943313989,0.0263727707234353,8.17958876089241e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,38832,-0.0213867994023113,0.0043412620321059,-0.0298956729852388,-0.0128779258193837,8.46522457561189e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,36731,0.0159189541983243,0.00324314008444215,0.00956239963281768,0.0222755087638309,9.29002882303909e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,39024,-0.0108394248919626,0.00221106051272817,-0.0151731034969099,-0.00650574628701542,9.56694271942297e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,36792,0.0116984109379131,0.00239308181197844,0.00700797058643535,0.0163888512893909,1.02864104104121e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,36767,0.0224322678886448,0.00458976040974373,0.013436337485547,0.0314281982917425,1.03373342833576e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,38727,0.025839632457809,0.0053167146448082,0.0154188717539849,0.0362603931616331,1.18538687082504e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36470,0.0123804245952245,0.00255100497151573,0.00738045485105368,0.0173803943393954,1.22967128715605e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,38948,0.0120051429160717,0.00247475743705653,0.00715461833944089,0.0168556674927025,1.24042925252493e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,39022,-0.0122662228802573,0.00254084361643933,-0.0172462763684784,-0.00728616939203626,1.39522869934371e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,38979,-0.0169498704441665,0.00351173213541365,-0.0238328654295773,-0.0100668754587557,1.40211686661583e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,36743,0.0422334844332984,0.0087563577416432,0.0250710232596777,0.0593959456069191,1.42904335510884e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,36747,0.0163576724519361,0.00339954819937196,0.00969455798116705,0.0230207869227051,1.51333148535323e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,39071,-0.0296984519638068,0.00618153718741167,-0.0418142648511337,-0.0175826390764799,1.56712716672676e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,39165,-0.0435608676051727,0.00906832866284803,-0.0613347917843549,-0.0257869434259906,1.57293313580775e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,38832,-0.0163803227146069,0.00341017045947169,-0.0230642568151714,-0.00969638861404236,1.57525230194265e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,39035,-0.0343154984817394,0.00715353488571833,-0.0483364268577474,-0.0202945701057315,1.62591424360692e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,38832,0.0232845947758617,0.00487780834461254,0.0137240904204212,0.0328450991313023,1.82693132021473e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39086,-0.0134818578515425,0.00282783841206092,-0.0190244211391819,-0.00793929456390313,1.88205815436776e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,38987,-0.0150751288070993,0.00316393003822369,-0.0212764316820177,-0.00887382593218086,1.90906410946988e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,38727,0.0235405909640619,0.0049465003483246,0.0138454502813457,0.0332357316467781,1.96346628259326e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,36420,0.0274972366950257,0.00577996198662469,0.0161685112012413,0.0388259621888101,1.98345239228338e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39099,-0.0511463093317212,0.0107559518029582,-0.0722279748655193,-0.030064643797923,2.00100272957357e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,36500,0.0121956827411313,0.00256738670497509,0.00716360479938011,0.0172277606828825,2.0541747854933e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,38739,-0.0236315555674331,0.004978525223396,-0.0333894650052892,-0.0138736461295769,2.08688984510997e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,35946,-0.0103414402912024,0.00217918349026107,-0.0146126399321141,-0.0060702406502907,2.10315558503709e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,38987,-0.0141315195622406,0.00298498752047059,-0.019982095102363,-0.00828094402211827,2.21916903822876e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,36791,0.0319201318050575,0.0067521478069782,0.0186859221033802,0.0451543415067348,2.29807336050517e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,36718,0.0134007349649889,0.00283677863313927,0.00784064884403591,0.0189608210859418,2.33780959110441e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,36731,0.0225302985605857,0.00477364608232321,0.0131739522392323,0.0318866448819392,2.38650653622367e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39069,0.00733298364230423,0.00155503886074653,0.00428510747524103,0.0103808598093674,2.43106532583338e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39093,-0.0141692110184852,0.00301143059609336,-0.0200716149868282,-0.0082668070501422,2.55917785629445e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,36731,0.0219768563666566,0.00467368441939029,0.0128164349046516,0.0311372778286616,2.59975328847723e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,39093,-0.0514485970400286,0.010942521296482,-0.0728959387811333,-0.0300012552989239,2.60248574695445e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,36796,-0.0259067365381972,0.00552452356710777,-0.0367348027297285,-0.015078670346666,2.76799502002343e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39023,0.0228850667936983,0.00488382371298587,0.013312772316246,0.0324573612711506,2.81166708046237e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,38841,-0.0200780698268263,0.00428658449637509,-0.0284797754397215,-0.0116763642139311,2.83895121720434e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,38832,0.00981700233507077,0.00209676137029287,0.00570735004929675,0.0139266546208448,2.8660491203107e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39099,0.0219964238782491,0.0047041210811026,0.012776346559288,0.0312165011972102,2.95047723977471e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,36806,-0.0072754056460614,0.00155631170321652,-0.0103257765843658,-0.00422503470775701,2.97247185061555e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,38713,0.0294675201521319,0.00630462854332132,0.0171104482072221,0.0418245920970417,2.98056800889573e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,36517,-0.0128422114565065,0.00274918959617373,-0.018230623065007,-0.00745379984800594,3.02421999332478e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36500,-0.0374757218134161,0.00802312314170731,-0.0532010431711624,-0.0217504004556698,3.02878302391801e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,39099,-0.0222152316107884,0.00476221428724746,-0.0315491716137934,-0.0128812916077833,3.11398256750972e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36420,-0.0292275811136199,0.00627279900562016,-0.0415222671646354,-0.0169328950626044,3.20364910976153e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,38608,0.0319237260547528,0.00685883435962936,0.0184804107098792,0.0453670413996263,3.27762124730483e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,38924,-0.0159939558474738,0.00343857188405016,-0.0227335567402121,-0.00925435495473548,3.32594155271119e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39023,0.00860744313217892,0.00185504271028138,0.00497155942002742,0.0122433268443304,3.51283323875944e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,38741,0.0143890684235093,0.00310694800208492,0.00829945033942286,0.0204786865075957,3.66532519825733e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36430,0.0135780698813466,0.00293775093791128,0.0078200780430405,0.0193360617196527,3.83974872851302e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,38950,0.0300645439594039,0.00650721193201898,0.0173104085726467,0.0428186793461611,3.86562990954108e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,36784,0.015620746518383,0.0033832226126709,0.00898963019754801,0.022251862839218,3.92851241151647e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,39069,-0.0325001595703062,0.00705883501679013,-0.0463354762032148,-0.0186648429373975,4.17443543268551e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,39153,0.0242116948504274,0.00526205443425698,0.0138980681592837,0.0345253215415711,4.23464951171256e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,39023,0.0231510392317145,0.00503292617405256,0.0132865039305714,0.0330155745328575,4.26081174220466e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39023,-0.0139507498096971,0.00304423342184634,-0.0199174473165159,-0.00798405230287828,4.62714428505614e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,38962,-0.0240306095229245,0.0052655443037061,-0.0343510763581885,-0.0137101426876605,5.06448342844066e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,36500,0.0381977098547907,0.00838274393829568,0.0217675317357312,0.0546278879738502,5.24485399143084e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,39023,0.0279920932403396,0.00614973813785011,0.0159386064901534,0.0400455799905259,5.36140653465995e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,39019,-0.0290124162182078,0.00637560515465095,-0.0415086023213237,-0.0165162301150919,5.39251636601392e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",36791,0.0171976696941893,0.00378124539930172,0.00978642871155796,0.0246089106768207,5.46116281905896e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,38741,-0.0132636861236965,0.0029174189958883,-0.0189818273556376,-0.00754554489175548,5.50075553703894e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39076,0.0337193364675275,0.00741822950313487,0.0191796066413831,0.0482590662936718,5.52351787073168e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,36500,-0.0443749282277385,0.00976286172051973,-0.0635101371999572,-0.0252397192555199,5.53715943485867e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,36731,0.0197536163442376,0.00434605005576234,0.0112353582349434,0.0282718744535318,5.53861482701501e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,36747,0.0116691393484939,0.00256809314701843,0.00663567678033781,0.01670260191665,5.57267335917338e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,38832,0.0151560282372083,0.00334316089597993,0.00860343288108762,0.021708623593329,5.84797766605678e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,39099,-0.0264297627281621,0.00583317923975326,-0.0378627940380785,-0.0149967314182457,5.91690612745653e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,38841,-0.0265684411815574,0.00586943817240851,-0.0380725399994781,-0.0150643423636367,6.04094980601191e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39162,-0.0525930696913736,0.0116308103137399,-0.0753894579063039,-0.0297966814764433,6.17545116375983e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,35989,0.0440059046458696,0.00973594445553105,0.0249234535130288,0.0630883557787105,6.24420090262321e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39162,-0.0262586029264364,0.00581207931143513,-0.0376502783768492,-0.0148669274760235,6.29126393840061e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,39255,0.0174997533273868,0.00387538211983288,0.00990400437251434,0.0250955022822592,6.36004280577171e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,38987,-0.0102204064599958,0.00226649468953214,-0.0146627360514788,-0.00577807686851276,6.55167976210456e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39106,0.0102802790329651,0.00228544090937988,0.00580081485058058,0.0147597432153497,6.90503352155275e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39147,-0.0109175218256402,0.00243087974485047,-0.0156820461255471,-0.00615299752573329,7.13478241938891e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36421,0.0135289834337796,0.00301260789793322,0.00762427195383052,0.0194336949137288,7.1592660963474e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,36747,0.0254188260405285,0.00566461323131961,0.0143161841071421,0.036521467973915,7.27558120037759e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,36747,0.0245794053030222,0.00548570638546295,0.0138274207875148,0.0353313898185296,7.50649569486515e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,39023,0.0525443116302243,0.011736077829315,0.0295415990847669,0.0755470241756816,7.61939019154789e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,38652,-0.0277047308912902,0.00620072835997646,-0.0398581584768441,-0.0155513033057363,7.95474672441447e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,39106,-0.0279123439104239,0.00624881305483214,-0.0401600174978948,-0.0156646703229529,7.99604775083358e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,36743,0.0228242295815869,0.00512838219701594,0.0127726004754357,0.0328758586877381,8.63612188626832e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,36791,-0.00910403750754941,0.00204954146209785,-0.0131211387732612,-0.00508693624183763,8.98717429927326e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,38841,0.0314842842645524,0.00709858951271425,0.0175710488196324,0.0453975197094723,9.26044007729578e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,39099,0.0303311905746752,0.00684609214418632,0.01691284997207,0.0437495311772804,9.46972614031248e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,36743,0.02373515445578,0.00536002809557799,0.0132294993884471,0.0342408095231128,9.58153278778201e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,36727,-0.0350624882746837,0.00792432369056875,-0.0505941627081985,-0.019530813841169,9.73854005729717e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,36796,0.0241061573232581,0.005461781391322,0.013401065796267,0.0348112488502492,1.02485591660129e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,36725,0.0164925232408872,0.00373978994081598,0.00916253495688791,0.0238225115248865,1.04203299071252e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',36747,0.0160123759163447,0.00363523725974825,0.00888731088723816,0.0231374409454513,1.06751456257924e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39023,0.023510475658826,0.00534617510158115,0.0130319724597269,0.033988978857925,1.10186920604888e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,38977,0.0144945857358001,0.00329697273019788,0.00803251918461229,0.020956652286988,1.1084683251025e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39291,0.0130793754717216,0.00298160534597561,0.00723542899360945,0.0189233219498338,1.15851940234563e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36420,0.016178019970291,0.00368943080934656,0.00894673558397175,0.0234093043566103,1.16948880991134e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39023,-0.0274190410399632,0.00625629989798667,-0.0396813888400171,-0.0151566932399093,1.18043848399415e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,36747,0.0272535937972482,0.00621869766086721,0.0150649463819484,0.0394422412125479,1.18240154159533e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39147,-0.0105886750620943,0.00241711463986756,-0.0153262197562348,-0.00585113036795392,1.19081262009517e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,39106,0.0248551793852528,0.00567956048054624,0.0137232408433822,0.0359871179271235,1.21540868731807e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,36743,-0.0377537001007624,0.00864031711872507,-0.0546887216534635,-0.0208186785480612,1.25516681428831e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,38907,-0.0412198697054061,0.00944334919803079,-0.0597288341335465,-0.0227109052772658,1.27992272306842e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,36792,-0.0384063172029562,0.00883698185737507,-0.0557268016434114,-0.0210858327625011,1.39644020552814e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,36796,-0.0236813139956719,0.00545022520875993,-0.0343637554048414,-0.0129988725865024,1.40327775620727e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,39099,-0.0249475917244933,0.00574573663955924,-0.0362092355380294,-0.0136859479109571,1.42147365603219e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36363,0.0258186857263202,0.00594597655872847,0.0141645716712124,0.037472799781428,1.4216619788371e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,36774,-0.0132020134871562,0.00304111578481812,-0.0191626004253997,-0.00724142654891266,1.42802273754457e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,39006,-0.0262655689306715,0.00606747191708001,-0.0381578138881483,-0.0143733239731947,1.50807738309472e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,39023,-0.0109579103762688,0.00253477053262265,-0.0159260606202092,-0.00598976013232845,1.54876543128613e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,38741,-0.0172676116638184,0.0039988924254598,-0.0251054408177196,-0.00942978250991722,1.58397595029875e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,36527,-0.00873098153496785,0.00202275230683561,-0.0126955760563656,-0.00476638701357006,1.59808343963877e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39093,-0.013916663259457,0.00323598303948053,-0.0202591900168388,-0.00757413650207512,1.7139775831404e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39136,0.0247385688380813,0.0057574860954984,0.0134538960909045,0.0360232415852582,1.74380178759196e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39099,-0.046877658689155,0.0109379515345294,-0.0683160436968327,-0.0254392736814774,1.83216880474756e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,36778,0.0177875542166113,0.00415078022574951,0.00965202497414227,0.0259230834590804,1.83771681432341e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,38727,0.0209720398739709,0.00489509631480356,0.011377651096956,0.0305664286509859,1.84471309886414e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,39136,-0.0209581258171025,0.00489314149223435,-0.0305486831418818,-0.0113675684923232,1.85380508577766e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,38824,0.0551718523340619,0.0128904766152061,0.029906518168258,0.0804371864998658,1.88015897763103e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36500,0.015134164418482,0.00355275201131757,0.00817077047629954,0.0220975583606644,2.06051237518186e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,36792,0.0303832357683983,0.00713454126979033,0.0163995348796092,0.0443669366571873,2.0715430546313e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39023,-0.0120305800048612,0.00282538549236905,-0.0175683355699045,-0.00649282443981785,2.07476522583199e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39023,-0.0360184955351076,0.00847332103406422,-0.0526262047618734,-0.0194107863083417,2.14270728219415e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,39255,0.00995516031552334,0.0023450199058372,0.00535892130008244,0.0145513993309642,2.19644422797108e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,36791,-0.019202415690824,0.00453347503180086,-0.0280880267531537,-0.0103168046284943,2.2942324962691e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,39114,-0.0350836085214524,0.008285768749701,-0.0513237152708664,-0.0188435017720384,2.30709349821214e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,39093,-0.0192043749308607,0.0045417377849176,-0.0281061809892992,-0.0103025688724222,2.36711262312187e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,36767,-0.0139035805489522,0.00329270956705708,-0.0203572913003841,-0.00744986979752036,2.43225440088975e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39046,-0.0127317262981615,0.00301629188148397,-0.0186436583858701,-0.00681979421045292,2.44649934258771e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,36614,0.00965604109097142,0.00229204382348726,0.00516363519693639,0.0141484469850064,2.53899888929158e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,39023,-0.0312324406552041,0.00741579559744053,-0.0457674000261876,-0.0166974812842207,2.55020606894863e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",38841,-0.0273180846690539,0.00649054575208957,-0.0400395543431494,-0.0145966149949583,2.58108107203337e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39106,0.0105615913185742,0.00251142692787748,0.00563919453993436,0.0154839880972141,2.62091995374097e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,39106,0.0131438400860925,0.00312590851381294,0.00701705939901916,0.0192706207731659,2.6279687360387e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,36792,0.0115664157646216,0.00275076411466632,0.0061749180998756,0.0169579134293676,2.63070578677873e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39234,-0.00792175741070271,0.00188816744541733,-0.0116225656037207,-0.00422094921768475,2.73829449369716e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",36743,-0.0383219629672398,0.00916629667436606,-0.0562879044489973,-0.0203560214854823,2.92474031496033e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,38888,-0.0102617330951285,0.00245541419186197,-0.015074344911178,-0.00544912127907905,2.94156198723181e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,36767,0.0217147716036067,0.00519784804342708,0.0115269894384896,0.0319025537687238,2.96478630560115e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39147,-0.0135296466709524,0.00324192497533799,-0.0198838196226148,-0.00717547371928992,3.0183003204674e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,36767,-0.0291106908235725,0.00699243854997641,-0.0428158703815263,-0.0154055112656188,3.15900996448487e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,38987,-0.0124803170883395,0.00299935845123917,-0.0183590596527683,-0.00660157452391077,3.18614421538618e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39206,0.0214495710445507,0.00515690193902087,0.0113420432440698,0.0315570988450317,3.20833082495071e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,36792,0.0145689497886854,0.0035081813839846,0.0076929142760756,0.0214449853012952,3.30468112933721e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,36631,0.0205799668043655,0.00495833501595941,0.0108616301730851,0.030298303435646,3.33784665112164e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,38741,-0.0272751757398069,0.0065741639428728,-0.0401605370678376,-0.0143898144117762,3.3601601486919e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,39099,-0.0237847907932959,0.00573397032579981,-0.0350233726318635,-0.0125462089547282,3.37138188207972e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,39145,-0.0124864905231945,0.00301157865057616,-0.0183891846783238,-0.00658379636806525,3.39919992607783e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,36391,-0.0223795235004183,0.0054045601887632,-0.0329724614703941,-0.0117865855304424,3.48274119197217e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39165,0.0169086563211732,0.00408535687156432,0.00890135685290712,0.0249159557894393,3.50927835942894e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,38811,-0.0200089611337961,0.00483985494030001,-0.0294950768167841,-0.0105228454508081,3.58125934152291e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39291,-0.0279987855222901,0.00677407586992719,-0.0412759742273474,-0.0147215968172328,3.59595954105494e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,38832,-0.0146397234908448,0.00354392224614135,-0.0215858110932819,-0.00769363588840779,3.6324825656973e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,39099,0.0197912234092358,0.00479482637590323,0.0103933637124655,0.0291890831060061,3.68486465148491e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,38812,-0.0150737756755938,0.00365888994886438,-0.022245199975368,-0.00790235137581962,3.81296635758705e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,36500,0.0234654823114023,0.00571340686021403,0.0122672048653828,0.0346637597574218,4.03195899814557e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,39057,0.0248769945431551,0.0060642321764996,0.0129910994772159,0.0367628896090943,4.11284565487139e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36500,-0.0236626068129212,0.00577120434045932,-0.0349741673202214,-0.0123510463056209,4.15526354080396e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,36767,-0.0365418534097779,0.00892037822497803,-0.0540257947307348,-0.0190579120888209,4.22101371371504e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,36712,0.016134253971356,0.0039402906287347,0.00841128433903601,0.023857223603676,4.25328022865948e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,38951,-0.0292792838611895,0.00715390256653602,-0.0433009328916001,-0.0152576348307789,4.28466221361901e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,36506,0.00771385230133353,0.00188506743273872,0.00401912013316563,0.0114085844695014,4.30168796123658e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36430,0.0130862408114108,0.00319798317310825,0.00681819379211867,0.019354287830703,4.30284323362003e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39023,0.0290849202631311,0.00711102087088527,0.0151473193561959,0.0430225211700662,4.33378915883311e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,38733,-0.040429276257862,0.00988614350918879,-0.059806117535872,-0.0210524349798519,4.34599348509604e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,38987,0.0131046625950026,0.00320518382143731,0.00682250230498542,0.0193868228850197,4.36258367377482e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,36743,0.011224643352792,0.00274586527823535,0.00584274740745076,0.0166065392981333,4.38060129883733e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,39246,-0.0106594406453114,0.00261942816567541,-0.0157935198500352,-0.00552536144058756,4.73743445273641e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,36731,-0.0140272440126573,0.0034505453344385,-0.0207903128681568,-0.00726417515715787,4.82714426115623e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39099,-0.0297637526732741,0.00734556382257251,-0.0441610577655163,-0.015366447581032,5.10474967691602e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39118,-0.0176742989078944,0.00436483905977993,-0.026229383465063,-0.00911921435072569,5.1637160538185e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,39023,0.0185616535081075,0.00458779553143389,0.00956957426649705,0.0275537327497179,5.23860540049836e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39106,0.0118447777919849,0.00292868417646784,0.00610455680610792,0.0175849987778618,5.27148865250658e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,39023,-0.0273064043933533,0.00676730998952491,-0.0405703319728221,-0.0140424768138845,5.48594781091054e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36421,0.0219881163675112,0.00545972060637087,0.0112870639790243,0.0326891687559981,5.67447012742261e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,36743,0.010588747616053,0.00262937665134332,0.00543516937942005,0.0157423258526859,5.67940879938097e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,38727,0.0225868313970594,0.00561254067566052,0.0115862516727648,0.033587411121354,5.74157241962751e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39055,-0.00717477736918119,0.00178551960717026,-0.0106743957992349,-0.00367515893912747,5.88986298855134e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,39093,-0.00957472662200184,0.00238579292729454,-0.0142508807594991,-0.00489857248450454,6.01809606983022e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,39218,-0.0257431079437948,0.00641863733708046,-0.0383236371244725,-0.0131625787631171,6.08303621658392e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,39198,-0.0409019099879171,0.0102044392837685,-0.0609026109841034,-0.0209012089917309,6.14604261020151e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39147,-0.0121575907698664,0.00303611802456605,-0.0181083820980159,-0.00620679944171695,6.24898531029385e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,39058,0.0227615268790342,0.00568778710340906,0.0116134641563525,0.033909589601716,6.31539745991457e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,36731,0.00770002134569239,0.00192508084220726,0.00392686289496617,0.0114731797964186,6.37388989635979e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36420,-0.0190039602696262,0.00475685909968617,-0.0283274041050111,-0.00968051643424128,6.50454948264977e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39106,0.0227078343612692,0.00569162117295255,0.0115522568622822,0.0338634118602562,6.646742529029e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39093,-0.0097847928287419,0.00245567652296224,-0.0145979188137479,-0.00497166684373591,6.79196940317286e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,36767,-0.0213781866641281,0.00537531350151386,-0.0319138011270953,-0.0108425722011609,7.01399861121162e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39241,-0.0457282692097632,0.0115025805325549,-0.0682733270535708,-0.0231832113659556,7.05587055929508e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,38841,-0.0130792162255923,0.00329070613271633,-0.0195290002457164,-0.00662943220546835,7.08303781896682e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,38963,-0.0251270029184686,0.00632390235900717,-0.0375218515421227,-0.0127321542948146,7.12015130868117e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39255,0.0212394960227566,0.00535475609318505,0.0107441740801139,0.0317348179653993,7.32742289832246e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39162,-0.0234513264058349,0.00591889773346328,-0.035052365963423,-0.0118502868482469,7.46271248348385e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,39093,-0.0258361510695037,0.00652462721860497,-0.0386244204179695,-0.013047881721038,7.53568593242761e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,39091,-0.0207612988781909,0.00524809215198167,-0.0310475594960749,-0.0104750382603068,7.65698113217104e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,39099,-0.0116291270736607,0.00293994915878882,-0.0173914274248868,-0.00586682672243463,7.67031569314646e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,38727,0.0208477777003589,0.00527607740327252,0.0105066659899448,0.0311888894107731,7.80614450872345e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,38922,0.0164670929750431,0.004167605117712,0.0082985869443276,0.0246355990057586,7.81108702518028e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36430,0.0195535556781859,0.00495786271342796,0.00983614475986712,0.0292709665965047,8.05859158335946e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39093,0.014451827307996,0.00366463092252791,0.00726915069984129,0.0216345039161507,8.06278191735873e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39183,0.0109661103541446,0.00278178375632599,0.00551381419174562,0.0164184065165435,8.11252557009556e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39101,0.020276788254122,0.00514835902283672,0.010186004569362,0.0303675719388819,8.23592064131255e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,38832,-0.0113913522960324,0.00289245272626188,-0.0170605596395057,-0.00572214495255912,8.24321122564508e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,36731,0.0229562374925327,0.00583620108931604,0.0115172833574733,0.0343951916275922,8.4184736481584e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,39106,0.00896332014722158,0.00227911638859009,0.004496252025585,0.0134303882688582,8.43320006585415e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39291,-0.0127517224702502,0.00324839805248768,-0.0191185826531261,-0.00638486228737436,8.69105100287363e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,39241,0.0130593613304972,0.00333050433115847,0.00653157284142664,0.0195871498195678,8.85147429178226e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39147,0.00758215122739042,0.00193560333515076,0.00378836869049493,0.0113759337642859,8.99718437002259e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39023,0.0232735399353847,0.00594318307027985,0.0116249011176362,0.0349221787531332,9.04222771131602e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,38704,-0.015349883979777,0.00392059788989062,-0.0230342558439626,-0.00766551211559139,9.07369636662041e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,39106,-0.0165097400507813,0.00422366948556436,-0.0247881322424875,-0.00823134785907521,9.31330898892318e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36500,-0.0126821909629742,0.00324859320703896,-0.0190494336487706,-0.00631494827717784,9.51455259060784e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,39044,-0.0362163320861808,0.00928579889271046,-0.0544164979158933,-0.0180161662564683,9.65332070741526e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,38987,-0.0134013056021851,0.00343957144699643,-0.0201428656382982,-0.00665974556607214,9.81288989077661e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,39223,-0.0143030147895567,0.00367426803634673,-0.0215045801407963,-0.0071014494383171,9.95322124792872e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,36747,0.02258074517648,0.00582822145848704,0.0111574311178454,0.0340040592351146,0.000107425552559865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,38727,0.0222528566749218,0.00574430809990111,0.0109940127991157,0.033511700550728,0.000107568006707027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36531,0.0151718557143119,0.00391695522155941,0.00749462348005547,0.0228490879485684,0.000107876115646746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,39099,-0.00945595199677994,0.00244848832644932,-0.0142549891166206,-0.00465691487693927,0.000112948251381827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,39190,0.0237188861177667,0.00614692075730101,0.0116709214334567,0.0357668508020767,0.000114476757850179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39099,0.021907368506383,0.00568110777488317,0.010772397267612,0.0330423397451541,0.000115646613259437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",38951,-0.033276776669831,0.00862977361529405,-0.0501911329558074,-0.0163624203838547,0.000115715606712902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39099,0.0210592727458206,0.00546308686664113,0.010351622487204,0.0317669230044372,0.000116285373082912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39162,-0.0295131200259562,0.00767535217529799,-0.0445568102895403,-0.0144694297623721,0.000120951242024026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,39013,0.0192816027931532,0.00502071860712256,0.00944099432319295,0.0291222112631134,0.000123330504859414
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,39241,0.0106011526648563,0.00276966830188247,0.00517260279316663,0.0160297025365459,0.00012991689014108
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39147,0.0155452404085226,0.0040659164892973,0.00757604408949991,0.0235144367275453,0.000132196946862222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,38727,0.0210299099341593,0.00550861166879924,0.0102330310633128,0.0318267888050058,0.000135279586945664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,38684,0.0298562271854412,0.00782217961355797,0.0145247551428675,0.0451876992280148,0.00013570592077635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39274,-0.0122859132264629,0.00321943345921079,-0.018596002806516,-0.00597582364640975,0.000136067366869942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39145,-0.00985622071781053,0.00258745519637768,-0.0149276329027108,-0.00478480853291027,0.000139943824713782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39023,0.0182817029440863,0.0048128953174461,0.00884842812189197,0.0277149777662807,0.000146152382624538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,38741,-0.035880656490691,0.00945809830487106,-0.0544185291682383,-0.0173427838131437,0.00014904012187623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39283,-0.00531944488688132,0.00140478424908978,-0.00807282201509728,-0.00256606775866536,0.00015326280868941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,38913,-0.0398142689308927,0.0105200726713249,-0.0604336113666895,-0.0191949264950958,0.000154552858470351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,39211,0.0167100250026379,0.00441705385369638,0.00805259944939303,0.0253674505558828,0.000155493760152328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,38923,-0.0112272892211419,0.00296931777194592,-0.0170471520541559,-0.00540742638812792,0.000156739480180198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39023,-0.0286045646310403,0.00756864345768614,-0.0434391058081051,-0.0137700234539755,0.000157839393473507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,36737,-0.015801837237419,0.00418148720781108,-0.0239975521647287,-0.00760612231010926,0.000158169787539765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39099,0.0156081607053856,0.00413528139907716,0.00750300916319434,0.0237133122475768,0.000161008433835413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,39255,-0.03764026502035,0.00997994762481681,-0.0572009623649909,-0.018079567675709,0.00016281806325817
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,36743,-0.0301312164980748,0.00798898749787179,-0.0457896319939035,-0.0144728010022461,0.00016293370008899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,36500,-0.00751089259399751,0.001992874500203,-0.0114169266143954,-0.00360485857359963,0.000164731383362568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39147,0.00803728064042189,0.0021348094087973,0.00385305419917918,0.0122215070816646,0.000167259353439357
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36430,-0.00884310203652491,0.00234992900504531,-0.0134489628864137,-0.0042372411866361,0.00016855884326364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39182,-0.0158823607046061,0.00422900747681503,-0.0241712153591635,-0.0075935060500486,0.000173582966159548
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,36792,-0.00959094008905003,0.00255462289125059,-0.0145980009559012,-0.00458387922219886,0.000174555376064485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,36421,0.0152616552547239,0.00406684310579112,0.00729064276737328,0.0232326677420745,0.000175725507041061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,36391,0.0132005435652932,0.00352595396882367,0.0062896737863988,0.0201114133441876,0.000182052841646513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,38741,0.0127977937176231,0.00342511942760791,0.00608455963951164,0.0195110277957347,0.000187332792724081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,38741,0.0218587441422413,0.00585100096330593,0.0103907822541617,0.033326706030321,0.000187745059962481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36391,-0.00865438977174697,0.00231972361866359,-0.0132010480643276,-0.00410773147916634,0.000191726833242231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,39023,0.0154517549691319,0.00414979995177631,0.00731814706365031,0.0235853628746135,0.000197195962836164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,39162,-0.0162104858012546,0.0043536091212156,-0.0247435596788371,-0.007677411923672,0.000197216639551248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39092,-0.0168289196905485,0.00452387991967685,-0.0256957243331151,-0.00796211504798184,0.000199923169046836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36500,-0.0396734996078526,0.0106915075868463,-0.0606288544780713,-0.0187181447376338,0.000207533262580082
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36420,-0.0290067690850368,0.00782120125672263,-0.0443363235482132,-0.0136772146218605,0.000209193796964932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,36767,-0.0380040351184815,0.0102571306584628,-0.0581080112090686,-0.0179000590278944,0.000212161977571347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,38741,0.00908437285547437,0.00245295148801251,0.00427658793896985,0.0138921577719789,0.00021345954781677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,38727,-0.0172854722017606,0.00466765572734173,-0.0264340774273504,-0.00813686697617077,0.0002136293032474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39099,-0.0179851763727665,0.00486052067185238,-0.0275117968895972,-0.00845855585593584,0.000216138958726109
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36500,0.00929729459892132,0.00251859141043047,0.0043608554344776,0.014233733763365,0.000223902851032479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,39237,-0.0101726146274893,0.00275640555072396,-0.0155751695069083,-0.00477005974807036,0.000224554447448553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39291,-0.0227671952809923,0.00617483607150772,-0.0348698739811474,-0.0106645165808371,0.000227608124846331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39229,0.0197581840043599,0.00536711233850182,0.00923864382089638,0.0302777241878235,0.000232802208111262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39291,-0.0137767111750916,0.00374449980093586,-0.0211159307849258,-0.00643749156525727,0.000234775373256429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,38841,-0.0136663827232892,0.00371462847857822,-0.0209470545413025,-0.00638571090527592,0.000234904880123243
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,36796,-0.0241222469829484,0.00655836710081593,-0.0369766465005476,-0.0112678474653492,0.000235941999488151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,39260,0.0226008635545621,0.00614545841058167,0.010555765069822,0.0346459620393022,0.000236190818175283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36430,0.023259960102676,0.00632734984115409,0.010858354414014,0.0356615657913381,0.00023781421591541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36420,0.0128315124631753,0.00349838465349077,0.0059746785423334,0.0196883463840172,0.000245619467844132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39098,-0.00867248879848157,0.00236509050308207,-0.0133080661845224,-0.00403691141244071,0.000246368817619811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,36731,0.0196215342736987,0.00535691973098273,0.00912197160097251,0.0301210969464248,0.000250435797668233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39099,-0.00842554509340286,0.00230383871615311,-0.012941068977063,-0.00391002120974277,0.000255867344535992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,36584,-0.0107447510147095,0.00293987819678164,-0.0165069122804015,-0.00498258974901747,0.000258389400217294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,38727,0.0185329212447247,0.00507109523085875,0.00859357459224152,0.0284722678972078,0.000258450798846192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,36538,-0.0117337825559613,0.00321071046197513,-0.0180267750614326,-0.00544079005049005,0.00025864833772785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,39093,0.0134371397354655,0.00368154887718914,0.00622130393617482,0.0206529755347563,0.000263260023397795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,36747,0.0213103104796204,0.00584824303711805,0.00984775412686901,0.0327728668323718,0.000269611081542922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,36791,-0.0161881750000394,0.00444818775012031,-0.0249066229902752,-0.0074697270098036,0.000274472890790584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,36791,0.0130649399050658,0.00359118040722011,0.0060262263069144,0.0201036535032172,0.00027576547728982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,39195,0.0132890519654606,0.00365527161439446,0.0061247196012475,0.0204533843296738,0.000278257791719818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,36420,0.0167766812492833,0.00462568683371545,0.00771033505520102,0.0258430274433656,0.000288034010970329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39045,-0.0369465110073781,0.0102162692809108,-0.0569703987979632,-0.0169226232167929,0.000299651861625809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,39165,-0.0152368832075908,0.00422168230394549,-0.023511380523324,-0.00696238589185767,0.000308126274271742
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39117,-0.0107403468003073,0.00297655073866976,-0.0165743862481,-0.00490630735251453,0.000309172047471258
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39283,-0.0188547842170823,0.00522809891446538,-0.0291018580894344,-0.00860771034473016,0.000311416029194873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,36806,-0.00728860202153123,0.00202109684612056,-0.0112499518399275,-0.00332725220313493,0.00031180953569004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",38705,-0.0151354660722543,0.0042090997201127,-0.0233853015236752,-0.0068856306208334,0.000324331352932301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",36767,-0.0138774758844209,0.00388328206447645,-0.0214887087307947,-0.00626624303804702,0.000353328351963491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,36767,-0.0245379094101449,0.00686721102021572,-0.0379976430097678,-0.0110781758105221,0.000353932281433565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,38935,-0.00831923655339748,0.00233473361548338,-0.0128953144397449,-0.00374315866705005,0.000367424312303511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,36792,0.0102985280778808,0.00289173976153554,0.00463071814527119,0.0159663380104905,0.000370263470728551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,38644,-0.0186616202730966,0.00524087500562644,-0.0289337352841244,-0.00838950526206878,0.000370911264213283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,38931,-0.0134590865479564,0.0037845227505386,-0.0208767511390121,-0.0060414219569008,0.000377196387640152
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36391,-0.00886061725825149,0.00249175494604209,-0.013744456952494,-0.003976777564009,0.000377968915630328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,38958,0.0142943604703541,0.00402346439655699,0.00640837025310237,0.0221803506876058,0.00038238993947999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39086,0.0218134502092691,0.00614004181812065,0.0097789682457526,0.0338479321727855,0.000382517198958124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,38939,0.00944658749988006,0.00265903312851648,0.00423488256798777,0.0146582924317724,0.000382550203408671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,36767,0.014223199781984,0.00400974566702275,0.00636409827461936,0.0220823012893486,0.00039079256031892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,38727,0.0226015168257317,0.00637231106194564,0.0101117871443182,0.0350912465071451,0.000391092934697684
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39070,-0.0172441100162161,0.00486925244511405,-0.0267878448086397,-0.0077003752237926,0.000399156708950887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,36420,0.0236062376714108,0.00667034648582364,0.0105323585591965,0.0366801167836252,0.000403124177646714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",38987,-0.0182326994012882,0.00515262005450027,-0.0283318347081088,-0.00813356409446769,0.000403568183819977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36500,-0.0131340067780929,0.00371472044770341,-0.0204148588555916,-0.00585315470059425,0.000408205469980024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39095,-0.00884840721914577,0.0025051024330499,-0.0137584079879236,-0.00393840645036796,0.000413408170946738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39069,-0.014017525616186,0.00397120155338016,-0.0218010806608111,-0.00623397057156086,0.000417111136434388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36420,0.0103179027331644,0.0029265405786308,0.00458188319904806,0.0160539222672808,0.000423979901189728
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36421,-0.0100860775351017,0.00286246834906642,-0.0156965154992719,-0.00447563957093151,0.000427304881682571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39145,-0.00843128322311868,0.00239453195592221,-0.0131245658567262,-0.00373800058951115,0.000431082301381465
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,38987,-0.0103998259013117,0.00295953672332622,-0.0162005178790311,-0.00459913392359232,0.000442694392827828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,38707,-0.0240627341141821,0.00685312214443397,-0.0374948535172727,-0.0106306147110916,0.000447399659676632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39283,-0.0225477861015415,0.00642725451859774,-0.0351452049579931,-0.00995036724508996,0.00045251579507816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39093,-0.00795204945018371,0.00227035809233752,-0.0124019513111652,-0.00350214758920216,0.00046214267524711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,39283,-0.00832552880898583,0.00238678899264401,-0.0130036352345681,-0.00364742238340358,0.000487691889077721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,36743,0.0301803580501919,0.00865361416701231,0.0132192742828477,0.047141441817536,0.000488999283006331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,38727,-0.0240394159443364,0.00689409406692983,-0.0375518403155189,-0.010526991573154,0.000489958970450084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39099,0.0234413637913063,0.00673207913956643,0.0102464886777561,0.0366362389048565,0.000499005207887513
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39147,-0.0226097808952836,0.00650258151866746,-0.0353548406718718,-0.00986472111869534,0.000508377791356113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,36767,0.0107423541016415,0.00308945773471662,0.00468701694159694,0.0167976912616861,0.000508536800698313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,36792,0.0173956498111872,0.00500444066471217,0.00758694610835133,0.027204353514023,0.000510541014387174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,36391,0.0147453782002578,0.00424264840157578,0.00642978733316927,0.0230609690673463,0.000511603759668588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,36679,-0.00835367703693879,0.00240367617850262,-0.0130648823468039,-0.00364247172707365,0.000511826555971001
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,38987,-0.0128840126967191,0.00370800435177521,-0.0201517012261985,-0.00561632416723968,0.000512955329406648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,36608,-0.00252300341207921,0.000726154887941069,-0.00394626699244371,-0.00109973983171472,0.000513564608719707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39117,-0.0103094178840139,0.00296966412201938,-0.0161299595631719,-0.00448887620485594,0.000518842845471279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,36806,-0.00567856954775014,0.00163649373672207,-0.00888609727172539,-0.00247104182377489,0.000522229028228526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39291,-0.017683545077325,0.00510931405616343,-0.0276978006274053,-0.00766928952724464,0.000539546895563251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,38444,-0.00655290959916779,0.0018934414223156,-0.0102640547869064,-0.00284176441142923,0.000540021632523072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,39049,-0.0184161750529773,0.00532391728269595,-0.0288510529270614,-0.00798129717889323,0.000543389771428174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,38727,-0.0229048453909083,0.00662260333029993,-0.0358851479182962,-0.00992454286352046,0.000544539196261663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,36731,-0.0162467881162392,0.00469835937942204,-0.0254555724999064,-0.00703800373257204,0.000546020940680253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39147,-0.0171912634606479,0.00497317574387803,-0.0269386879186489,-0.00744383900264698,0.000548120797312193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39241,0.00720312686971466,0.00208658801589261,0.00311341435856514,0.0112928393808642,0.000557720742707497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,38828,0.00924479767527265,0.00267875269091851,0.00399444240107237,0.0144951529494729,0.000559728072586706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36500,-0.0295270943553825,0.0085674909948344,-0.0463193767052579,-0.012734812005507,0.000569933264498162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,36792,-0.0205411751818756,0.00596548163944476,-0.0322335191951873,-0.00884883116856388,0.00057639896026362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39062,-0.00692080721114819,0.00201345460255699,-0.0108671782321599,-0.00297443619013649,0.000589160764185089
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,38727,-0.0249209079700592,0.00725673992036369,-0.039144118213972,-0.0106976977261463,0.000595983853425846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36430,0.00985545167824855,0.00287079828469359,0.00422868704024912,0.015482216316248,0.000598865116051484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,38630,-0.0379099052211829,0.0110436407153066,-0.0595554410231839,-0.0162643694191819,0.000599161398391964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,39093,0.0141146368720588,0.00411310234535886,0.00605295627515542,0.0221763174689621,0.000601563066393791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36391,0.0206924702013444,0.00603381142020881,0.0088661998177351,0.0325187405849536,0.000606821927744456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36500,-0.0271214123940699,0.00790983130351288,-0.0426246817489551,-0.0116181430391846,0.000608138623902822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,39283,0.0175831681203275,0.00513045587765425,0.00752747460012522,0.0276388616405299,0.000611400701292969
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,36731,0.014953053907398,0.00436482442754112,0.00639799802941737,0.0235081097853786,0.000614886050478753
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,36731,0.0129473885050035,0.00378150676829642,0.00553563523914253,0.0203591417708645,0.000619284879007245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,36772,0.0108760703089318,0.00318909801491721,0.00462543819969405,0.0171267024181695,0.000650684555993477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,39106,-0.023490080048552,0.00689073808715973,-0.0369959266993851,-0.00998423339771897,0.00065385743877704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,36767,-0.0212020219005112,0.00622323304687146,-0.0333995586723793,-0.00900448512864316,0.000659021898451586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39095,-0.0113910016137008,0.00334365996183389,-0.0179445751388952,-0.00483742808850634,0.000659120402903102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,39255,0.0114095051386045,0.0033494479420584,0.00484458717217004,0.017974423105039,0.000659978269330569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36430,-0.0183377825030612,0.00538469511675544,-0.0288917849319019,-0.00778378007422057,0.000662404378237532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,39255,0.0179032077154634,0.00527960502018371,0.00755518187590333,0.0282512335550235,0.000698098855621073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,36767,0.0168986894590429,0.0049853281672497,0.00712744625123348,0.0266699326668523,0.000701826021702301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36420,-0.0292370596862305,0.00864126236810233,-0.0461739339277111,-0.01230018544475,0.000718066030722007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,36420,0.0182893802557688,0.00542210986262311,0.00766204492502748,0.0289167155865101,0.000745484325460229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,39291,0.0124278499179096,0.00368460357047475,0.00520602691977909,0.0196496729160401,0.000745600798080407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,36418,-0.00788089329771033,0.0023385179544816,-0.0124643884884943,-0.0032973981069264,0.000753842716675461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36391,-0.0170207588064951,0.00505090984131243,-0.0269205420954675,-0.00712097551752278,0.00075438727842091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,38987,-0.0239506835748599,0.00711280939232083,-0.0378917899838087,-0.0100095771659111,0.000761080644224991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,36747,0.00908336444750853,0.00270234087532702,0.00378677633186758,0.0143799525631495,0.000778034246590355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39099,-0.0278076814320855,0.00827762933984415,-0.04403183493818,-0.011583527925991,0.000783098452371071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,38987,0.02225702639809,0.00663139022790687,0.00925950155139257,0.0352545512447875,0.000791833633533683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,39062,-0.020011614165947,0.0059630403992491,-0.0316991733484752,-0.00832405498341873,0.000792890140594124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39062,-0.0264846677731768,0.00789286637853301,-0.0419546858751015,-0.0110146496712522,0.000794099390433662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36420,0.0180267602645928,0.00537234529226798,0.00749696349174756,0.028556557037438,0.00079464097024444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,39255,-0.0180477550647782,0.00537959045333492,-0.0285917523533146,-0.00750375777624172,0.000795978872737937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,36665,-0.028315895163173,0.00843994871807545,-0.0448581946506008,-0.0117735956757451,0.000796000292689651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,36806,-0.00458162882783594,0.00136579947740454,-0.00725859580354883,-0.00190466185212304,0.000797253627323769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,38841,-0.012550090939741,0.00374569958331244,-0.0198916621230334,-0.00520851975644865,0.000808553605966585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,38832,-0.0336512248952711,0.0100501474764724,-0.0533495139491569,-0.0139529358413852,0.000815001668804975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,38741,0.0127211854894877,0.00380586751813059,0.00526168515395172,0.0201806858250236,0.000832262188307168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,36500,-0.012347017346777,0.00369401785615051,-0.019587292344832,-0.00510674234872197,0.000832875651722762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,36792,-0.0294974783312541,0.00883139015056287,-0.0468070030263573,-0.0121879536361509,0.000839936259688317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,36747,0.0197765151471318,0.00592691835825086,0.00815975516496008,0.0313932751293035,0.0008501057597347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,39099,-0.0197266756631222,0.00591733819738006,-0.0313246585299872,-0.00812869279625732,0.00085900919743714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39099,-0.0103401149460383,0.00310352256078465,-0.0164230191651762,-0.00425721072690035,0.000865116223485202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,36731,0.020564286624747,0.00617309317844097,0.00846502399500274,0.0326635492544913,0.000866916816429532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,39106,0.0159149296535417,0.00478169416029227,0.00654280909936881,0.0252870502077145,0.000875835076030587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,39067,-0.0198132749879858,0.00596296350191104,-0.0315006834517314,-0.00812586652424011,0.000893537558943666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39106,0.0216519929127113,0.00651699539019698,0.00887868194792523,0.0344253038774974,0.000894601674319969
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,36791,-0.018313730101317,0.00552139434553672,-0.029135663018569,-0.00749179718406505,0.000912839371498963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,36702,0.0143134095566277,0.00431556403341657,0.00585490405113128,0.0227719150621242,0.000913418129767367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39162,-0.0326709390515462,0.00985814038516694,-0.0519928942064734,-0.013348983896619,0.000921495776635678
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36391,-0.00963162213804557,0.00291349186262904,-0.0153420661887985,-0.00392117808729265,0.00094948442818604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,39130,-0.0148465586887742,0.00449185219991236,-0.0236505890006024,-0.00604252837694599,0.000951206091687524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,36500,0.0204363701903435,0.00618347026330177,0.008316768474272,0.0325559719064149,0.000952406778441284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,38713,-0.027126265912251,0.00821248612317733,-0.0432227387136786,-0.0110297931108235,0.000958647615090687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39115,-0.0145316728844531,0.00440136301475766,-0.0231583443933781,-0.00590500137552811,0.000963455233918347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,38841,0.0115565055631866,0.00350314436183371,0.00469034261399251,0.0184226685123806,0.000972925445176017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39241,0.00823757227087579,0.00250205775104202,0.00333353907883343,0.0131416054629181,0.000995888513917841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,39079,-0.0195506665289396,0.00594151572345014,-0.0311960373469019,-0.00790529571097731,0.00100230373865636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39241,-0.0171304501162585,0.005214593703311,-0.0273510537747481,-0.00690984645776896,0.00102174968139523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",38841,0.0176444004672296,0.00537111986404163,0.007117005533708,0.0281717954007512,0.00102198157726384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,36743,-0.0349262064219338,0.01063948485689,-0.0557795967414381,-0.0140728161024294,0.0010309287124072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39234,0.0137064475296246,0.00418052878192361,0.00551261111705428,0.0219002839421949,0.00104540401065589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39241,-0.020776045686179,0.00634277160128661,-0.0332078780247007,-0.00834421334765724,0.00105690912944994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,38741,0.0151344940864311,0.00462290925271733,0.0060735919511051,0.024195396221757,0.00106352727241448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39023,-0.0259461892393288,0.00793617406617596,-0.0415010904090337,-0.0103912880696239,0.00108032271460144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,36792,0.0166069122899887,0.00508376725663046,0.00664272846699301,0.0265710961129844,0.0010910983855368
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,36731,0.0119438877410675,0.00365648494618364,0.00477717724654755,0.0191105982355874,0.00109172916041538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39147,-0.0198393470298423,0.00607739997186422,-0.0317510509746962,-0.00792764308498846,0.00109919260358786
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,39025,-0.0211867324048707,0.00649539328592798,-0.0339177032452895,-0.00845576156445184,0.00110948263664561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,36052,0.0359279730052948,0.0110240761585256,0.0143207837345846,0.057535162276005,0.00112093747473829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39106,0.00816267659311292,0.00250820055975273,0.00324660349599758,0.0130787496902283,0.00113881573597587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36363,-0.0138633731596042,0.00426006978676519,-0.022213109941664,-0.00551363637754443,0.00113990397228765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36500,0.015527741388449,0.00477156453630986,0.00617547489728168,0.0248800078796163,0.00114001279049101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39241,0.00848914389574586,0.0026089804259067,0.00337554226096874,0.013602745530523,0.00114111529745138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,36747,0.0179960007415452,0.00555682836711145,0.00710461714200677,0.0288873843410837,0.00120448160380206
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,39241,-0.0172976958315302,0.00534387259304694,-0.0277716861139022,-0.00682370554915822,0.0012108249660981
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,38727,0.014767208005035,0.00456387559505262,0.00582201183873187,0.0237124041713381,0.00121621882002186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,36792,0.0084184099113303,0.0026041704003298,0.00331423592668389,0.0135225838959767,0.00122948775507207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39241,-0.0198358277612329,0.00614024773109751,-0.031870713314184,-0.00780094220828182,0.00123850741393143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,38741,-0.00843748146757507,0.00261503757835012,-0.0135629551211413,-0.00331200781400884,0.00125574722375141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,36548,-0.010491641342262,0.00325373675373625,-0.0168689653795851,-0.004114317304939,0.00126516690475324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,39023,0.0210383979068681,0.00652675839183446,0.00824595145887251,0.0338308443548636,0.00126943381493927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",38741,0.015592149044472,0.00483833855097472,0.0061090054845616,0.0250752926043825,0.00127295372660397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,36743,-0.0228187346548984,0.00708382740422097,-0.0367030363671715,-0.00893443294262534,0.00127952504500804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,39023,-0.0127031012257608,0.00394499163005377,-0.0204352848206662,-0.00497091763085543,0.00128434750217044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,36796,-0.00793112078620442,0.00246315151263314,-0.0127588977509654,-0.00310334382144346,0.00128548472704596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,38832,0.0062504054095463,0.00194362318377349,0.00244090396935027,0.0100599068497423,0.00130333840480829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,38602,0.0171309351873275,0.0053286261261213,0.00668682798012974,0.0275750423945252,0.00130776621656522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,36731,-0.0205397979813778,0.00639449573082359,-0.0330730096137921,-0.0080065863489636,0.00132089857282151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39165,0.0119211194963035,0.00371386439875634,0.00464194527474104,0.0192002937178659,0.00133056812351863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,36363,0.0114140441970328,0.00355696637472458,0.0044423901025726,0.0183856982914929,0.00133567602950458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,38987,0.0149058591502781,0.00465327194623158,0.00578544613566421,0.024026272164892,0.00136140451106527
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,36792,-0.0153073200969458,0.00477976752865601,-0.0246756644531115,-0.00593897574077998,0.00136558801552524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,38987,-0.0293315947005349,0.00916362836578715,-0.0472923062974777,-0.011370883103592,0.001372957660675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,39283,-0.0116895931298188,0.00366204158846774,-0.0188671946432156,-0.00451199161642206,0.00141527024818292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",38832,0.0260556930602569,0.00817063098677615,0.0100412563261757,0.0420701297943382,0.00143086985188341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,39083,-0.00960829994405031,0.00301800812592547,-0.0155235958708642,-0.00369300401723639,0.0014572032768377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,38907,0.0102545991577842,0.00322202758042913,0.00393942510014312,0.0165697732154253,0.00146228609558504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,36747,0.00628658466059828,0.00197664375760074,0.00241236289570082,0.0101608064254957,0.00147403017221012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,36743,-0.0282065038409744,0.0088723908551436,-0.0455963899170559,-0.010816617764893,0.00148066124692142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,39291,0.0140110491281518,0.00441679478404975,0.00535413135141434,0.0226679669048894,0.00151574199834726
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,36791,-0.00614991806670915,0.00193987220745525,-0.00995206759332144,-0.00234776854009686,0.00152652779750332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,38987,-0.0174043976224647,0.0054910355123791,-0.0281668272267278,-0.0066419680182017,0.001529519518613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39086,0.0323191429341885,0.0102113863064585,0.0123048257735297,0.0523334600948472,0.00155382780261807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,39147,-0.00832971801982625,0.00263540427157039,-0.0134951103921042,-0.00316432564754828,0.00157698482321772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,39202,-0.0170019027859092,0.00538442017770869,-0.0275553663342183,-0.0064484392376002,0.00159375971252384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,36731,0.01611719970238,0.00512481599204262,0.00607256035797643,0.0261618390467835,0.00166503230687285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36391,-0.0141163612658478,0.00449274003057293,-0.0229221317257707,-0.0053105908059248,0.00168166882814293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,39255,0.0182758418843954,0.0058230341836826,0.00686269488437747,0.0296889888844133,0.00170110709830385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,38578,0.0113413264270833,0.00361431271321956,0.00425727350917294,0.0184253793449936,0.00170502807248855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,38951,-0.00845715053558629,0.00269735316493486,-0.0137439627388586,-0.00317033833231396,0.00171977619988785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",36767,-0.0196857649709778,0.00628185570810786,-0.0319982021588692,-0.00737332778308641,0.0017297437707147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,38998,-0.0101269488870652,0.00323398440241018,-0.0164655583157892,-0.00378833945834126,0.00174297082716266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39106,-0.0244676180881783,0.00781924031450632,-0.0397933291046107,-0.00914190707174589,0.00175640120756944
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,39099,-0.0162372239769275,0.00521672545244419,-0.0264620058637181,-0.00601244209013689,0.00185833147549196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,39229,-0.0167802192179504,0.0053965779063191,-0.0273575119143358,-0.00620292652156496,0.00187798560956085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,36391,0.0165065961264426,0.00530897948700077,0.00610099633192108,0.0269121959209641,0.00188025023901273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36108,-0.030329668785103,0.00975586757379399,-0.0494511692297393,-0.0112081683404668,0.001882383785282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,38832,-0.0235549636571941,0.007600928428227,-0.038452783376519,-0.00865714393786917,0.00194561895200002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36391,0.00972334387948688,0.00313862395150722,0.00357164093453274,0.015875046824441,0.00195286039288935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,36767,0.0119192952314128,0.00385184615681541,0.00436967676405456,0.019468913698771,0.00197608407539494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,36430,-0.0136099260445603,0.00439997574085681,-0.0222338784966397,-0.00498597359248097,0.00198456700457019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,36806,-0.00471990108130557,0.00152698433215334,-0.00771279037232612,-0.00172701179028502,0.0019991042191223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,36776,-0.00679206328693974,0.00220175983115585,-0.0111075125560052,-0.00247661401787427,0.00204096092346264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,36767,0.00821371669182796,0.00266479021164958,0.00299072787699478,0.0134367055066611,0.0020583182276905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,36723,-0.0155987492403001,0.00506371161382199,-0.0255236240033912,-0.005673874477209,0.00207091393620238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39204,0.0284950403697774,0.00925246532348662,0.0103602083357436,0.0466298724038112,0.00207558574033235
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,36767,-0.0123947465858481,0.00402729210899729,-0.0202882391194828,-0.00450125405221336,0.00209050786179094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39291,-0.0153971353891537,0.00501080742410421,-0.025218317940398,-0.00557595283790946,0.00212440582958403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,39106,0.0171108175279304,0.00557009698984889,0.00619342742782654,0.0280282076280342,0.00213071061759318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,36195,-0.0126621450435709,0.00412285700717548,-0.0207429447776348,-0.00458134530950694,0.00213659652653147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,39234,0.0159077930343648,0.00518764750468117,0.00574000392518975,0.0260755821435399,0.0021697471294795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39099,-0.0136393582765369,0.00444900997701232,-0.022359417831481,-0.00491929872159271,0.00217536435022394
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39099,-0.0165855021344784,0.00541473612650808,-0.0271983849424343,-0.00597261932652258,0.00219489868911489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39255,0.035348993818565,0.0115579523490746,0.0126954072143787,0.0580025804227513,0.00222894604193791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36500,0.0101479525373705,0.00332543621067366,0.00363009756445016,0.0166658075102909,0.00228085679952438
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,36646,0.00869400599007849,0.00285002271103014,0.00310796147645943,0.0142800505036976,0.00228925452355069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39099,0.0250976249027646,0.00824538989088236,0.00893666071663514,0.041258589088894,0.00233979614830965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,36791,0.0303651905007356,0.00998383518772345,0.0107968735327976,0.0499335074686735,0.00235924672263441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39028,-0.0122283159995,0.0040242457848132,-0.0201158377377339,-0.00434079426126617,0.00238037047819913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39023,-0.031804001850067,0.0104727150049757,-0.0523305232598193,-0.0112774804403146,0.00239475250832485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,36767,0.0103181011109109,0.00340040027107551,0.00365331657960288,0.0169828856422189,0.00241511531505178
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,36767,0.00687507777209706,0.00226758541606835,0.00243061035660311,0.011319545187591,0.00243506973138531
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39093,-0.00719561764011316,0.00237470604804837,-0.011850041494288,-0.00254119378593835,0.00244875702032948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,36806,-0.00826643318326036,0.00273506013887851,-0.0136271510554622,-0.00290571531105848,0.00251273113234229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36391,-0.0183646475667063,0.00607786126023073,-0.0302772556367585,-0.00645203949665403,0.00251979873969067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39067,-0.00745686182470032,0.00247071219077249,-0.0122994577186144,-0.00261426593078624,0.00254784331071745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,38841,-0.0250666834889533,0.0083138627785913,-0.0413618545349922,-0.00877151244291432,0.0025737008882667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36391,-0.0109631861301872,0.00363837357565257,-0.0180943983384662,-0.00383197392190816,0.00259015825535137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39021,-0.00721509819552655,0.00239472763046435,-0.0119087643512367,-0.00252143203981642,0.00259182945467533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,36548,0.0112466080977402,0.00373294690701713,0.00393003215998664,0.0185631840354938,0.00259363208706373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,39117,0.0085874405864119,0.00285096482258114,0.00299954953415287,0.0141753316386709,0.00259857380941801
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39237,0.00723261358624775,0.00240253354077499,0.00252364784632877,0.0119415793261667,0.00261317598713379
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39162,-0.0237655605009206,0.00790716532458676,-0.0392636045371106,-0.00826751646473052,0.00265510830493345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,36655,-0.0268811178873086,0.00894645004679946,-0.0444161599790356,-0.00934607579558166,0.00266385155071045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39106,0.0209909922491366,0.00698682523760286,0.00729681478343504,0.0346851697148383,0.00266565749825766
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,39291,0.00802046243392883,0.00267136301945985,0.00278459091578753,0.0132563339520701,0.00268301313522523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,38506,0.0165644157930543,0.00551881566883506,0.00574753708213754,0.027381294503971,0.00269155265157564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,38841,0.0128584960509185,0.00428561117584969,0.00445869814625313,0.0212582939555839,0.00270079540903213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,39106,-0.0107014708051732,0.00356705651742285,-0.0176929015793219,-0.00371004003102438,0.00270340903269629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36500,0.0100747508193572,0.00335892348652409,0.00349126078577,0.0166582408529444,0.0027103989790897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39106,0.0168140847304253,0.00560887011533943,0.00582069930436002,0.0278074701564906,0.00272403910041697
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39023,-0.0114951522681568,0.00383477388423895,-0.0190113090812652,-0.00397899545504845,0.00272547416298587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,38832,0.0171761506684374,0.0057432386830605,0.00591940284963885,0.028432898487236,0.00278815940463075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,36791,0.00878054344522661,0.00293614119368687,0.00302570670560034,0.0145353801848529,0.0027904154308919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,36363,-0.0117554923184416,0.00393454877805935,-0.0194672079234379,-0.00404377671344527,0.00281574550026144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36421,0.0129497838141837,0.00434020750833962,0.00444297709783806,0.0214565905305294,0.00285353440170509
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,36767,-0.0338653727274578,0.0113795397432925,-0.0561692706243112,-0.0115614748306045,0.00292587693714099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,36792,0.00640244887562442,0.00215315887365589,0.00218225748325888,0.01062264026799,0.00294953608838023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39023,0.0118009019980072,0.00396911767485122,0.00402143135529884,0.0195803726407156,0.00295194767936161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39241,0.0368717327799965,0.0124017233690563,0.0125643549766461,0.0611791105833468,0.00295252171954176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39255,-0.00948526501257625,0.00319423957512728,-0.0157459745798257,-0.00322455544532677,0.00298753580688122
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39095,-0.0090276706395174,0.00304113584684753,-0.0149882968993386,-0.00306704437969624,0.00299703828203643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39093,-0.0110599595023097,0.00372666629772223,-0.0183642254458453,-0.00375569355877413,0.00300416418578148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39023,0.010191579413377,0.00343566926951608,0.00345766764512544,0.0169254911816285,0.00301775248223234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36391,-0.0114777475159572,0.00388122951307083,-0.019084957361576,-0.00387053767033835,0.00310980251373445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,39241,0.00600561253965216,0.00203358212191008,0.0020197915807084,0.00999143349859592,0.00314954788352206
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,38727,0.0118173443773447,0.0040019095791521,0.00397360160220661,0.0196610871524828,0.00315269363522126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36155,0.0131130392692108,0.00444783303326138,0.00439528652401848,0.0218307920144031,0.00320245701193843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39171,-0.0295934713006139,0.0100685642053645,-0.0493278571431283,-0.00985908545809946,0.0032955755876287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",38832,-0.0245257204018462,0.00835074336655606,-0.0408931774002961,-0.00815826340339633,0.00331961669107799
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,36203,0.0102819247897545,0.00350639399764565,0.00340939255436904,0.01715445702514,0.0033704063597476
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,39210,0.00942971682658082,0.00321886478272399,0.0031207418524418,0.0157386918007199,0.00339989610606986
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39117,-0.00623449925048425,0.00212880645455355,-0.0104069599014092,-0.00206203859955929,0.0034095635935433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39123,-0.0314409871239028,0.0107441142872418,-0.0524994511268968,-0.0103825231209087,0.00343475758060366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,39037,0.00782889627007296,0.0026785385615148,0.00257896068950395,0.013078831850642,0.0034738474677215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36420,0.0163617837635136,0.00560281568386654,0.0053802650231352,0.027343302503892,0.00350340223839097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,39016,-0.0101921680283492,0.00349191828727029,-0.017036327871399,-0.00334800818529944,0.00351912284786252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39229,0.00787025456544342,0.00269853688285579,0.00258112227504607,0.0131593868558408,0.0035450653755542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,38987,0.012249597018555,0.00421003634687315,0.00399792577868367,0.0205012682584264,0.00362398057256417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,38727,0.017525705894281,0.00602955718041572,0.00570777382066616,0.0293436379678958,0.00365881835968721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,38807,0.0140909423115135,0.0048503657027953,0.0045842255340347,0.0235976590889923,0.00367638934279476
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39218,-0.00730040143932258,0.00251498995940385,-0.0122297817597541,-0.00237102111889104,0.00370421269474534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,36747,0.00791878837237943,0.0027361848584088,0.00255586604989817,0.0132817106948607,0.00380886662377726
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,36791,0.022303565759141,0.00771097502976392,0.00719005470080369,0.0374170768174783,0.003828945681171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,39291,-0.00666328111168556,0.00230394959571235,-0.0111790223192818,-0.00214753990408935,0.00383195680219363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,39165,0.00777553755451604,0.00268882935360078,0.00250543202145851,0.0130456430875736,0.00383589742679626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39211,0.0182787259084864,0.00632459901832721,0.00588251183256505,0.0306749399844077,0.00385658344707127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,36466,-0.0268341556202878,0.00928931565114523,-0.0450412142965325,-0.00862709694404315,0.00387482216135554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39099,-0.0158891943400978,0.0055012651151979,-0.0266716739658857,-0.00510671471430991,0.00387900180112796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36391,-0.0130802671975168,0.00453987456111774,-0.0219784213373076,-0.00418211305772606,0.00396841883708385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,39241,0.0107940572457371,0.00374718999501156,0.00344956485551444,0.0181385496359598,0.00397500408631427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,36792,-0.00879695168798744,0.00305456913863476,-0.0147839071997116,-0.00280999617626331,0.00398413901375413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,36767,0.0123760966895135,0.00430076705996873,0.00394659325197475,0.0208056001270522,0.00401308241046767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36391,-0.0219126108881693,0.00762658424558631,-0.0368607160095185,-0.00696450576682011,0.00407034833447994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36391,-0.00519119551648624,0.0018082401940289,-0.00873534629678288,-0.0016470447361896,0.00410048909514437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,38925,-0.0129413083920956,0.00451474404875438,-0.0217902067276541,-0.00409241005653697,0.00415672961408898
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,36796,-0.0235707503095778,0.00822510845629396,-0.039691962883914,-0.00744953773524167,0.00416750019569911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,38987,0.0133720898363091,0.0046675856647962,0.00422362193330851,0.0225205577393096,0.00417736977294855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39084,-0.00570070687982466,0.00199144705346727,-0.0096039431046205,-0.00179747065502881,0.00420760240296519
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",36747,-0.0272854744412156,0.00954246719140981,-0.0459887101363789,-0.00858223874605242,0.00425160588719221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39093,0.0100512823244133,0.00351567101086449,0.00316056714311887,0.0169419975057077,0.00425563692229045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39106,-0.00754537557246277,0.00264137611511462,-0.0127224727580874,-0.00236827838683812,0.0042877356681304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,35080,0.0259116424995113,0.00907030332477417,0.00813384798295392,0.0436894370160687,0.00428781449068376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,39095,0.00898167893367068,0.00314662628482193,0.00281429141541969,0.0151490664519217,0.00431785917830003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,36791,-0.021102728625714,0.00739721855460916,-0.035601276992748,-0.00660418025868005,0.00434056851306202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39208,-0.0173783874933416,0.00609647950055678,-0.0293274873144329,-0.00542928767225029,0.0043700329807466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,38727,0.0217695517554651,0.00764309135713056,0.00678909269548919,0.036750010815441,0.00440185764559739
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39137,-0.00797102467215731,0.00279861646010414,-0.0134563129339614,-0.0024857364103532,0.00440257226735009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,39051,-0.0121607002241713,0.00426971063194975,-0.0205293330627928,-0.0037920673855498,0.00440356948811832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,36747,0.0225059909003922,0.00790523991848598,0.00701172066015969,0.0380002611406247,0.00442070953688462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39093,-0.00902076399775666,0.00317131341008432,-0.0152365382815219,-0.00280498971399139,0.00445420929449945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,36792,-0.0257842937073857,0.00906724107325796,-0.0435560862109713,-0.00801250120380011,0.00446663399239831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,38841,-0.00906106207233961,0.0031896073607442,-0.0153126924993982,-0.00280943164528099,0.00450600879500563
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39283,-0.0104015173048251,0.00367022288533802,-0.0175951541600876,-0.00320788044956255,0.00460248891638371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,36500,0.0127084781658489,0.00448439511738098,0.0039190637357822,0.0214978925959156,0.00460517387288659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,38841,0.0180151406309098,0.00636148680761096,0.0055466264879923,0.0304836547738273,0.00463329694212011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39140,-0.0132122114855869,0.00467135225943135,-0.0223680619140723,-0.00405636105710142,0.00468497550344751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,38741,0.0131262915338694,0.00464598189509845,0.00402016701947647,0.0222324160482624,0.00472992806687369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39147,-0.0183693233230309,0.00650714859135795,-0.0311233345620924,-0.00561531208396928,0.00476461909722919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36420,-0.0116051963915668,0.00411510138117667,-0.0196707950986731,-0.00353959768446056,0.00480766630760866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,39114,-0.0147742834298407,0.00524950896868607,-0.0250633210084654,-0.00448524585121598,0.00489290635838995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36420,-0.014636344727604,0.00522494067182212,-0.0248772284443754,-0.00439546101083266,0.00509835277502121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,38942,-0.0157524264629337,0.00563132892262778,-0.0267898311512842,-0.0047150217745833,0.00515994997712893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,39162,-0.00899679889624789,0.00321976545771246,-0.0153075391933643,-0.00268605859913146,0.0052086488583397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,36796,-0.00639525906948334,0.00229253637074401,-0.0108886303561416,-0.00190188778282508,0.00528504119538179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,39024,-0.0166833849445717,0.00598506512855975,-0.0284141125965488,-0.00495265729259455,0.00531821104715711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",38741,-0.00755155281116551,0.00271296893070551,-0.0128689719153483,-0.00223413370698271,0.00538434637594578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36391,-0.00909536721821017,0.00326889111468681,-0.0155023938029963,-0.00268834063342402,0.0054038975048696
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,39162,-0.0102331187925963,0.00367818515754488,-0.0174423617013843,-0.00302387588380835,0.00540727224605651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,38795,0.0179798718940485,0.00646292890079375,0.00531253124849277,0.0306472125396043,0.0054092714129273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,39099,-0.0105200797392978,0.003786953385589,-0.0179425083750522,-0.00309765110354336,0.00547649251135903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39165,0.00688307105916896,0.00248029270060386,0.0020216973659854,0.0117444447523525,0.00552509463068693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,38727,-0.011722960155051,0.00422602908292151,-0.0200059771575772,-0.00343994315252482,0.00554425283349015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,39147,-0.00669514894217943,0.0024144971448006,-0.0114275633459886,-0.00196273453837026,0.00556272011688315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37339,0.00763696456353941,0.00275448001474266,0.0022381837346438,0.013035745392435,0.00556934147000054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39099,0.0153796420621815,0.00555161313754068,0.00449848031260175,0.0262608038117612,0.0056072241892032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,39017,-0.00830161336261028,0.00299911663204359,-0.0141798819614157,-0.00242334476380485,0.00564665339340851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,36743,0.0282397606658082,0.0102043234903512,0.0082392866247199,0.0482402347068965,0.00565806389465755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,39086,0.00924560373762745,0.00334382994837101,0.00269169703882027,0.0157995104364346,0.00569957998665769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,39132,-0.0065655390775711,0.00237499682398897,-0.0112205328525895,-0.00191054530255272,0.00570887524112443
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39136,0.0125526522366078,0.00454382396349449,0.00364675726815862,0.021458547205057,0.00574160489270058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,39283,-0.0180427122382892,0.00653338516565372,-0.0308481471629705,-0.00523727731360795,0.00575838159799597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,36538,0.0138935933544468,0.00503219743751583,0.0040304863769158,0.0237567003319778,0.00577182011147319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39075,-0.0234104238385696,0.00848485096849409,-0.040040731736818,-0.00678011594032122,0.00580327570576598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,36743,-0.0224830827727614,0.00814905369298408,-0.0384552280110102,-0.00651093753451261,0.00580637742046733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,36792,0.0225378550079996,0.0081800566907091,0.00650494389420973,0.0385707661217894,0.00587347636851447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,38960,-0.012646633302656,0.00459904517043133,-0.0216607618367014,-0.00363250476861055,0.00596955128392715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36500,0.00694206244083688,0.00253106449881498,0.00198117602315951,0.0119029488585142,0.00610139351982865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,36792,-0.0175517943546812,0.00640007458493136,-0.0300959405411466,-0.00500764816821569,0.00610692617224887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,38832,0.00911324942487471,0.00332379461082463,0.00259861198765842,0.015627886862091,0.00611722048770664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,36724,-0.0174715269716727,0.00637213536409019,-0.0299609122852895,-0.00498214165805592,0.00611761155631846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39241,0.00520635257956753,0.00190284153593431,0.00147678316913629,0.00893592198999878,0.00622446611332919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,36591,-0.0136869572846837,0.00500396830818406,-0.0234947351687245,-0.00387917940064296,0.00624247864859834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,36430,-0.00832985691039872,0.00304919844024421,-0.0143062858532774,-0.00235342796752007,0.00630737421633683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,38987,0.0130227084664043,0.00477504449412066,0.00366362125792777,0.0223817956748807,0.00639395496054448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,39095,0.0128994438833317,0.00473210174531185,0.00362452446252044,0.0221743633041429,0.00641911716272113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,36747,0.021254477495764,0.00779731017091557,0.00597174956076943,0.0365372054307585,0.00642183052122188
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,38741,-0.0274868358444592,0.0100904194694592,-0.0472640580045992,-0.00770961368431916,0.00645614507909156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,36430,0.00724979518617684,0.00266304532555975,0.00203022634807973,0.0124693640242739,0.00649048543757551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39099,0.0189457208803982,0.0069692271261257,0.00528603571319184,0.0326054060476046,0.00656563523167605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39140,-0.0186379129400058,0.0068578291746061,-0.0320792581222338,-0.00519656775777784,0.00658001866807528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,36538,-0.00858200242253363,0.00315982936244879,-0.0147752679729333,-0.002388736872134,0.00661714339050053
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,39034,0.00782038555442462,0.00288048723428476,0.00217463057522648,0.0134661405336228,0.00663602716681564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,36731,-0.022999312927421,0.00847806807455192,-0.0396163263535427,-0.00638229950129922,0.00668058286673036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,38841,-0.0207244787465027,0.00764284196027203,-0.0357044489886359,-0.0057445085043695,0.00670317751913027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,38987,-0.0244889977577844,0.00903306997695187,-0.04219381491261,-0.0067841806029587,0.00671485947760221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,39106,-0.00743131712091468,0.00274151733746986,-0.0128046911023556,-0.00205794313947375,0.00672249107888134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,38741,0.0189250613615149,0.00698237813406863,0.0052396002187404,0.0326105225042894,0.0067278452974792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36500,-0.0306243323896839,0.0113224852451888,-0.0528164034702539,-0.00843226130911394,0.00684502753180867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,36430,-0.0253164936175278,0.00937043425151477,-0.0436825447504968,-0.00695044248455888,0.00690698491395689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,38841,0.0116349640028884,0.00431230373370203,0.00318284868483244,0.0200870793209444,0.00698176540120545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,38946,-0.00687155645963343,0.00254709153749175,-0.0118638558731173,-0.0018792570461496,0.00698759104241941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,36767,-0.0206353657455107,0.00765354688988754,-0.0356363176496903,-0.00563441384133111,0.00702300113662807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,38960,-0.00559183404734852,0.00207470200859739,-0.0096582499841994,-0.00152541811049765,0.00704143746043217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,39255,0.0107028220453179,0.00397223167407918,0.00291724796412272,0.0184883961265131,0.00705897843441013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,36792,-0.0173920725256632,0.00645476481551198,-0.0300434115640667,-0.00474073348725974,0.00705949241621497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,39093,-0.00460742198564317,0.00171116766529349,-0.00796131060961842,-0.00125353336166793,0.00709832685513429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39226,-0.00613100293764697,0.00227723877729379,-0.0105943909411428,-0.00166761493415114,0.00710386402713217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,38727,0.0126957928006486,0.00471839521508031,0.00344773817909124,0.0219438474222061,0.00713816691500267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,36420,0.0156145529819807,0.00581298531827176,0.00422110175816801,0.0270080042057933,0.0072375593705064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36430,0.0115267332488241,0.00429267976462784,0.00311308091015358,0.0199403855874947,0.00725800507355485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39099,-0.0200450167386464,0.00747111116436388,-0.0346883946207996,-0.00540163885649323,0.00730429955613214
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39041,0.0447268501775846,0.0167124402156561,0.0119704673548987,0.0774832330002705,0.00745286020933567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39099,-0.0230621121454736,0.00862067621202462,-0.0399586375210418,-0.00616558676990532,0.00747624050721597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,36538,-0.0121919476539012,0.00455932916760792,-0.0211282328224127,-0.00325566248538968,0.00750337424817937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39099,0.00828715978928251,0.00310032764507314,0.00221051760493915,0.0143638019736259,0.00752574670738045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,36792,0.00804512416297598,0.00301064746212278,0.00214425513721533,0.0139459931887366,0.0075444814400173
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36507,0.0156309565597697,0.00585075553126413,0.00416347571849202,0.0270984374010474,0.00755842652090503
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,36708,-0.0210860712033247,0.00791219797654473,-0.0365939792373523,-0.00557816316929698,0.00770826949707012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,36743,0.0100528120638901,0.00378092372559532,0.00264220156172327,0.0174634225660569,0.00785107537421376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,36587,-0.00320694451190466,0.00120796335768167,-0.00557455269296072,-0.000839336330848589,0.00794457388459455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,38832,0.0134409832232741,0.00506330369432983,0.00351690798238758,0.0233650584641605,0.00794893878006274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,39139,-0.00698903652392685,0.0026357259231759,-0.0121550593333516,-0.00182301371450209,0.00801809486779198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39078,0.00575955319877361,0.0021726642430231,0.00150113128244833,0.0100179751150989,0.00803566005321832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",38994,0.017750853646471,0.00669715024274582,0.00462443917068922,0.0308772681222528,0.00804543242735151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,36767,-0.0185507838850348,0.00699889412820681,-0.0322686163763201,-0.00483295139374941,0.00804634662663426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,36258,-0.0192176219477605,0.00725767525450072,-0.0334426654465819,-0.00499257844893908,0.00810952058859514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,36420,0.0121210145169408,0.00457868174915326,0.00314679828860038,0.0210952307452812,0.00812454214296315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,36796,-0.00586560932273393,0.0022171763113211,-0.0102112748929233,-0.00151994375254457,0.00816613593424629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36500,0.00777335895899539,0.00293852788233964,0.0020138443096097,0.0135328736083811,0.00817136404354593
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",38832,0.0209877460988444,0.0079430908591865,0.00541928801483884,0.0365562041828499,0.00824393934275586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39006,-0.00673415230688111,0.0025490533475223,-0.0117302968680248,-0.0017380077457374,0.00825454302171194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,39024,-0.020775208195832,0.00786710910121987,-0.036194742034223,-0.00535567435744111,0.0082803165811344
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39162,-0.00798001136236462,0.00302188049379204,-0.013902897130197,-0.00205712559453221,0.00828083236296578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,36729,-0.020140570454002,0.00763094243966127,-0.0350972176357381,-0.00518392327226592,0.00831703513884207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,36747,-0.0154421551951354,0.00585860067366006,-0.0269250125155091,-0.00395929787476169,0.00840373885130223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,38832,-0.0050643929660794,0.0019214292888068,-0.00883039437214073,-0.00129839156001807,0.00840399452879068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,36792,0.00621375238384144,0.00236570632667516,0.00157696798355812,0.0108505367841248,0.00863455864890019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,36792,0.00603647360500233,0.00230119231140812,0.00152613667464242,0.0105468105353622,0.00872119007107301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,36747,0.0111175357022241,0.0042427854219021,0.00280167627529594,0.0194333951291522,0.00879454571696922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,36391,0.0145926472126539,0.0055697037961338,0.00367602777223167,0.0255092666530762,0.00880347088318163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39043,-0.0045057617578391,0.00172487591027181,-0.00788651854197184,-0.00112500497370636,0.00900439379591405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,38987,0.0116735287765251,0.00447007766875121,0.00291217654577274,0.0204348810072775,0.00902396511716287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36391,0.0159763849508528,0.00612213383554526,0.00397700263318413,0.0279757672685215,0.00907531135481822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36391,-0.016845120503907,0.00645715574022688,-0.0295011457547517,-0.00418909525306232,0.00909808705119357
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,38832,0.00943088165608529,0.0036166643302394,0.00234221956881606,0.0165195437433545,0.00912649093699608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39023,0.01272630527998,0.00489046020634663,0.00314100327554066,0.0223116072844194,0.00926985711370198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,36747,0.013265436281686,0.005099431876076,0.003270549804577,0.0232603227587949,0.00929622454456834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,36747,-0.00868623179556714,0.00333989324144393,-0.0152324225487972,-0.00214004104233704,0.00931260833249988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,36791,-0.00530757348888448,0.00204333833404446,-0.00931251662361163,-0.00130263035415733,0.00940112312366015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,39185,-0.00916985287130137,0.00353130248591812,-0.0160912057437009,-0.00224849999890186,0.00942046862612433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39106,-0.02985381071261,0.0114988578588425,-0.0523915721159414,-0.00731604930927863,0.00943402417880125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39165,-0.00768303405967142,0.00296129676370393,-0.0134871757165311,-0.00187889240281171,0.00948236152497304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,39023,-0.00679420548035738,0.00262687693371219,-0.0119428842704333,-0.0016455266902815,0.00970711379071385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39184,0.00589995294339746,0.00228155028195251,0.00142811439077055,0.0103717914960244,0.0097205122432642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36261,0.0123982144581981,0.00479889601925438,0.00299237826045952,0.0218040506559367,0.00979010627724729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,39162,0.0100315552654214,0.00388600516285471,0.00241498514622614,0.0176481253846166,0.00984763908931115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,39106,0.00879803354159197,0.00341052604974573,0.00211340248409035,0.0154826645990936,0.00989873537673721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,38841,-0.0119063624579719,0.00461719032703291,-0.0209560554989564,-0.00285666941698741,0.00992665324714298
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,36430,0.0110141466045932,0.00427561636163646,0.00263393853578574,0.0193943546734007,0.0100053011096674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39274,-0.0115711766469405,0.00449316651610737,-0.0203777830185109,-0.00276457027537005,0.0100250352480605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,38987,-0.00766145361359365,0.00297660798059055,-0.0134956052555511,-0.00182730197163618,0.0100657298770785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39093,-0.0179170961983642,0.00696112368139563,-0.0315608986138997,-0.00427329378282878,0.0100658812876581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,36705,-0.00644968339021977,0.00251155747712509,-0.0113723360453849,-0.0015270307350546,0.0102398741930011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,36743,0.0088983380849525,0.00346608925975011,0.00210480313584227,0.0156918730340627,0.0102618759966129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,36796,0.01663555571268,0.00649843191935543,0.00389862915074331,0.0293724822746166,0.0104804688710498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,36430,-0.0212642408738428,0.00831468258635351,-0.0375610187430957,-0.00496746300458994,0.0105564275059139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,38727,0.00916716969888351,0.00358480412560935,0.00214095361268919,0.0161933857850778,0.010560770373837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36421,0.0178591273279668,0.00698753528948466,0.00416355816057691,0.0315546964953568,0.0106043897158758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,36747,0.0176020406475569,0.00689019656216627,0.00409725538571105,0.0311068259094028,0.010640853357268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,39106,-0.0175349497619404,0.00686981125371052,-0.0309997798192131,-0.00407011970466784,0.0107060388090113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,38727,-0.00910428588655041,0.00356734536269138,-0.0160962827974255,-0.0021122889756753,0.010716939715589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39283,-0.00713571277056068,0.00279806407755887,-0.0126199183625761,-0.0016515071785453,0.0107747035261461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,38741,-0.0166822936768446,0.0065417186781998,-0.0295040622861162,-0.00386052506757301,0.0107779203068961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36430,-0.0072619612569699,0.00284815691533685,-0.0128443488110301,-0.00167957370290968,0.0107931605537754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,39283,-0.00365609038749196,0.0014355862802376,-0.00646983949675766,-0.000842341278226253,0.0108825201076664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36420,-0.0208759494779869,0.00820224397565574,-0.0369523476702722,-0.00479955128570169,0.0109349023536625
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,36538,0.00766047608590177,0.00301091117185855,0.00175909018905902,0.0135618619827445,0.0109633869331935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,39218,-0.0158781820592815,0.00624249362457975,-0.0281134695634578,-0.00364289455510516,0.0109825113025247
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39099,0.0129219793610729,0.00508412637103186,0.00295709167385047,0.0228868670482954,0.011043440421516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,38994,0.0170813735563164,0.00672563486803716,0.00389912921496356,0.0302636178976692,0.0111033600618935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,36731,0.00995591267712825,0.00392034317042579,0.0022720400630937,0.0176397852911628,0.0111111381175966
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,36363,-0.0120499576226736,0.00474868624916403,-0.0213573826710351,-0.00274253257431207,0.0111756609988999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,38832,-0.0171424553574944,0.00675999052305231,-0.0303920367826769,-0.00389287393231182,0.0112269245026053
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,39023,-0.0203277672094021,0.00801644708733738,-0.0360400035005834,-0.00461553091822083,0.011230388823312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,36743,-0.0105573817719924,0.00416535619871886,-0.0187214799214813,-0.00239328362250341,0.0112703187052665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39023,0.0238996055041006,0.00944086292194648,0.00539551417708546,0.0424036968311157,0.0113673882750849
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,39255,0.00374507381493905,0.00147968949983463,0.000844882395263177,0.00664526523461493,0.0113841022670995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,36430,-0.00590979416788515,0.00234004371719977,-0.0104962798535967,-0.0013233084821736,0.0115653726684783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,36767,0.00791171169942868,0.00313650089095757,0.00176416995315185,0.0140592534457055,0.0116654977556935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,36779,-0.0032799525553907,0.00130258350979052,-0.00583301623458011,-0.000726888876201284,0.0118131026995712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,39291,0.0102444218748077,0.00407008616921701,0.00226705298314233,0.018221790766473,0.0118458091990863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,39093,0.00536516125521452,0.00213595432066703,0.00117869078670713,0.0095516317237219,0.012020835984348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36393,0.00897326795405113,0.00357711973572832,0.00196211327202362,0.0159844226360786,0.0121364165695943
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,36747,-0.0224524701346594,0.00896775930746553,-0.0400292783772919,-0.00487566189202697,0.0123029058340016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39023,-0.00762486103152519,0.00304987150811921,-0.0136026091874388,-0.00164711287561155,0.0124277127923562
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,38741,-0.0164857420483511,0.00659469344113358,-0.0294113411929729,-0.00356014290372926,0.0124352813423182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39147,0.00593098363635826,0.00237396395472151,0.00127801428510409,0.0105839529876124,0.0124878471495316
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,36141,-0.00524675401891284,0.00210233198199724,-0.00936732470362743,-0.00112618333419825,0.012584508003397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,36737,0.00567993484601845,0.00227841404757106,0.00121424331277918,0.0101456263792577,0.0126817164125945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,38706,-0.0193742057654979,0.00778014346969772,-0.0346232869661054,-0.00412512456489034,0.0127775454059417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,38727,0.0219510860809711,0.00881742350263977,0.00466893601579717,0.0392332361461451,0.0128026866956593
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36420,-0.0112082710686193,0.00451088910358714,-0.0200496137116501,-0.00236692842558852,0.0129784643757721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,38674,-0.00670459491367341,0.00269893838470743,-0.0119945141477,-0.00141467567964684,0.0129967079984715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,38106,-0.0106561250116046,0.00429215871855949,-0.0190687560999812,-0.00224349392322796,0.0130506590956209
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39023,-0.012753885350476,0.00513937270517667,-0.0228270558526223,-0.00268071484832972,0.0130900223702217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36500,0.00707405761249805,0.0028531327152597,0.00148191749058903,0.0126661977344071,0.0131732944426016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,36743,0.0185841861612388,0.00750285307841487,0.00387859412754562,0.0332897781949319,0.0132638102856932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,39291,0.0110126439634287,0.00445106854567207,0.00228854961391141,0.0197367383129459,0.0133657592260863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,38741,0.00899500160600362,0.00365266470656094,0.00183577878114419,0.0161542244308631,0.0138051461251696
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39057,-0.0241813525300995,0.00983069818538891,-0.0434495209734617,-0.0049131840867372,0.0139132817433399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39099,-0.0230010442197873,0.00935732549339758,-0.0413414021868466,-0.00466068625272809,0.0139792959658086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,39283,-0.019505176158992,0.00795764946596371,-0.0351021691122809,-0.00390818320570313,0.0142521535346816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39106,0.0058718157131812,0.00239926514507504,0.00116925602883411,0.0105743753975283,0.0144027342562594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",38727,-0.011107181176969,0.00454671646483083,-0.0200187454480374,-0.00219561690590059,0.014581263667124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,39283,0.0128844612564222,0.00527638984251178,0.00254273716509911,0.0232261853477453,0.0146210033882594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,39023,-0.00632019012682649,0.0025892286717189,-0.0113950783233955,-0.00124530193025745,0.0146598489716663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",36792,0.0166047978401299,0.0068026370898554,0.00327162914401336,0.0299379665362465,0.0146625950873227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,39162,-0.00911577134013882,0.00373641792651794,-0.016439150476114,-0.00179239220416366,0.014710385130947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,39140,-0.0190755489578164,0.00782221769983205,-0.0344070956494872,-0.0037440022661456,0.0147540803074735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,39140,0.0123537815207984,0.00508415218576025,0.00238884323670831,0.0223187198048885,0.015116067442057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39095,-0.0203625261367067,0.00838872202920413,-0.0368044213139468,-0.00392063095946657,0.0152202779668979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39099,0.0109972447563127,0.00453334555082045,0.00211188747670465,0.0198826020359208,0.0152838483040671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,38832,0.0253033273458577,0.0104409851316583,0.00483899648780736,0.0457676582039081,0.0153851487977758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,38951,-0.0165218826060921,0.006818788040756,-0.0298867071659739,-0.00315705804621033,0.0154048682198899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39057,-0.00615798774085796,0.00254556150906398,-0.0111472882986234,-0.00116868718309257,0.0155702931925242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,36421,0.0129552276036593,0.00535766777151995,0.00245419877148023,0.0234562564358385,0.015617112313013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36363,-0.0106455494751005,0.00440481611960822,-0.0192789890695327,-0.00201210988066843,0.0156719381974113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36430,0.00772478054527734,0.00320425896859188,0.00144443296683725,0.0140051281237174,0.0159324704300259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,36391,0.0172794516051683,0.00716984749796504,0.00322655050915685,0.0313323527011798,0.0159661087221276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,38841,0.00659043282224442,0.00274128519208157,0.00121751384576455,0.0119633517987243,0.0162226368502522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,36792,0.00947338853724806,0.00394262885150929,0.00174583598828984,0.0172009410862063,0.0162836319711237
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36420,0.00448726316858448,0.00186880897030361,0.000824397586789399,0.00815012875037955,0.0163587375256941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,39023,-0.00606110580810154,0.0025315127267422,-0.0110228707525162,-0.00109934086368684,0.0166658981951853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,36430,0.00968799872988336,0.00404792851883939,0.00175405883295816,0.0176219386268086,0.0167111315884334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36420,0.00741574887592582,0.00309935193017181,0.00134101909278907,0.0134904786590626,0.0167405474942386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,36767,0.00680046646721602,0.00284556758807833,0.00122315399458249,0.0123777789398496,0.0168697277288198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36421,0.0147190748039654,0.00615901429332324,0.00264740678905181,0.0267907428188789,0.0168702462591183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,36747,-0.0115507231846276,0.00483496557124833,-0.0210272557042744,-0.00207419066498091,0.0169086897760851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,39111,-0.0101076663627654,0.00423111498721397,-0.0184006517377047,-0.00181468098782598,0.0169114639625158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,38951,0.0130451503198684,0.00546140512542931,0.00234079627402694,0.0237495043657098,0.0169245985957845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,36607,0.00500318857731728,0.00209469694207127,0.000897582570857583,0.00910879458377697,0.0169316624372658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,38832,0.00870436704052028,0.00364573844846685,0.00155871968152526,0.0158500143995153,0.0169736230559145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,38841,0.0127602656454133,0.00534939211712037,0.00227545709585739,0.0232450741949692,0.0170744254159954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,36731,-0.0114122083260355,0.00478692485478254,-0.0207945810414093,-0.00202983561066175,0.0171382612486213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,38823,-0.0072149912080455,0.0030307129382842,-0.0131551885670825,-0.00127479384900847,0.0172957351757135
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,39241,-0.0140998021741364,0.00592460860831883,-0.0257120350464414,-0.00248756930183154,0.0173308314523451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,36339,-0.0100282565487115,0.00421499152402422,-0.018289639935799,-0.00176687316162406,0.017365778392464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,36796,0.0129764239107502,0.00545494163715238,0.0022847383019315,0.0236681095195688,0.0173817184708362
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,36779,-0.00399419480080475,0.00168199110564237,-0.00729089736786379,-0.000697492233745712,0.0175785703056616
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39099,0.0157609103419025,0.0066458487372743,0.00273504681684485,0.0287867738669601,0.0177263819479031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,38915,0.0124790468968291,0.00526520067668609,0.00215925357052434,0.0227988402231338,0.0177958511586755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36500,-0.0182793593222149,0.00771725016301116,-0.0334051696417168,-0.00315354900271306,0.017868747377302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,39106,-0.00555897009227803,0.00234706007226342,-0.0101592078339143,-0.000958732350641728,0.0178736343550752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,38727,-0.00832493711348879,0.00352727499795143,-0.0152383961094736,-0.00141147811750398,0.0182798446207711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,39291,0.012847578414305,0.00544441661632415,0.00217652184630969,0.0235186349823004,0.0182985803064749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,36796,-0.00461655451528867,0.00195724663019674,-0.00845275791047428,-0.000780351120103056,0.0183539393109751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,36791,-0.0098838516445095,0.00419490304795538,-0.018105861618502,-0.00166184167051696,0.0184799317724067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36391,-0.0102998132688098,0.00437474819307308,-0.0188743197272331,-0.00172530681038659,0.0185690502127462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39029,-0.0133632893150427,0.00568030537549932,-0.0244966878510214,-0.00222989077906403,0.0186571190997345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36391,-0.011399746273267,0.00485419288861602,-0.0209139643349544,-0.00188552821157961,0.0188680503617629
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,36792,-0.0130980548945783,0.00558156893275833,-0.0240379300027846,-0.00215817978637194,0.0189574442599822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39147,0.00728728862992282,0.00311334033433625,0.00118514157462377,0.0133894356852219,0.0192621857642433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,36430,-0.0102663329290936,0.00438648873372099,-0.0188638508471867,-0.00166881501100046,0.0192763612768988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39106,0.00730123923910612,0.00312003102329402,0.00118597843344984,0.0134165000447624,0.0192905021902416
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39099,-0.00963536894620423,0.00411982918581857,-0.0177102341504086,-0.00156050374199983,0.0193597425134966
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,39244,-0.0110541201512514,0.00472658836835988,-0.0203182333532368,-0.00179000694926604,0.0193631751802186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,36251,0.00911285059502454,0.00390600290435644,0.00145708490248593,0.0167686162875632,0.0196621043708445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,39023,0.019840702303709,0.00850719390133927,0.00316660225708399,0.0365148023503339,0.0197018038294015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39162,0.00794180617142006,0.00340534248047236,0.00126733490969424,0.0146162774331459,0.0197051377255528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,38741,0.0104768299420111,0.00449240224296996,0.00167172154579,0.0192819383382323,0.0197075446776575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,38841,0.00897291594174185,0.00385037449604553,0.00142618192949262,0.0165196499539911,0.0197981826143149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36391,0.00762733478146858,0.00327563291930433,0.00120709425963209,0.0140475753033051,0.0199010128690523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,36724,0.00842763296796785,0.00363507633741258,0.00130288334663919,0.0155523825892965,0.020442114164061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,36743,-0.0183326682375962,0.00791369673413053,-0.033843513836492,-0.00282182263870033,0.0205425281979677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,36466,0.00786850754226015,0.00339680432972189,0.00121077105600524,0.0145262440285151,0.0205499832086418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,38841,-0.012314577840591,0.00531831033931608,-0.0227384661056505,-0.00189068957553148,0.0205987119232101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39099,-0.0208219014035252,0.00900299526599227,-0.0384677721248701,-0.00317603068218038,0.0207482713508602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,36538,-0.0267091071415519,0.0115502617669676,-0.0493476202048084,-0.00407059407829537,0.0207702431984909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39106,-0.0166957121919619,0.00724429610587037,-0.0308945325594679,-0.00249689182445603,0.0211984300097638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,39241,-0.0237543515456009,0.0103116751842843,-0.0439652349067981,-0.00354346818440369,0.0212563241493834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36500,-0.0148927273761589,0.00647078614687365,-0.0275754682240313,-0.00220998652828658,0.0213777108869816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36430,-0.00414463157626071,0.00180442666795102,-0.00768130784544471,-0.0006079553070767,0.0216394445722807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36500,-0.0051616729270005,0.00224898798542677,-0.00956968937843698,-0.000753656475564026,0.0217431716932456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39274,0.010769759874677,0.00469487567786049,0.0015678035460704,0.0199717162032835,0.0218073709191447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39121,-0.00480210000977929,0.00209516530075217,-0.00890862399925355,-0.000695576020305031,0.0219197123581862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,38841,-0.0160938859177109,0.00702563452763577,-0.029864129591877,-0.0023236422435448,0.0219924109049393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,36792,-0.0182727342651491,0.0079830772330932,-0.0339195656420118,-0.00262590288828642,0.0220992517543492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",36743,-0.0302117186775894,0.013206549114155,-0.0560965549413332,-0.0043268824138457,0.0221751154373928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,36767,0.0123336655223932,0.00540153573275953,0.00174665548618455,0.0229206755586019,0.0224251854471905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36500,-0.00614119862888623,0.00268958583494269,-0.0114127868653739,-0.000869610392398564,0.022427749041973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39147,0.00834975629536659,0.00366014156368022,0.00117587883055337,0.0155236337601798,0.0225464041331877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,38987,0.014305643277294,0.0062716991344454,0.00201311297378105,0.026598173580807,0.0225632520429644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36420,0.0106755219781304,0.00468122089561955,0.00150032902271612,0.0198507149335448,0.0225947556540268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,38727,-0.0258731097994208,0.0113720592629615,-0.0481623459548253,-0.00358387364401618,0.0229112671816644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,36421,-0.00998759038021472,0.00439946502748531,-0.0186105418340859,-0.00136463892634351,0.0232133514887035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,36747,0.0112144849271506,0.00494477429931737,0.0015227273004885,0.0209062425538126,0.0233489292075182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,36512,0.00651859151893743,0.00287800072065642,0.000877710106450859,0.012159472931424,0.0235312265003187
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39106,-0.0168857402282094,0.00746922165898777,-0.0315254146798254,-0.00224606577659336,0.0237912909655074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36421,0.00985758906224937,0.00436353837481437,0.00130505384761321,0.0184101242768855,0.0238953811785434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,36731,-0.0115595719520096,0.00511706035746327,-0.0215890102526376,-0.00153013365138161,0.0238984317743425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36420,-0.0124829487099763,0.00553023623722376,-0.0233222117349349,-0.00164368568501775,0.02401156154454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,39086,0.00584721025230232,0.00259120365030408,0.000768451097706323,0.0109259694068983,0.0240496111412328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39207,-0.00462800605594622,0.00205145727769905,-0.00864886232023636,-0.000607149791656077,0.0240871382059822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,38841,-0.00718960700424803,0.00318724941740437,-0.0134366158623606,-0.000942598146135462,0.0241012620704253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,36743,-0.020922816761971,0.00927811551356257,-0.0391079231685536,-0.00273771035538832,0.0241455356996194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36391,-0.00842123873369899,0.00373860419317738,-0.0157489029523267,-0.00109357451507132,0.0243073698540463
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,36664,0.0061233681482739,0.00271953976820813,0.000793070202585958,0.0114536660939618,0.0243632215428399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,38713,0.00718832571724599,0.00319711368315576,0.000921982898260704,0.0134546685362313,0.0245665850196036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,39219,-0.00606714522174379,0.00269864423559374,-0.0113564879235075,-0.000777802519980057,0.0245763041370895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39023,0.0196737436418884,0.00875598048718347,0.00251202188700884,0.036835465396768,0.0246612466520701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39291,0.00691869118803424,0.00308000350742705,0.000881884313477215,0.0129554980625913,0.0246972348328484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36363,-0.018110417042079,0.00807210429565962,-0.0339317414615719,-0.00228909262258617,0.0248768286625428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,36792,-0.0182075911625104,0.00812292437493126,-0.0341285229373757,-0.00228665938764511,0.025010150070277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36391,0.0151873325760886,0.00678349467512514,0.00189168301284336,0.0284829821393339,0.025182146217014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,38987,-0.0162469888216157,0.00726844579931477,-0.0304931425882726,-0.00200083505495876,0.0254137123501827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,38502,-0.00935372741162334,0.00419293311476434,-0.0175718763165614,-0.00113557850668524,0.0257073764750034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,38727,0.0165325638040278,0.00742009049187181,0.00198918643995902,0.0310759411680965,0.025890003765552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,38727,0.0103948533835068,0.00466609197151036,0.00124931311934648,0.0195403936476671,0.0259125680731262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39044,0.0130444184304212,0.00586539353173074,0.00154824710822896,0.0245405897526135,0.0261655820381566
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36343,-0.0110682982284841,0.00498825933095263,-0.0208452865171513,-0.00129130993981695,0.0265134947204223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,36414,-0.0084679893680128,0.00381708281983346,-0.0159494716948864,-0.000986507041139228,0.0265423074314891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39093,0.00567519276593721,0.00256044865202027,0.000656713407977484,0.0106936721238969,0.0266731070674415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,36657,0.00541970334152823,0.00245561482064834,0.000606698293057488,0.010232708389999,0.0273271513290596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36500,0.00834235917666724,0.00378047164905845,0.000932634744512675,0.0157520836088218,0.0273530767412951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,36421,0.00987097070776516,0.00447566896769256,0.00109865953108775,0.0186432818844426,0.0274389088453786
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36500,-0.0223098707794865,0.0101173089449386,-0.0421397963115662,-0.00247994524740685,0.0274636800579053
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,38841,-0.00961669191635391,0.00436361356876976,-0.0181693745111426,-0.00106400932156517,0.0275509825033306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,38841,-0.0067537354026239,0.00306943615548585,-0.0127698302673762,-0.000737640537871639,0.0277995542972572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",38727,-0.0159792133731182,0.00726726351996534,-0.0302230498722503,-0.00173537687398615,0.0279079413404806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,36779,-0.00444528644420701,0.00202189627778278,-0.00840820314866127,-0.000482369739752758,0.0279259690536462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,36796,0.00503474460982957,0.00229011590832194,0.000546117429518558,0.00952337179014058,0.0279334773922257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,38727,0.00975052169990889,0.00443662437316097,0.00105473792851338,0.0184463054713044,0.0279834075489798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,38816,0.00818813673309658,0.00372817905544411,0.000880905784426133,0.015495367681767,0.0280869795544605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39162,-0.00517358333701315,0.00235614166225381,-0.00979162099503062,-0.000555545678995691,0.0281222061409896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,36391,-0.00818900318896791,0.00373251483999087,-0.01550473227535,-0.000873274102585798,0.0282562939733762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39162,-0.0208958484304581,0.00952862000550575,-0.0395719436412494,-0.00221975321966682,0.0283255166524378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39023,0.0117181224532074,0.00535235814278909,0.00122750049334077,0.022208744413074,0.0285874524664518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,39140,-0.010060935102438,0.0045996015372223,-0.0190761541153937,-0.00104571608948229,0.0287321377278473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39076,0.0124369122361161,0.00569426430970036,0.00127615418910338,0.0235976702831288,0.0289692163983304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,36631,-0.0124219826106621,0.00569270874868932,-0.0235796917580932,-0.00126427346323104,0.029121314647352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36321,0.0121263352138378,0.00556393447943604,0.00122102363414311,0.0230316467935324,0.0293166728638462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,39093,-0.00770829744170915,0.00354214162110623,-0.0146508950190774,-0.000765699864340949,0.0295579672917166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,36806,-0.00406962104768714,0.00187136954264987,-0.00773750535128089,-0.00040173674409339,0.0296725040003283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36391,-0.0071785849513543,0.00330166500310649,-0.013649848357443,-0.00070732154526558,0.0297063828381693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,39093,0.00873815230378315,0.00401971334750894,0.000859514142665625,0.0166167904649007,0.0297336473510978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",36792,0.00954640873121165,0.00439487045008352,0.000932462649047939,0.0181603548133754,0.0298608980443247
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,36796,0.00500185547306342,0.00230436995541276,0.000485290360454421,0.00951842058567242,0.029979877029975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,39147,-0.013638073735327,0.00629534577470675,-0.0259769514537522,-0.00129919601690176,0.0302980166071041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,36538,-0.0143616518648616,0.00663354659604475,-0.0273634031931093,-0.00135990053661391,0.030406009341399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,36791,0.00685896040054533,0.00317024123145346,0.000645287586896543,0.0130726332141941,0.0305175226534724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,38841,0.00833353117033826,0.00385577370305795,0.000776214712344685,0.0158908476283318,0.0306870136636277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39106,-0.00849395244820469,0.00393114744979928,-0.0161990014498113,-0.00078890344659809,0.0307355773470037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39033,0.00664469711565884,0.00307574216530582,0.000616242471659443,0.0126731517596582,0.0307607493197948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39023,0.0039241558683612,0.00181911649057526,0.00035868754683369,0.00748962418988872,0.0310075541482478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39099,-0.0101184925849865,0.00469350252737471,-0.0193177575386409,-0.00091922763133202,0.0311108967901332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,36767,-0.0131957084296481,0.00612399967493732,-0.0251987477925253,-0.00119266906677099,0.0311995864263117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,36731,-0.00936910897068047,0.00435017821868251,-0.0178954582792982,-0.000842759662062743,0.0312798686971904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36391,-0.00733068607099208,0.00341041312821359,-0.0140150958022907,-0.000646276339693454,0.0316138018644156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,36767,0.0041695007797648,0.00194125240122001,0.000364646073373583,0.00797435548615602,0.0317449769727813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,36363,0.00840829547045662,0.00391564550613955,0.000733630278423108,0.0160829606624901,0.0317839024184507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36420,0.00600765926986367,0.00279962002625722,0.000520404018399521,0.0114949145213278,0.0319013561248016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36430,0.0098948058131925,0.00461933182671085,0.000840915432839227,0.0189486961935458,0.0322092072266096
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,38743,0.00721783570897737,0.00337337976327797,0.000606011372952546,0.0138296600450022,0.0323996686991323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,36391,-0.00826014789839912,0.00386151946191615,-0.0158287260437548,-0.000691569753043463,0.0324474341635914
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36430,0.00643546025694005,0.0030131121901551,0.000529760364236062,0.012341160149644,0.032713489779594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,36767,-0.0146057381498105,0.00684479035862682,-0.0280215272527191,-0.00118994904690197,0.0328740696916438
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,38856,0.0141919271700239,0.00665570737447874,0.0011467407160456,0.0272371136240023,0.0329988568027164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,36731,0.00753802357430984,0.00354825674313443,0.00058344035776636,0.0144926067908533,0.033653198758311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",38741,-0.00518409162664439,0.00244063058364544,-0.00996772757058945,-0.000400455682699324,0.0336800013821485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38294,-0.00680471062672984,0.0032096518449411,-0.0130956282428144,-0.00051379301064529,0.0340165245916991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,36420,-0.0222229685251188,0.0104938298501383,-0.0427908750313899,-0.00165506201884775,0.0342185812096202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,38987,-0.00549692386915946,0.00259912893053071,-0.0105912165729996,-0.00040263116531928,0.0344539229198499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,36731,-0.00788320968205105,0.00373176926770549,-0.0151974774467538,-0.000568941917348296,0.0346663034718827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,39023,0.00616559050584028,0.00292192032262538,0.000438626673494535,0.011892554338186,0.0348647113044793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,39031,-0.0159677807844648,0.00756849678181213,-0.0308020344768165,-0.00113352709211301,0.0348945804024142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,36731,0.00712221125090937,0.00337655312108918,0.000504167133574585,0.0137402553682442,0.0349367339399223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,36731,0.00520571952642768,0.00247175995817605,0.000361070008402631,0.0100503690444527,0.0352168811076967
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39241,0.0122248431463159,0.00580619436107457,0.000844702198609755,0.0236049840940221,0.0352654603450589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,36261,0.013181023649253,0.00626476002572476,0.000902093998832466,0.0254599532996735,0.035398965211515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36394,-0.0161335051971879,0.00767185663999884,-0.0311703442115856,-0.00109666618279014,0.035490318603224
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,36538,-0.00620295664535864,0.00295107041544091,-0.0119870546596228,-0.000418858631094454,0.0355786921460742
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,36767,-0.00897860564734465,0.00427365857964014,-0.0173549764634393,-0.000602234831249982,0.0356675208037451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,36391,-0.00631436957095049,0.00300583653444993,-0.0122058091784723,-0.000422929963428621,0.0356869810137278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,36731,-0.0206112610733298,0.00982694057879439,-0.0398720646077668,-0.00135045753889275,0.0359755130739695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,39106,-0.0140371022027147,0.00669612032041703,-0.0271614980307321,-0.000912706374697311,0.0360716933176523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,36743,-0.00892640067467021,0.00425901086625605,-0.0172740619725321,-0.000578739376808348,0.0361117791559347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,39106,-0.00509671548302799,0.0024338104498549,-0.00986698396474359,-0.000326447001312384,0.0362648710110847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36391,-0.0116955934295353,0.00559219443003883,-0.0226562945124113,-0.000734892346659155,0.0365110570835395
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39099,-0.00687195089413192,0.00328714817118438,-0.0133147613096533,-0.000429140478610542,0.0365848590448924
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,38832,0.0108095780971584,0.00517326468414664,0.000669979316231004,0.0209491768780858,0.0366788521251572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36363,0.00815777655619131,0.00390647950890715,0.000501076718733305,0.0158144763936493,0.0367938388787193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39147,0.0155073592393102,0.00744355676813757,0.000917987973760576,0.0300967305048599,0.0372380445788383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,38960,0.00735735508932908,0.00353326117660622,0.000432163183180894,0.0142825469954773,0.0373306976048764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,36363,-0.010857298490707,0.0052168535691208,-0.0210823314861838,-0.000632265495230211,0.0374362044328276
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,36743,0.00551492445535157,0.00265463583472408,0.000311838219292376,0.0107180106914108,0.0377780269104536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36363,-0.0140333212938353,0.00676011346683447,-0.0272831436888309,-0.000783498898839767,0.0379235646787491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36500,-0.0194211488747668,0.00935875790512132,-0.0377643143688046,-0.00107798338072907,0.0379896218530788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36420,-0.0142547460857428,0.0068800545369944,-0.0277396529782518,-0.000769839193233748,0.0382956567321808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36391,-0.00675714550796619,0.00326425424482297,-0.0131550838278192,-0.000359207188113175,0.0384687894235552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,36420,0.00960234003230714,0.00463872503079418,0.000510438971950539,0.0186942410926637,0.0384691182420442
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36420,-0.00669291351368649,0.00323705408564286,-0.0130375395215465,-0.00034828750582649,0.0386986510750327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,36743,0.00903163444839653,0.00437927046596628,0.000448264335102614,0.0176150045616904,0.0391934290740644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,39106,0.00646308575589801,0.00313621298326101,0.000316108308706427,0.0126100632030896,0.0393397159269072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39283,-0.00567871432174891,0.00275576194791845,-0.0110800077396691,-0.000277420903828754,0.0393513213356123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,36430,0.0064162745821152,0.00311459872256527,0.000311661085887269,0.0125208880783431,0.039412903055834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,36430,-0.0108107688197736,0.00525030355859122,-0.0211013637946124,-0.000520173844934833,0.0395076078384785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36420,-0.0178812834139385,0.00869066191253836,-0.0349149807625137,-0.000847586065363289,0.039656024403524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,38741,-0.0113676005511153,0.00553110067077425,-0.0222085578658328,-0.000526643236397787,0.0398756663195537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36391,0.00656960454180116,0.00319860286079138,0.000300342934650047,0.0128388661489523,0.0400062507576488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39023,-0.0133715948797842,0.00651972973592318,-0.0261502651621936,-0.000592924597374743,0.0402896332259342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,38832,0.00892051309423183,0.00435014060341996,0.000394237511528695,0.017446788676935,0.0403207154666064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,38727,-0.0105397011975211,0.00514414930214523,-0.0206222338297258,-0.000457168565316458,0.0404921930609446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,39165,-0.0105300184212647,0.00514955669956237,-0.020623149552407,-0.000436887290122452,0.0408877243280124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,38923,0.0122432340888778,0.00598915058710132,0.000504498938159171,0.0239819692395964,0.0409476410068033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,38987,0.0118882900470073,0.00581561850725905,0.000489677772779583,0.0232869023212351,0.0409510252153132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,39241,-0.00403496008046575,0.00197463850833428,-0.00790525155680094,-0.000164668604130563,0.041030674284932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,36391,-0.010909191306807,0.00534371854117167,-0.0213828796475034,-0.000435502966110503,0.041222241836871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,36731,0.0208917093775024,0.0102526610285747,0.000796493761496046,0.0409869249935087,0.041601698299411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,39241,-0.0060636874962477,0.00297656680854403,-0.011897758440994,-0.000229616551501403,0.0416529573597698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36363,-0.0102581912501589,0.0050361180579596,-0.0201289826437597,-0.00038739985655805,0.0416786485039843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,36743,-0.0128507842217762,0.00631750060745182,-0.0252330854123818,-0.000468483031170624,0.0419562725030422
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,39106,0.00642300073636745,0.00316277246503606,0.000223966704896772,0.0126220347678381,0.0422912432973065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39093,0.00546914851678414,0.00269597779654349,0.000185032035558894,0.0107532649980094,0.0425130829868804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,39023,-0.0100330072329156,0.00495301962557442,-0.0197409256990415,-0.000325088766789737,0.0428197365094201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,38927,-0.0104098196810762,0.00514174161175541,-0.0204876332401168,-0.000332006122035641,0.0429290642345768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,36747,0.0113610840506122,0.00562193714325173,0.000342087249838774,0.0223800808513856,0.0433160740790387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,39099,-0.0123845086605991,0.00613109613929225,-0.0244014570936119,-0.0003675602275863,0.0434060214907146
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39255,0.0061183307504935,0.0030320413266205,0.000175529750317318,0.0120611317506697,0.0436198646064612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36430,-0.00566182812204977,0.00280950616850043,-0.0111684602123106,-0.000155196031788925,0.043900794265825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39099,0.0155633848249128,0.00773016680785255,0.000412257881521751,0.0307145117683038,0.0440973628134286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39147,-0.0151028238523759,0.00750421509124649,-0.029811085431219,-0.000394562273532753,0.0441764668415078
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",38999,-0.0188167489572474,0.00935650317194085,-0.0371554951742515,-0.000478002740243368,0.0443338812034978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,39283,-0.00348838323885921,0.00173772778333318,-0.00689432969419224,-8.24367835261862e-05,0.0447203082129417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,38922,-0.00571567200015073,0.0028549700069161,-0.0113114132137063,-0.000119930786595179,0.0453017992704897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36363,-0.0136442663171054,0.00683734816774773,-0.0270454687258909,-0.000243063908319819,0.046004646483639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,36743,-0.0251392260974053,0.0126146456876857,-0.0498639316452692,-0.000414520549541459,0.0462978101452945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39053,0.00953709935994201,0.0047871091414877,0.000154365442626127,0.0189198332772579,0.0463619308202474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39099,-0.0150513036606707,0.00755615743872366,-0.0298613722405691,-0.000241235080772333,0.0463970332614639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,36792,-0.0115330141835503,0.00579574730889442,-0.0228926789089833,-0.000173349458117214,0.0466218981891775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,38987,-0.0168108314975343,0.00847536462201119,-0.0334225461566762,-0.000199116838392327,0.0473303712281751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36421,-0.00938316446707147,0.00474262864499205,-0.0186787166112559,-8.76123228870547e-05,0.047897141140433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36430,0.00556080217814807,0.00281156287944789,5.01389344302059e-05,0.0110714654218659,0.0479693406684067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,36538,-0.0078208431358637,0.00395539247358897,-0.0155734123840981,-6.82738876293144e-05,0.0480337668540468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,38841,-0.0085617419792775,0.00433484677129535,-0.0170580416510164,-6.54423075386219e-05,0.0482754928301258
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,36397,0.0118278204713082,0.00598854634294538,9.02696391352469e-05,0.0235653713034811,0.048281685492371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,36747,-0.0149017821921019,0.00755898524348329,-0.0297173932693292,-8.61711148746665e-05,0.0486995200508841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,39165,0.00902164929467839,0.00458918665453686,2.68434517861505e-05,0.0180164551375706,0.049334072821878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39106,-0.0117503659750262,0.0059772913323389,-0.0234658569864105,-3.48749636420054e-05,0.0493358421774452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,36806,-0.0053262168939466,0.00270939693586642,-0.0106366348882448,-1.57988996484096e-05,0.0493394574645129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36420,0.00764341243911669,0.00389873607284788,1.8897363348435e-06,0.0152849351418985,0.0499612349314248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,36538,0.0133448498629637,0.00680879157748873,-3.81628914199184e-07,0.0266900813548416,0.0500242149115896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,36363,-0.0083201652182989,0.00424854710105251,-0.0166473175363618,6.98709976401472e-06,0.0502105243926911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,36500,0.00809225873313747,0.00413438421120348,-1.11343208213602e-05,0.0161956517870963,0.0503333728495498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,38575,0.00606153392931988,0.00309931910313349,-1.31315128217638e-05,0.0121361993714615,0.0505119632514461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,36363,-0.0195242961619678,0.0100069851414636,-0.0391379870392366,8.93947153009431e-05,0.0510714079912134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36339,0.00984892284227609,0.00506408805379191,-7.66897431560571e-05,0.0197745354277082,0.0518147264340521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,39099,-0.00746279570678861,0.00383941927694193,-0.0149880574895948,6.24660760175626e-05,0.0519463620977295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36391,-0.0110140505368617,0.00567102857225383,-0.0221292665384792,0.00010116546475583,0.0521399900904953
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,36747,0.0048781598075547,0.00251266260818909,-4.66589044959241e-05,0.00980297851960532,0.0522278517482092
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",38832,0.0145673462035509,0.00750815544195123,-0.000148638462673475,0.0292833308697753,0.0523737677271389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,39241,-0.00512085303964576,0.00263953296935163,-0.010294337659575,5.26315802834394e-05,0.0523906204677059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,36767,-0.0146965844517727,0.00757753241575428,-0.0295485479866511,0.000155379083105719,0.0524628825017492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39023,0.0145889662583251,0.00752424165908244,-0.000158547393476507,0.0293364799101267,0.052528580239473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,36420,0.0155745669613904,0.00803429030221386,-0.000172642030948777,0.0313217759537296,0.0525831821738366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39093,-0.00651275705955359,0.00336211023779458,-0.013102493125631,7.69790065237976e-05,0.0527511015623433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39147,0.00848247096128472,0.00438459245970089,-0.000111330259729023,0.0170762721822985,0.0530567523621342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,36767,0.00642454132243989,0.0033237159662993,-8.99419715067306e-05,0.0129390246163865,0.053265519258215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,36618,-0.018554978780923,0.00961194651165796,-0.0373943939437726,0.000284436381926632,0.0535784362048672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,39017,0.00503402086918949,0.00260870889876533,-7.90485723905499e-05,0.0101470903107695,0.0536628832564421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,38987,0.0104016363957975,0.00539527972543017,-0.000173111866045605,0.0209763846576407,0.0538844961864606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,36743,-0.0112375900200136,0.00583097321004962,-0.0226662975117108,0.000191117471683702,0.0539737148890275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",36791,-0.0106855415449747,0.00554801611242552,-0.0215596531253287,0.000188570035379329,0.0541248638155409
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,39283,-0.00494952228088205,0.00257703626218068,-0.0100005133547562,0.00010146879299207,0.0547973193310479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36339,0.0110557330169217,0.0057687151624305,-0.000250948701442112,0.0223624147352854,0.05532451052186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,36430,-0.00703391169624352,0.00367034460486217,-0.0142277871217734,0.000159963729286321,0.0553346592370499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39211,0.0101799268938754,0.00531596052125936,-0.000239355727792961,0.0205992095155437,0.0555143658332045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,38727,-0.0145850401811255,0.00761633528704616,-0.029513057343736,0.000342976981484958,0.055515721888961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,38869,-0.0118710578207056,0.00620577039517384,-0.0240343677952463,0.000292252153835108,0.0557790466873185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,38727,0.011112934275266,0.00581408958332593,-0.000282681308052793,0.0225085498585849,0.0559749780225806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,39099,-0.00987600000973246,0.0051794538682975,-0.0200277295915956,0.000275729572130644,0.0565698461082246
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36363,-0.0128199969662247,0.00673514334911909,-0.0260208779304981,0.000380883998048738,0.0570050178259242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,36731,0.00576514886578424,0.00303956938855812,-0.000192407135789676,0.0117227048673582,0.0578900149926257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39283,-0.00384004228896767,0.00202691541262449,-0.00781279649771168,0.000132711919776334,0.0581740234461067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,36806,-0.00438326405390301,0.00231559359090022,-0.00892182749206744,0.000155299384261421,0.0583890326354631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,39123,-0.00500912091481018,0.00264843757135629,-0.0102000585546685,0.000181816725048153,0.0585966296097227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39088,-0.013295008249154,0.00703205437047731,-0.0270778348152895,0.000487818316981562,0.0586928092670637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,39069,-0.0152923812401787,0.00809366148233562,-0.0311559577455566,0.000571195265199068,0.0588536603777211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36430,0.00732662743800315,0.00388238225433361,-0.000282841780490727,0.014936096656497,0.05916352828798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,36538,-0.0142070206020187,0.00752935115457096,-0.0289645488649778,0.000550507660940409,0.0591986076252125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,36339,-0.00698571972190036,0.00370762048722352,-0.0142526558768585,0.000281216433057745,0.0595676737636736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,38727,-0.0231686082371353,0.0123170371336974,-0.0473100010191821,0.000972784544911589,0.0599885586280539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39241,0.0112372616170052,0.00597977484594484,-0.000483097081046652,0.0229576203150571,0.0602345126675139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,36747,-0.00507387295118109,0.0027001053802684,-0.0103660794965072,0.000218333594144965,0.0602480837329942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,36731,0.0182582305982724,0.00971753958213697,-0.000788146982716086,0.0373046081792609,0.0602814947270752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,38727,0.00871784085444817,0.00464366399721136,-0.000383740580086094,0.0178194222889824,0.0604879850203505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36430,0.00613693033500584,0.00327120611560633,-0.000274633651582553,0.0125484943215942,0.0606722360248048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,36363,0.00823762500181036,0.00439139419699868,-0.000369507624307061,0.0168447576279278,0.0606982786438378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,36743,0.00677616954668482,0.00361421269623292,-0.000307687337931704,0.0138600264313013,0.0608335737740172
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,36677,-0.01211229247845,0.00646135693994844,-0.0247765520807489,0.000551967123848959,0.0608740619045827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",36792,0.00504947173037221,0.00269408092212657,-0.000230926876995866,0.0103298703377403,0.0609138710006409
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,36538,-0.0104769447478195,0.00559250919288979,-0.0214382627658835,0.000484373270244491,0.061037687309835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,39229,-0.00323919000807339,0.00172962039074487,-0.00662924597393334,0.000150865957786556,0.0611184161198433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,36747,-0.00773011520324299,0.00413959326528707,-0.0158437180032056,0.000383487596719674,0.06187387014096
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36391,0.0162554158878418,0.00870584753734442,-0.000808045285353266,0.0333188770610369,0.0618992814083604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,36767,-0.00751399230072334,0.0040304219957376,-0.015413619412369,0.000385634810922356,0.0622996035862981
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36401,-0.00609986356972328,0.00327457615865384,-0.0125180328406848,0.000318305701238249,0.0625144992179164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,38832,-0.00951397869867463,0.00510823512189348,-0.0195261195375859,0.000498162140236595,0.0625552287903846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,39093,0.00561050374744719,0.00301499115480146,-0.000298878915963666,0.011519886410858,0.062781922676359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36421,-0.00608651630887579,0.00327444448798548,-0.0125044275053273,0.000331394887575743,0.0630797777852911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39106,0.00732443867035348,0.00394982666431274,-0.000417221591699501,0.0150660989324065,0.0637055909568514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,36792,-0.00459074600195552,0.00247614342922629,-0.00944398712323904,0.000262495119328001,0.0637632953373723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39046,-0.00445827364334545,0.00240502338527485,-0.00917211947848415,0.000255572191793262,0.0637966021919642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39099,0.0163045715499956,0.00879724985197516,-0.00093803815987566,0.033547181259867,0.0638484537964666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39197,-0.00570372894692343,0.00308279261190772,-0.0117460024662626,0.000338544572415697,0.064306470406806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36430,0.00934085089068834,0.00505254822713081,-0.000562143634488046,0.0192438454158647,0.0645187496981872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36391,0.0143340705626725,0.00776898590735169,-0.000893141815736806,0.0295612829410818,0.0650556606247695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,36747,-0.0119936705307829,0.00651182546617841,-0.0247568484444926,0.000769507382926759,0.06552309569573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,36538,-0.011878029953606,0.00644951560651008,-0.0245190805423657,0.000763020635153778,0.0655433623525273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36391,0.007676919137735,0.00416952398284149,-0.000495347868634331,0.0158491861441043,0.0656161741383171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36421,0.0110675375379312,0.00601153944266098,-0.000715079769684279,0.0228501548455468,0.0656379743701374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,36731,-0.00922653197838351,0.00501338694387576,-0.01905277038838,0.000599706431612978,0.0657356240330599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,38741,-0.011007170893197,0.00598454008665881,-0.0227368694630482,0.000722527676654313,0.0658957408936975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",36750,0.00664906610731223,0.00361938935634931,-0.000444937031132418,0.0137430692457569,0.0662227947756935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,39085,-0.00836880314989151,0.00455688182208894,-0.0173002915211858,0.00056268522140281,0.0663003184936759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,39093,-0.00862334104063987,0.00469610179693574,-0.0178277005626339,0.000581018481354183,0.0663362602525387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,36391,-0.00696319147200974,0.00379718827236962,-0.0144056804858542,0.000479297541834714,0.0667110031689529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,36743,0.00586710229499565,0.00320263086232807,-0.000410054195167367,0.0121442587851587,0.0669799579327497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,36500,0.00906087120148658,0.00494801621249088,-0.000637240574995552,0.0187589829779687,0.0670922945461885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,36391,-0.00809128770389154,0.00442227977675419,-0.0167589560663298,0.000576380658546679,0.0673238890879347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,38727,0.00969545960230093,0.00530232760529707,-0.000697102504081323,0.0200880217086832,0.0674902276573514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,36500,-0.00715491703419471,0.003916292401712,-0.0148308501415502,0.000521016073160813,0.0677290662236374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",36731,-0.00597926563818783,0.00327338950594951,-0.0123951090698489,0.000436577793473206,0.0677788372729249
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39023,-0.0146958891458938,0.00806279939656018,-0.0304989759631517,0.00110719767136419,0.0683718193290568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39241,-0.0156999265926302,0.00861419725982828,-0.0325837532218936,0.00118390003663322,0.0683888444517602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39283,-0.00492092244537421,0.00270088644494354,-0.0102146598774635,0.000372814986715124,0.0684795492375782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39283,0.0065405065378048,0.00359026364807659,-0.000496410212425322,0.0135774232880349,0.0685146664068336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,36767,-0.0171874299331016,0.00943646613721608,-0.0356829035620451,0.0013080436958419,0.0685716189085554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,36391,0.00842886990183036,0.00462985288449983,-0.000645641751789319,0.01750338155545,0.0686994174270472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36224,0.00521097417918311,0.00286486368871621,-0.000404158650700657,0.0108261070090669,0.0689469457978895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,38727,0.0164989781090446,0.00907348640281329,-0.00128505524046943,0.0342830114585587,0.0690273321306787
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,36363,-0.0147755450870222,0.00812837800245495,-0.0307071659718339,0.00115607579778953,0.0691227751406653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,39291,0.00566494883153063,0.00311957882281625,-0.00044942566118923,0.0117793233242505,0.0693999152189839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,38500,-0.00502076544785266,0.00276489640010057,-0.0104399623920498,0.000398431496344452,0.0694067100926887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36500,-0.00985953769484972,0.00543201085005897,-0.0205062789609653,0.000787203571265851,0.0695352081777589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36339,-0.00589722768797898,0.00324904140870833,-0.0122653488490473,0.000470893473089343,0.0695376161308465
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,36538,-0.00672115532553016,0.00370444925363752,-0.0139818758626597,0.000539565211599384,0.0696479896269824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,36731,-0.00838552361324048,0.00462180078356514,-0.0174442531490281,0.000673205922547186,0.0696484824770047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39099,-0.016462963291427,0.00907667461563674,-0.034253245538075,0.00132731895522099,0.0697334277506837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,36391,-0.0178020436793867,0.00982032767218878,-0.0370498859168767,0.00144579855810336,0.0698904624953692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,36430,-0.0043528883695529,0.00240273523425507,-0.00906224942869283,0.000356472689587039,0.0700658814135186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,38841,-0.00850687882748883,0.0046958257496618,-0.017710697296826,0.000696939641848297,0.0700706462245169
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,38741,-0.00722711077033535,0.00399444997911841,-0.0150562327294074,0.000602011188736726,0.0704264285455832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,36747,-0.0150073600933168,0.00831146184520583,-0.0312978253099203,0.0012831051232866,0.0710006970517328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",36538,-0.0113570612475455,0.00629427193625692,-0.0236938342426091,0.000979711747518017,0.0712003857063778
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36500,0.011214361202097,0.00621784746852369,-0.000972619836209453,0.0234013422404034,0.0713215839183764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,39241,-0.00559338883787265,0.00310189908109259,-0.0116731110368141,0.000486333361068837,0.0713741250934189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36363,-0.0117078798658905,0.0064945797166722,-0.024437256110568,0.00102149637878705,0.0714569686195179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39229,-0.00915770045329978,0.00508195585576162,-0.0191183339305926,0.000802933023992987,0.0715644974150428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36500,-0.01338185029962,0.00743013840573203,-0.0279449215748548,0.00118122097561477,0.0717230774105873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,36731,0.00705997374638474,0.00393026269704958,-0.000643341139832432,0.0147632886326019,0.0724685255802932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39099,-0.00527037974449817,0.0029349137778072,-0.0110228107490003,0.000482051260003943,0.0725536374566353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,36743,-0.0123308857772731,0.00688051156712412,-0.0258166884488364,0.00115491689429016,0.0731329345182913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36391,-0.00788742089363181,0.00440503976834892,-0.0165212988395957,0.00074645705233208,0.0733905084615995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,38741,-0.0113843000586316,0.00636027961393452,-0.0238504481019433,0.00108184798468005,0.0734894144445113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,36791,0.0125647233040739,0.00702102378108809,-0.0011964833068588,0.0263259299150065,0.0735439423223764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,36747,-0.00439234200289546,0.00245520180365613,-0.00920453753806149,0.000419853532270558,0.0736392134401268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39106,0.0062495251183186,0.00349770988780176,-0.000605986261772854,0.0131050364984101,0.0739981368347381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,36718,-0.00576710001824423,0.00322800699815363,-0.0120939937346253,0.000559793698136878,0.0740285843420844
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,36421,-0.0097138852297687,0.00544427242991759,-0.0203846591924072,0.000956888732869775,0.0744089071447675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36363,0.0136642125004158,0.00765836118076145,-0.00134617541387665,0.0286746004147082,0.0744119260494348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39052,-0.00938009839902134,0.00526193752343902,-0.0196934959449618,0.000933299146919137,0.0746661845203507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36421,0.00472264273478282,0.00264961291870772,-0.000470598585884318,0.00991588405544995,0.0747098532181423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,36731,0.00710708217927357,0.00399815677172638,-0.000729305093310138,0.0149434694518573,0.0754948778609933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,36767,-0.012060756111496,0.00679040704299368,-0.0253699539157637,0.00124844169277158,0.0757323649738311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,36767,0.010648522362806,0.00599625278833966,-0.00110413310233968,0.0224011778279518,0.0757790861612974
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39023,-0.00900813973721629,0.00507466645123668,-0.0189544859816402,0.00093820650720761,0.0758982018436062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,38727,-0.00770720098669915,0.0043437137540504,-0.0162208799446379,0.000806477971239629,0.0760283050446689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39093,0.00826771374086788,0.00466002418357677,-0.000865933658942594,0.0174013611406784,0.0760536342798672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,36538,-0.00534291873529725,0.00301482367776277,-0.0112519731437123,0.000566135673117777,0.0763827215823951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36430,-0.00338011269240826,0.00190898422951061,-0.00712172178224906,0.000361496397432548,0.0766457885444451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,36538,-0.0117070792496118,0.00662025792619937,-0.0246827847849626,0.00126862628573894,0.0770227655651907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36421,-0.00771128953814676,0.00436481115505024,-0.0162663194020452,0.000843740325751715,0.0773036224293164
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,36430,-0.00853338438748074,0.00483188923162988,-0.0180038872814753,0.000937118506513833,0.0774108136719683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,39273,0.00512080448280867,0.00290095594705178,-0.000565069173412808,0.0108066781390302,0.0775478120005553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36363,-0.00894022722191245,0.00506599100157599,-0.0188695695850014,0.000989115141176486,0.0776295513364639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36363,-0.00970466934656971,0.00550761855022205,-0.0204996017050049,0.0010902630118655,0.0780862008165657
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,39001,-0.00831825159127044,0.00472251776935103,-0.0175743864191985,0.000937883236657593,0.0781905905735791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39093,-0.00592479211987883,0.00337183247928413,-0.0125335837792757,0.000683999539518065,0.0789135106214714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,36450,0.00686585258604465,0.00391373389961018,-0.000805065857191303,0.0145367710292806,0.079403914380095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,36538,-0.0113900406129743,0.00649913541000765,-0.0241283460165893,0.00134826479064069,0.0797039574091682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,36731,-0.0153077836769265,0.0087361979484192,-0.0324307316558282,0.00181516430197511,0.0797589527436445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,38727,-0.00770295942132356,0.0044050571390603,-0.0163368714138818,0.000930952571234641,0.0803699665812441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,38997,0.00942568540278677,0.00539476076250687,-0.0011480456917267,0.0199994164973002,0.0806242356035297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,39025,-0.00645538961341107,0.00369803849141051,-0.0137035450565757,0.000792765829753538,0.0808963313424594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,39241,-0.00398345584155077,0.00228285958494303,-0.00845786062803911,0.00049094894493758,0.0810150683583552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,38741,-0.00581998460072043,0.00334679160520227,-0.0123796961469169,0.000739726945476011,0.0820599626014697
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,38832,-0.00514873288319072,0.00296198497468074,-0.010954223433565,0.000656757667183525,0.0821836142187223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,36731,0.0119647114114118,0.00688826797992564,-0.00153629382924249,0.025465716652066,0.082416477347519
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39255,-0.00926707357684763,0.00534065177232933,-0.0197347510506131,0.00120060389691785,0.0827262395016514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36339,-0.0103072710116043,0.00594176741944536,-0.0219531351537172,0.00133859313050862,0.0828160507030121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,38727,0.00527169086412923,0.00303947942406192,-0.000685688807032133,0.0112290705352906,0.0828668266801196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,38832,0.00813934446326781,0.00470068698110506,-0.00107400201969812,0.0173526909462337,0.0833792450808812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36445,-0.00524187255798466,0.00303068759012989,-0.0111820202346392,0.000698275118669931,0.0837265626671645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,36339,-0.0123414221608988,0.00713713817377812,-0.0263302129815039,0.00164736865970627,0.0838009742438716
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36339,0.00789093546920354,0.00456860059029962,-0.00106352168778372,0.0168453926261908,0.084154588253854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,36767,-0.00813276822014173,0.00470908388178808,-0.0173625726284464,0.0010970361881629,0.0841847103841286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36430,-0.0136779061871535,0.00793575337434698,-0.0292319828008736,0.00187617042656655,0.0848082729489206
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36345,0.015171369205867,0.00880310515309045,-0.00208271689419026,0.0324254553059243,0.0848389662561711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36421,-0.0160572557360082,0.00931755489843692,-0.0343196633369445,0.0022051518649282,0.0848528183450269
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,38727,-0.0047071317757212,0.0027326260574005,-0.0100630788482262,0.000648815296783776,0.0849876333223282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,36743,-0.00827481642328029,0.00480751228682627,-0.0176975405054598,0.00114790765889921,0.0852337814058444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,38727,-0.00867251288039219,0.00504453388955308,-0.0185597993039162,0.00121477354313185,0.0856005728478123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,36430,-0.00973808746075793,0.00567532536355278,-0.0208617251733214,0.00138555025180553,0.0862115466207997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,39093,-0.00395965193019583,0.00230851451187101,-0.00848434037346302,0.000565036513071357,0.0863219281566236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,36420,0.00448843991890112,0.00261677075701112,-0.000640430764840672,0.0096173106026429,0.0863223938329538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,39106,-0.0104287885497799,0.00608286642513918,-0.0223512067430527,0.00149362964349288,0.0864658867844852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,38713,0.00944494101936557,0.00552759920054933,-0.00138915341371111,0.0202790354524423,0.0875296973949794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39099,-0.0172929871617816,0.0101254237517456,-0.037138817715203,0.00255284339163979,0.0876793731981567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36421,-0.0102966407369693,0.00604135769054715,-0.0221377018104417,0.00154442033650311,0.0883388195628149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,39029,0.0114405522587894,0.00671538477217945,-0.00172160189468228,0.0246027064122611,0.0884701228475809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,36420,-0.00647423079040178,0.0038069024213986,-0.013935759536343,0.000987297955539482,0.0890323892683731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,36339,-0.0109482138061803,0.00644916505152621,-0.0235885773071717,0.00169214969481102,0.0896049595659177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36339,-0.00456357886484471,0.00268826795615549,-0.00983258405890948,0.000705426329220048,0.0896099602346049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39064,-0.0103370808969579,0.00609312880560021,-0.0222796133559343,0.00160545156201854,0.089808971268992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36339,-0.0126993016101584,0.00750261147439507,-0.0274044200999727,0.00200581687965595,0.0905469100352448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,36761,-0.00934466984797169,0.00552316076455122,-0.0201700649464921,0.0014807252505487,0.0906880125494755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,39106,-0.0186060215558102,0.0109974341692977,-0.0401609925276338,0.00294894941601335,0.0906947950972665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36500,-0.0130941312147783,0.00774461578116017,-0.0282735781458523,0.00208531571629559,0.0909111374612084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36430,-0.00832326123756317,0.00492335871318436,-0.0179730443154045,0.00132652184027817,0.0909445783943579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36420,-0.00391545516752143,0.00231901289036448,-0.0084607204326358,0.000629810097592948,0.0913564988023895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36391,-0.00568267758696297,0.00336653796779739,-0.0122810920038458,0.000915736829919906,0.0914383087084208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36421,-0.00476993895196308,0.00282615490900543,-0.0103092025736137,0.00076932466968757,0.0914775318274162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,36767,-0.00585145028760951,0.00347177869049675,-0.0126561365209831,0.000953235945764126,0.0919292388191277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,38727,0.00910283870509596,0.00540281363933433,-0.00148667602799933,0.0196923534381913,0.0920417850157057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36391,-0.00555233784162272,0.0032960305518164,-0.0120125577231829,0.000907882039937418,0.0920997668323133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,38832,0.0093139924576781,0.00553229449578753,-0.00152930475406545,0.0201572896694217,0.0922860876393049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39283,0.00404433523452664,0.00240324640895827,-0.000666027727031573,0.00875469819608486,0.0924217938589084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36311,-0.0119170923476356,0.0070861826222664,-0.0258060102872778,0.0019718255920065,0.0926450139913699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",36755,0.00341259631823957,0.00202954021283226,-0.000565302498911665,0.0073904951353908,0.0926972766541574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,36430,-0.00642339214889393,0.00382036656752493,-0.0139113106212428,0.00106452632345494,0.0927188371954903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,36363,-0.0070685993435545,0.00420541399466303,-0.015311210773094,0.00117401208598502,0.0928203014796659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,36806,-0.00994188142209423,0.00591578996598939,-0.0215368297554334,0.00165306691124497,0.0928711739367692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39023,0.00587129767834904,0.00349427219599071,-0.000977475825792745,0.0127200711824908,0.0929266775376848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,39283,0.00400207956099239,0.00238252762417454,-0.000667674582389709,0.00867183370437449,0.093023868988393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,36791,-0.0127354734784035,0.00758638757313604,-0.0276047931217502,0.00213384616494312,0.0932294275421057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36391,-0.00780872888119604,0.0046536023991575,-0.0169297895835447,0.00131233182115266,0.093372704586373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39062,-0.00428052535830601,0.00255182532691808,-0.00928210299906545,0.000721052282453438,0.0934776829270162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,38987,-0.0145543347505099,0.0086771948275105,-0.0315616366124305,0.00245296711141067,0.0935027838534314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,38960,0.00495134724290261,0.00295617472552626,-0.000842755219128869,0.0107454497049341,0.0939712285596662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36421,0.0083682693763224,0.0049964256224108,-0.00142472484360276,0.0181612635962476,0.0939883260072505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36430,-0.00629958912967399,0.00376159108468221,-0.0136723076556511,0.00107312939630314,0.094015241257848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36391,-0.00463866778956478,0.00277375072452962,-0.0100752192096428,0.000797883630513278,0.0944813014505552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36430,-0.00610374000292247,0.00365295298695456,-0.0132635278573534,0.00105604785150846,0.0947651976079845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,36747,0.00558095979573979,0.00334442566967079,-0.000974114516814952,0.0121360341082945,0.0951942233720606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39147,-0.0148345878581546,0.00889387073837623,-0.032266574505372,0.00259739878906283,0.0953448801826075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,36796,0.00933185218548595,0.00559707656809139,-0.00163841788797316,0.0203021222589451,0.0954844263107395
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,38741,0.00487341268640236,0.00292304917474051,-0.000855763696089036,0.0106025890688937,0.0954885382015247
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,39099,-0.00725972644570307,0.00435636538301097,-0.0157982025964046,0.00127874970499842,0.0956415672721754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39113,-0.00850633111709161,0.0051060812004387,-0.0185142502699515,0.00150158803576824,0.0957495591317497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,36430,-0.0062733233162634,0.00376602012239632,-0.0136547227561602,0.0011080761236334,0.0957841527150831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36377,0.00596929359159625,0.00359010955602737,-0.00106732113821739,0.0130059083214099,0.0963965112422759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,38841,0.00734395141835441,0.0044239467506145,-0.00132698421285001,0.0160148870495588,0.0969262957653361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39291,-0.0067959373293085,0.00409415111189037,-0.0148204735086136,0.00122859884999661,0.0969521435866397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",36731,0.00751802704541076,0.00453179671825532,-0.00136429452236967,0.0164003486131912,0.0971501046633262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,39291,-0.005033327872302,0.00303475135440168,-0.0109814405269293,0.000914784782325298,0.0972241028883571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,36421,-0.00536125046608814,0.00323318492952904,-0.0116982929279651,0.000975791995788768,0.0973031214401438
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36430,-0.0141377700241761,0.0085266706703665,-0.0308500445380944,0.00257450448974225,0.0973293982173689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",36731,-0.00652715906977623,0.00393740910902875,-0.0142444809234726,0.00119016278392012,0.0973964548376971
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36391,-0.0105975659882117,0.00639794725057716,-0.023137542599343,0.0019424106229195,0.097665682745401
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39106,-0.00725296365725153,0.00437942741334547,-0.0158366413874086,0.00133071407290558,0.0977131830885355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36363,-0.0042690881803638,0.00258101055298765,-0.0093278688642196,0.000789692503492002,0.098145000948298
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",36538,0.00682817270055859,0.00413531964053071,-0.0012770537948816,0.0149333991959988,0.0987258222083217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,39283,-0.00472471841323013,0.00286524663973986,-0.0103406018271203,0.00089116500065999,0.0991732418999921
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,39241,-0.00903542215180476,0.00548376433752102,-0.019783600253346,0.00171275594973644,0.099441276613613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36500,0.0115168869994072,0.00698997416622424,-0.00218346236639231,0.0252172363652067,0.0994535975263222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,38642,0.00284859963928755,0.00173002777621028,-0.0005422548020846,0.0062394540806597,0.0996691684606222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36430,0.00667145777850736,0.00405430104844907,-0.00127497227645282,0.0146178878334675,0.099886387916373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,38727,-0.0108975058410657,0.00663798139785301,-0.0239079493808576,0.00211293769872623,0.100675473700888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39165,-0.00442357637207939,0.00269610437569564,-0.00970794094844285,0.000860788204284073,0.100874251238806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36363,-0.0113661756757798,0.00693191490424527,-0.0249527288881005,0.00222037753654097,0.101095272965031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39099,-0.00684821975262725,0.0041781241492847,-0.0150373430852253,0.00134090357997076,0.101220231502962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,38727,-0.00679000778211597,0.00415065381227823,-0.0149252892541813,0.00134527368994936,0.101884045880324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39165,-0.00433494454321696,0.00265160058710528,-0.00953208169394331,0.000862192607509389,0.102103012890297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,38741,0.00565534944118089,0.00346186752734542,-0.00112991091241614,0.0124406097947779,0.10236143406031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,38727,0.0122165059807907,0.00748257215759004,-0.0024493354480858,0.0268823474096671,0.102561428353648
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36500,0.00357581657807473,0.00219248514027765,-0.000721454296869472,0.00787308745301893,0.102927426154528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39241,0.00675065808762562,0.00414130959511096,-0.00136630871879186,0.0148676248940431,0.103105467294
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39162,0.00623337498174846,0.00382957629816995,-0.00127259456266465,0.0137393445261616,0.103610561300511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,36767,-0.016833824423703,0.0103503484252371,-0.0371205073371678,0.0034528584897618,0.103888638410144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,36726,0.0119240024758878,0.0073329909847841,-0.00244865985428901,0.0262966648060647,0.103957926619687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,38727,-0.0108801711641554,0.00669310945685259,-0.0239986656995865,0.00223832337127571,0.104060664367903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,35842,0.00754852678746851,0.00464710815661309,-0.00155980519949315,0.0166568587744302,0.104327588303861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,39114,-0.0155663508726013,0.00958378683946509,-0.0343505730779529,0.00321787133275025,0.10434568262958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,36747,0.00602406410500032,0.00371415084345703,-0.00125567154817547,0.0133037997581761,0.104844447113784
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36391,0.00892293694905574,0.0055034019330992,-0.0018637308398187,0.0197096047379302,0.104967903651928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,39274,0.00282202323160851,0.00174084482267496,-0.000590032620834415,0.00623407908405144,0.105024077097034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,36339,-0.0134017126468744,0.00826852360087818,-0.0296080189045956,0.00280459361084685,0.105083479415688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36391,0.00606173960889048,0.00374243339393132,-0.0012734298432149,0.0133969090609959,0.105314994939174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39147,-0.00368516280431736,0.00227573054887658,-0.00814559468011545,0.000775269071480736,0.105396523972289
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36420,0.00475945673102852,0.00293942618496389,-0.0010018185915007,0.0105207320535577,0.105433892713141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,38832,-0.00461911338374757,0.00285377444302658,-0.0102125112920797,0.00097428452458453,0.105554866062478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,36430,-0.00758281063769283,0.0046865393174341,-0.0167684276998637,0.001602806424478,0.105688146678405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39255,0.00557012367653531,0.00345602155667978,-0.00120367857455706,0.0123439259276277,0.107044351836447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,36420,0.00577439594521069,0.00358359980459901,-0.00124945967180337,0.0127982515622247,0.1071308710524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,39099,-0.00853634380451326,0.00530024489223389,-0.0189248237932917,0.00185213618426516,0.107297135019909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,36791,0.0037215930574932,0.00231108415848743,-0.000808131893142171,0.00825131800812857,0.107351666790384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,36500,-0.0167617866678935,0.0104216040756434,-0.0371881306561545,0.00366455732036762,0.107779324986407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,38841,0.00605060978555971,0.00377043255001712,-0.00133943801247384,0.0134406575835933,0.108569436268366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,36792,0.00475024658858177,0.0029607723206408,-0.0010528671598742,0.0105533603370377,0.108651559495128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,36731,-0.0115193589567564,0.00719557339379168,-0.025622682808588,0.00258396489507532,0.109424673203181
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,36430,-0.00441606026407188,0.00276486228471919,-0.00983519034212149,0.00100306981397773,0.110244478041156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,36731,0.00996045561700257,0.00623698942138858,-0.00226404364891904,0.0221849548829242,0.110290845451663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36500,-0.00753367514572154,0.00471883033613803,-0.0167825826045521,0.00171523231310899,0.110399248802342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,36714,0.00717963930707827,0.00450043209569187,-0.0016412076004778,0.0160004862146343,0.110664784219299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36363,-0.008900219689029,0.00560297825368635,-0.0198820570662542,0.00208161768819624,0.112203093357068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,36420,0.00665965801736095,0.00419770791689539,-0.00156784949975402,0.0148871655344759,0.112651407429257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,36792,-0.00702876004986214,0.00443572601998949,-0.0157227830490415,0.00166526294931727,0.113086381357965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,36792,-0.00383149612887916,0.00241829596042353,-0.00857135621130927,0.000908363953550961,0.113132063195245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,36743,-0.00829000849892782,0.0052354508287031,-0.0185514921231859,0.00197147512533026,0.113346356733759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,39291,-0.00909563145449386,0.00574629721111612,-0.0203583739882814,0.00216711107929373,0.113471988513097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,36421,-0.01882026770509,0.0118913240027527,-0.0421272627504853,0.00448672734030541,0.113517542671202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,38951,0.00453952428301693,0.00287383999271022,-0.0010932021026951,0.010172250668729,0.114218928908549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36363,-0.00606563731085277,0.00384012236315231,-0.0135922771426313,0.00146100252092576,0.114236923059107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,36538,0.0076213838703438,0.00482717945148373,-0.00183988785456431,0.0170826555952519,0.114395814502735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,36743,0.0153240979424117,0.00970991163203936,-0.00370732885638546,0.0343555247412088,0.114546222910098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,36743,-0.0136242102912241,0.00864285815743027,-0.0305642122797874,0.00331579169733924,0.114968629834923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36421,-0.00543282867621066,0.00344715547072189,-0.0121892533988256,0.00132359604640425,0.115043521978472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36430,-0.00840404075095967,0.00534215157352532,-0.0188746578350693,0.00206657633314996,0.115707740559665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,36538,-0.0053864536433588,0.00342495084985987,-0.0120993573090841,0.00132645002236654,0.115810991548809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36339,-0.0203166922277392,0.0129281580738927,-0.045655882052569,0.00502249759709058,0.116090258576737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,38705,-0.00672282075844761,0.00427981075242294,-0.0151112498331966,0.00166560831630135,0.116245319584768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36420,0.0119173300858085,0.00759388905537639,-0.00296669246272927,0.0268013526343462,0.116595882593707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,39162,-0.0130636218954726,0.00832826681778768,-0.0293870248583364,0.00325978106739128,0.116764577243499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,38841,-0.00845867516377028,0.00540015739833727,-0.0190429836645113,0.00212563333697077,0.117281816425868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,38741,-0.00677901231808339,0.00432995521160975,-0.0152657245328385,0.00170769989667173,0.117461690189668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,36743,0.00858554297311141,0.00548409247846078,-0.00216327828467171,0.0193343642308945,0.117481896655897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,36470,0.00507977371004356,0.00324552800739761,-0.00128146118445575,0.0114410086045429,0.117570267387909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36421,0.0112737227099503,0.00720859888137914,-0.00285513109755285,0.0254025765174534,0.117859894939522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39165,0.0059518758205546,0.00380896967688237,-0.00151370474613483,0.013417456387244,0.118168631609141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,36731,-0.0117354425166526,0.00751687643675263,-0.0264685203326877,0.00299763529938259,0.118498172910317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,38841,-0.0107487542768538,0.0068855957959646,-0.0242445220369444,0.0027470134832368,0.118533249663457
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39241,0.00659826989814428,0.0042295006350602,-0.00169155134657372,0.0148880911428623,0.11876654848252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,36391,-0.00988273498928083,0.00635650421001126,-0.0223414832409029,0.00257601326234124,0.120032371943676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,38713,-0.00713851477706225,0.00459424185675239,-0.0161432288162969,0.00186619926217243,0.120254382727561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39237,-0.00910163694856595,0.00586755629841331,-0.020602047293456,0.00239877339632413,0.120879093831506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36311,-0.0073235732055505,0.00472313987692627,-0.016580927364326,0.00193378095322498,0.121029460735127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39093,0.0121514001398125,0.00784223743934643,-0.00321938524130649,0.0275221855209315,0.12128684123556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36421,0.00608406555023282,0.0039265594070293,-0.0016119908875446,0.0137801219880102,0.121295222259069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,39106,-0.00538111744696499,0.00347448167192846,-0.0121911015239448,0.00142886663001479,0.121461619457023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,36391,-0.00890221551916835,0.0057598051175629,-0.0201914335495916,0.00238700251125493,0.122232296968271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,36743,0.00702493750833005,0.00454808267981788,-0.00188930454411301,0.0159391795607731,0.122469257965452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36430,0.0110523332814571,0.00716577076793254,-0.00299257742369066,0.0250972439866049,0.123006730629626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,36538,0.00736920358368373,0.00478370806157986,-0.00200686421701281,0.0167452713843803,0.123468504883761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,36363,0.00735822207739578,0.00478179699510487,-0.00201410003300976,0.0167305441878013,0.123878800113562
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36430,-0.012587730971294,0.00818734083379185,-0.028634919005526,0.00345945706293807,0.12420521748754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36363,0.0102834193541736,0.00669287569921739,-0.00283461701629244,0.0234014557246397,0.124447845254822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,38832,-0.0104645356491931,0.00682239634366082,-0.0238364324827684,0.00290736118438206,0.125087579772202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39117,0.00644209875876066,0.00420807468021951,-0.00180572761446957,0.0146899251319909,0.125817354244523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39050,-0.0122566364646364,0.0080120418303308,-0.0279602384520847,0.003446965522812,0.1260927860658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,36779,-0.00385382857940755,0.00252253835663474,-0.00879800375841164,0.00109034659959653,0.126597073484304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],38739,0.00661210365989033,0.00432883845713992,-0.0018724197161039,0.0150966270358846,0.12666929652124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36363,-0.00839236319312086,0.00549520689084391,-0.0191629686991749,0.00237824231293319,0.126732816837931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39161,-0.0109713261459299,0.00720271082514805,-0.0250886393632201,0.00314598707136028,0.127723889927932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,36796,-0.00305048494408896,0.00200730555536485,-0.00698480383260407,0.000883833944426149,0.128612999305542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,36743,0.006523013614166,0.00429638650962779,-0.00189790394470447,0.0149439311730365,0.128974470819364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39023,-0.00527424672656856,0.00347667831417033,-0.0120885362223424,0.00154004276920528,0.129278401070344
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,36538,0.00477270636061832,0.00314809425622422,-0.00139755838158116,0.0109429711028178,0.129528584310251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,39255,-0.00743637612579291,0.00491443369055883,-0.0170686661592882,0.0021959139077024,0.130256880974926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,36747,0.0094334632960492,0.00623554964719349,-0.00278821401245003,0.0216551406045484,0.130341797450995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36430,-0.0121933443272234,0.00806419267169804,-0.0279991619637515,0.00361247330930476,0.130550010811951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36420,0.00738377883278713,0.00488604594596734,-0.00219287122130886,0.0169604288868831,0.130763379354767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,36806,-0.00198636666438499,0.00131452106134846,-0.00456282794462798,0.000590094615857992,0.130788566313926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,36767,-0.00898653535574144,0.0059532370982268,-0.020654880068266,0.00268180935678309,0.131190216610685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39162,-0.00337070419772538,0.00223658650905649,-0.00775441375547611,0.00101300536002534,0.131812010261119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39266,-0.00357892059402074,0.0023761458636306,-0.00823616648673671,0.00107832529869524,0.132039615044772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39106,0.00374444535148698,0.00248711534754917,-0.00113030072970939,0.00861919143268336,0.132206667112347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,36731,0.00982372005008121,0.00653023936318232,-0.00297554910175613,0.0226229892019185,0.13251760246368
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",36767,-0.00486561233088104,0.00323843693885927,-0.0112129487310452,0.00148172406928312,0.133003582895955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36363,-0.0134434706406832,0.00895130114820753,-0.03098802089117,0.00410107960980354,0.133162288442796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39241,-0.0045343743844145,0.00302388627162603,-0.0104611914768015,0.00139244270797252,0.133759613283869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",38727,0.0111626244559296,0.00745516517074458,-0.00344949927872981,0.0257747481905889,0.134336247261508
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,39086,-0.0037773597691386,0.00252340057395105,-0.00872322489408267,0.00116850535580546,0.134431608472646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,39117,-0.00436037633591556,0.00291395998874837,-0.0100717379138624,0.00135098524203124,0.134576693906667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39234,0.00663208853937013,0.00443355093490107,-0.00205767129303597,0.0153218483717762,0.134703787876431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,38727,-0.00916222324917964,0.00613065295770483,-0.0211783030462811,0.00285385654792182,0.135067807161595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,36747,-0.00476268250321992,0.0031893502969661,-0.0110138090852735,0.00148844407883364,0.135381048330668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,36806,0.0025584481538121,0.00171374137656439,-0.000800484944254115,0.00591738125187831,0.135487176039729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,36430,0.00601365941428338,0.00402947588969613,-0.00188411332952104,0.0139114321580878,0.135614886503177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36430,0.00669299955342942,0.00448914914435712,-0.00210573276951053,0.0154917318763694,0.136005410117493
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,39023,-0.013698234984964,0.00919146607453485,-0.0317135084910524,0.00431703852112427,0.136160651653195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36420,0.0113425640141136,0.00761920567979428,-0.00359107911828319,0.0262762071465104,0.13659659114701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",36747,-0.013066481147304,0.00877821736323396,-0.0302717871792425,0.00413882488463461,0.136640411128802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,38976,-0.00381510481922949,0.00256429296118862,-0.00884111902315919,0.00121090938470021,0.136829674335579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,39095,-0.00331144467976492,0.00222663207567018,-0.00767564354807847,0.00105275418854862,0.136982992685704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36391,-0.00619951307770479,0.00417428182597032,-0.0143811054566066,0.00198207930119703,0.137524272841984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,36421,-0.00875872966599341,0.00590224910710709,-0.0203271379159233,0.00280967858393649,0.137843361679137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,38841,0.00534240527907453,0.00360792870534792,-0.00172913498340739,0.0124139455415564,0.138696832023695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,38987,0.00714390960476566,0.00482516787952968,-0.0023134194391125,0.0166012386486438,0.138746950697112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,39023,-0.00976972039360991,0.00659916371661142,-0.0227040812781683,0.00316464049094848,0.138774437754677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36430,-0.0104681935293504,0.00707162324551187,-0.0243285750905537,0.00339218803185288,0.138815638732369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,36796,-0.0045496109608369,0.00307562277486843,-0.010577831599579,0.00147860967790522,0.139098210765568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36391,0.00536862454960854,0.0036341323247569,-0.00175427480691499,0.0124915239061321,0.139626203273626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,39093,-0.00630111427872502,0.00426901258425549,-0.0146683789438658,0.00206615038641573,0.139961310688178
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36391,-0.00522491741455398,0.00354311310895486,-0.0121694191081055,0.00171958427899754,0.140326801853662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36430,-0.0143859089675643,0.00977029998249893,-0.0335356969332622,0.00476387899813362,0.140934635254087
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36363,-0.00447327791495151,0.00303900832082751,-0.0104297342237734,0.00148317839387041,0.141058694755488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,36747,0.00669117520886574,0.0045465383289844,-0.00222003991594367,0.0156023903336752,0.141124261225013
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36391,0.00566125652724052,0.00384860292253852,-0.00188200520093498,0.013204518255416,0.141318922950139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,36743,0.00570975954508765,0.00388225536590515,-0.00189946097208643,0.0133189800622617,0.141387867849827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,36731,0.00384031336140049,0.00261237148854594,-0.00127993475614956,0.00896056147895053,0.141573002680744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,36391,-0.00631481264732189,0.00429572029134249,-0.0147344244183532,0.00210479912370939,0.141580314844922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",36767,0.00828999340597685,0.00563971782347904,-0.00276385352804206,0.0193438403399958,0.141604944715115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,36767,-0.00844938445361509,0.00574885175280791,-0.0197171338891186,0.00281836498188842,0.141653397508509
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36339,0.0055362346757045,0.00376810109235007,-0.00184924346530164,0.0129217128167106,0.141793644604924
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,36731,-0.00821885717235402,0.00560079632803213,-0.019196417975297,0.00275870363058895,0.142279639582121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39265,0.00728961010297159,0.00497504913689919,-0.00246148620535082,0.017040706411294,0.142877551904594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36391,-0.0089279963469264,0.00609427188197939,-0.020872769235606,0.00301677654175319,0.142951018108464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,36767,0.00673572435260579,0.004610460819341,-0.00230077885330256,0.0157722275585141,0.144049242532878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,39246,-0.00586406998857038,0.00401552602620258,-0.0137345009999274,0.00200636102278667,0.144214560834562
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,36791,0.0036618777064566,0.00250782223849964,-0.00125345388100269,0.00857720929391589,0.144264265827471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,36743,0.00891126139802003,0.00610352546755943,-0.00305164851839646,0.0208741713144365,0.144309315052054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39023,-0.00705319739807799,0.00483538629522977,-0.0165305545367283,0.00242415974057236,0.144678693357148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,39291,0.00718558433545411,0.00492897905398007,-0.00247521461034683,0.016846383281255,0.144909390845454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,39140,-0.00399033082760807,0.00273734273639104,-0.00935552259093452,0.00137486093571837,0.144933093070157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36420,-0.0120505215252092,0.00826851085328151,-0.028256802797641,0.00415575974722252,0.145031204314623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,36421,-0.00551107483132279,0.00379856974969782,-0.0129562715407305,0.00193412187808495,0.146852476864012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,36796,-0.00294320581318053,0.00203175679693164,-0.00692544913516656,0.00103903750880549,0.147473157837944
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,38727,0.0052585666509164,0.00363303469804485,-0.00186218135725151,0.0123793146590843,0.147797364434665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,36770,0.00580172165063426,0.00400836573451328,-0.00205467518901176,0.0136581184902803,0.14780829336836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39165,0.00423617942964855,0.00292888482787763,-0.00150443483299161,0.00997679369228871,0.148100794069301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36363,-0.00924186572786713,0.00640205047254829,-0.0217898846540618,0.00330615319832751,0.148882485214826
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39099,-0.00481686060673455,0.00333684271346384,-0.0113570723251237,0.00172335111165458,0.148889418147182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36391,-0.0154430144257752,0.0107170642723969,-0.0364484603996731,0.00556243154812266,0.149616923446642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,36421,-0.00550531547243365,0.00382207595884947,-0.0129965843517786,0.00198595340691131,0.149779390107145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,36767,-0.00357812300778382,0.00248772992902619,-0.00845407366867515,0.00129782765310751,0.150370797938317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,39147,-0.00812560995026628,0.0056532478880322,-0.0192059758108094,0.00295475591027683,0.150643351080066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39283,-0.00868801353271084,0.00605081207084134,-0.0205476051915599,0.00317157812613819,0.151067425207573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36420,-0.00810693924223833,0.00565820474102762,-0.0191970205346525,0.00298314205017581,0.151946786527751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36531,-0.0127205919380312,0.00888259324020283,-0.0301304746888287,0.00468929081276636,0.152145342701959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,36430,-0.0050410306703367,0.00352172815797427,-0.0119436178599663,0.00186155651929288,0.152338112526528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36363,-0.00805265819541203,0.00562890951290167,-0.0190853208406993,0.00298000444987524,0.152572922183658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36391,-0.00406658769092887,0.00284433808553425,-0.00964149033857599,0.00150831495671826,0.152824281858159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36421,0.00850842461586535,0.00595338623086542,-0.00316021239663087,0.0201770616283616,0.15297910595655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,39030,0.0137674612662308,0.00963888936855436,-0.00512476189613578,0.0326596844285973,0.153219083526308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,36731,0.0103327689516675,0.00723613888477915,-0.00385006326249964,0.0245156011658346,0.153333519236963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,39241,0.00319328641213576,0.00224030927417087,-0.00119771976523915,0.00758429258951067,0.154068403147205
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36407,0.00356005130461673,0.00249968998046278,-0.00133934105709032,0.00845944366632378,0.154414283499177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,36339,-0.00758049230948734,0.00532275793435458,-0.0180130978608223,0.00285211324184764,0.154423351000067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39106,0.00403923626126406,0.00283708755419983,-0.00152145534496761,0.00959992786749573,0.154546172090824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,38987,0.00789499491297972,0.00554810607228226,-0.00297929298869351,0.0187692828146529,0.15475468884468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,38727,-0.00693956213707066,0.00488005508638187,-0.0165044701063791,0.00262534583223781,0.15503986449129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,38727,0.00371190119310643,0.00261132574608812,-0.00140629726922628,0.00883009965543914,0.155203371382982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,38727,-0.00975447591467063,0.0068667155962029,-0.0232132384832283,0.00370428665388705,0.155470158615494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39106,0.00838919842305336,0.00590602746331163,-0.00318661540503744,0.0199650122511442,0.15549806555896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,38832,0.00622574196971335,0.00438395144015604,-0.00236680285299248,0.0148182867924192,0.155593248795672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,39144,-0.0191650239035308,0.0135043897069111,-0.0456336277290767,0.00730357992201501,0.155869870769947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39023,-0.00331775968635429,0.00234099873811098,-0.00790611721305181,0.00127059784034323,0.156432988141905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36391,-0.00606036619779146,0.00428278475536777,-0.0144546243183123,0.00233389192272937,0.157077889760446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,36538,-0.00901842328105256,0.00637856514806733,-0.0215204109712645,0.00348356440915942,0.157426408374824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,36791,-0.00375334042379707,0.00265733947754046,-0.00896172579977636,0.00145504495218223,0.157843641900902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39093,-0.00337752327039554,0.00239170585267445,-0.00806526674163746,0.00131022020084638,0.157916891016161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36339,-0.00809924977965831,0.00574496706827078,-0.019359385233469,0.00316088567415242,0.1586239145886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36391,-0.00642740350026317,0.00456368238043554,-0.0153722209659168,0.0025174139653905,0.159043095267438
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39095,0.00309108191509349,0.00219519287433957,-0.00121149611861207,0.00739365994879905,0.159117708070732
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,38961,0.0158447281114589,0.0112602008040886,-0.00622526546455465,0.0379147216874725,0.159405165943326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,36538,-0.00924992329367703,0.0065929508008902,-0.0221721068634218,0.00367226027606775,0.160640725318883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36500,-0.00354633996464739,0.00253134160822272,-0.00850776951676392,0.00141508958746915,0.161246848367075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36363,-0.0075491850664172,0.00539437336063012,-0.0181221568532522,0.00302378672041783,0.161701265044635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,36735,0.00799648538714625,0.00571470238306246,-0.00320433128365618,0.0191973020579487,0.161752253043858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36391,-0.00811222287986874,0.00580039166743793,-0.0194809905480471,0.00325654478830962,0.161968313647184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,38840,-0.00659774986845903,0.00472907656644593,-0.0158667399386931,0.00267124020177499,0.162992652297869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,38727,-0.0116763093614334,0.00839349635014374,-0.0281275622077152,0.00477494348484832,0.164211710827674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39162,0.00324790734614973,0.00233558329278642,-0.00132983590771165,0.00782565060001111,0.164361105026883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39023,-0.00373754416875278,0.0026894738944316,-0.00900891300183872,0.00153382466433316,0.16464239741453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,38706,0.00489167001753531,0.00352301000308626,-0.00201342958851376,0.0117967696235844,0.165008213400146
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],38841,-0.00677215806734383,0.0048842015467852,-0.0163451930990428,0.00280087696435517,0.165601629688637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,36500,-0.00358199186088118,0.00258384191830432,-0.00864632202075765,0.00148233829899529,0.165678373999234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,36538,-0.0078927774123695,0.00569466394213577,-0.0190543187389556,0.0032687639142166,0.165772717880582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,38571,-0.0113639417893737,0.00821923502092695,-0.0274736424303905,0.00474575885164314,0.166807512047245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39099,0.0128432406960146,0.00929478444003485,-0.0053745368064537,0.0310610181984829,0.167063038083893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36421,-0.00633584010890402,0.00458850235263784,-0.0153293047200742,0.00265762450226614,0.16736261341234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,38960,-0.00341261665051515,0.0024719326538191,-0.00825760465200059,0.00143237135097028,0.167439042054853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,36421,0.00540197815751972,0.00391935959023702,-0.00227996663934483,0.0130839229543843,0.168141150582584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,38741,0.00831925256207008,0.00603612688461054,-0.00351155613176658,0.0201500612559067,0.168148846262793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,36792,-0.0100908154157375,0.00732860590639958,-0.0244548829922807,0.00427325216080564,0.16856455697845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,36731,0.0078778297880737,0.00572371178059804,-0.00334064530189846,0.0190963048780459,0.168737293200199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,38832,-0.00876668428945034,0.00637992663431303,-0.0212713404927039,0.00373797191380319,0.169429890445659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,36500,0.00662952552178456,0.00482642710965643,-0.00283027161314205,0.0160893226567112,0.169593781578445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,36767,0.00293301166883403,0.00213606237647984,-0.00125367058906646,0.00711969392673453,0.169747381344897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,36391,-0.00439122386187917,0.00319916488198821,-0.0106615870305761,0.00187913930681772,0.169896421638675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36391,-0.00707649087735203,0.00515937800106233,-0.0171888717594342,0.00303589000473014,0.170219312083832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,36796,0.00293065111261562,0.00214184804279227,-0.00126737105125722,0.00712867327648846,0.171247734512248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,38727,-0.00494610775514051,0.00361541335109896,-0.0120323179232945,0.00214010241301345,0.17131350743085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36420,-0.00696234174666311,0.00509734972608453,-0.0169531472097888,0.00302846371646256,0.172002707354742
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39023,0.0105755492405391,0.00774868242641606,-0.00461186831523638,0.0257629667963146,0.172330187274324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,39283,0.00206724553147878,0.00151487312481462,-0.00090190579315787,0.00503639685611543,0.172388403855444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,38727,-0.00571192419493875,0.00418893945947498,-0.0139222455355097,0.00249839714563222,0.172722682386441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,36391,-0.0101244610438974,0.00743463220177158,-0.0246963401593697,0.00444741807157489,0.173286388006686
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,38832,-0.00419407329824704,0.00308117518235026,-0.0102331766556536,0.00184503005915948,0.173473272601581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,38727,0.0056560033388291,0.00415686386712821,-0.0024914498407422,0.0138034565184004,0.173647495852248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39162,0.00341798807878616,0.00251569170880449,-0.00151276767047064,0.00834874382804297,0.174272063592892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,38987,0.00420025312390813,0.0030961607917536,-0.00186822202792892,0.0102687282757452,0.174928443571716
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,38727,-0.00823526035968539,0.00608278938346424,-0.0201575275512753,0.00368700683190452,0.175800833533286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,38741,0.00624207063921816,0.00461126982823768,-0.00279601822412769,0.015280159502564,0.175866879260099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,38727,0.00706238215450294,0.00522240083427377,-0.00317352348067365,0.0172982877896795,0.176292003856955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,38987,-0.00506966770749708,0.00374922587000329,-0.0124181504127035,0.00227881499770936,0.176334587735475
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39162,-0.00325257282370231,0.00241058348468639,-0.00797731645368763,0.00147217080628302,0.177264248116273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,36538,-0.00791110270934433,0.0058763901327685,-0.0194288273695706,0.00360662195088192,0.178245289004587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39106,-0.00410630937709531,0.00305718781025983,-0.0100983974852046,0.00188577873101395,0.179238364093062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,38741,0.00419887647234268,0.00312956744085484,-0.00193507571173281,0.0103328286564182,0.179720410164358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36420,0.00494876853634697,0.00369308381138381,-0.00228967573396528,0.0121872128066592,0.180266396783697
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,36791,-0.00444802227690775,0.00332121625541656,-0.0109576061375242,0.0020615615837087,0.180504666737138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,36743,0.00602607014269685,0.00450292414305664,-0.00279966117769418,0.0148518014630879,0.180836264002042
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36363,-0.00708386384469904,0.00529735246476745,-0.0174666746756432,0.00329894698624516,0.181166650362908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36421,0.00591578366238127,0.0044363481877277,-0.00277945878556502,0.0146110261103276,0.182398361331343
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36391,-0.00741188019451088,0.00555893844936428,-0.0183073995552649,0.0034836391662431,0.1824489034124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,38741,-0.00743687774017129,0.00557834672522307,-0.0183704373216085,0.00349668184126593,0.182496828165703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,36430,-0.0090530684630042,0.00679261708491642,-0.0223665979494404,0.00426046102343199,0.182627961753612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,38969,0.0112985206504042,0.00849392527749151,-0.00534957289347915,0.0279466141942876,0.183476291611745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,39099,-0.00730182018020879,0.00549133682470218,-0.0180648403566251,0.00346119999620748,0.183637661590119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39255,-0.00353635584327865,0.00266194379897643,-0.00875376568927245,0.00168105400271516,0.184037201507478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,38741,-0.0101158822799418,0.00761840167369322,-0.0250479495603805,0.00481618500049691,0.184257243690918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36430,-0.00445682942675722,0.00335841833692156,-0.0110393293671235,0.00212567051360904,0.184512271280414
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,36743,0.00569672197760487,0.00430056954469865,-0.00273239433000449,0.0141258382852142,0.185312879909277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39291,-0.00315349614140318,0.00238425893740877,-0.00782664365872438,0.00151965137591801,0.185977531373213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,36421,-0.00834951294864669,0.00631353017292855,-0.0207240320875867,0.00402500619029327,0.186032676784427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,36430,0.00380294949396163,0.00287877046616967,-0.00183944061973093,0.00944533960765418,0.186514557784628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36430,-0.00418584695229033,0.00317109022814502,-0.0104011837994546,0.00202948989487392,0.186858228552877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,39093,0.00384775403906407,0.00291823083396277,-0.00187197839550296,0.0095674864736311,0.187348504049103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,36743,0.00992073588972329,0.00753514961403837,-0.00484815735379191,0.0246896291332385,0.187998033247059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,36791,-0.00294127120143365,0.00223791878154274,-0.00732759201325742,0.00144504961039013,0.188772405366868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,36731,0.0117624983873,0.00895098762673313,-0.00578143736109696,0.0293064341356969,0.18883576459687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,36806,0.00287394709611125,0.00218871070022217,-0.0014159258763242,0.0071638200685467,0.18918005867592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36500,0.00436637536714853,0.00332630350587334,-0.00215317950436322,0.0108859302386603,0.189314300138544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",36792,-0.00634352841183361,0.00484023852422122,-0.0158303959193072,0.00314333909563999,0.19002237336947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39283,-0.002745794135346,0.00209861191032466,-0.00685907347958233,0.00136748520889034,0.190761965978366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,38741,-0.00574112153012458,0.00439606419575077,-0.0143574073537961,0.00287516429354694,0.191583444109064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,36339,-0.00713318473245824,0.00546603360330882,-0.0178466105949435,0.00358024113002706,0.191916232730684
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,39099,-0.0077991086620674,0.00597789433806863,-0.0195157815646819,0.0039175642405471,0.19202897435339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,36549,0.00291886909378116,0.00223958993898445,-0.00147072718662837,0.00730846537419068,0.192494252052141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,38841,-0.00522592275568135,0.00401065710552904,-0.0130868106825183,0.00263496517115557,0.1925916774892
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,38832,0.00614997001681613,0.00473131334401465,-0.00312340413745259,0.0154233441710848,0.193674398440834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36363,-0.0123055709188979,0.0094689727661858,-0.0308647575406221,0.00625361570282626,0.193773145057354
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,36782,0.0126799197854064,0.00977076499514931,-0.0064707796050862,0.0318306191758991,0.194399604310784
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36391,0.0134747741048621,0.0103903062363822,-0.00689022611844703,0.0338397743281713,0.194703188351158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,38727,-0.01282217220589,0.0098874765096803,-0.0322016261648633,0.00655728175308342,0.194716911153934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,38727,-0.00614132207707902,0.00473732571089345,-0.0154264804704302,0.00314383631627214,0.194868517572598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,39099,0.0109183692320499,0.00843074694706788,-0.00560589478420317,0.0274426332483029,0.195317266004028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,36430,0.00372648538875384,0.00288079710589205,-0.00191987693879457,0.00937284771630226,0.195841037857781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36500,-0.00981791755918524,0.00761634886735302,-0.0247459613391972,0.00511012622082667,0.19740141644552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,38727,0.00660569699899725,0.00512585872329295,-0.00344098609865693,0.0166523800966514,0.197522261222803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,36806,-0.00215104719406342,0.00167294077361208,-0.0054300111103431,0.00112791672221626,0.198540052297601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,39165,0.00521562918831069,0.00406003802287788,-0.00274204533652996,0.0131733037131513,0.198942555956256
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,39283,-0.00350684336538399,0.00273021079749775,-0.00885805652847957,0.00184436979771159,0.199000752464038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",36747,-0.00635481333845793,0.00495013955201709,-0.0160570868604114,0.00334746018349557,0.199247455992834
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,39106,0.00775565381366969,0.00606035889530286,-0.00412264962112392,0.0196339572484633,0.20065779958072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,36747,0.00374288307397424,0.00292724158421176,-0.00199451043108082,0.0094802765790293,0.201047497655478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39099,0.0121549401174215,0.00952012282802016,-0.00650450062549806,0.030814380860341,0.201705403907048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,36391,-0.00863448679348445,0.00676626662237577,-0.021896369373341,0.00462739578637206,0.201941004579891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,36796,-0.00303574131075597,0.00237943984692049,-0.00769944341072013,0.00162796078920819,0.202041415156798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39147,0.00291580916212208,0.00228716134818006,-0.00156702708031083,0.00739864540455499,0.202378384798931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,36796,0.00451505396351849,0.00354459262195284,-0.00243234757550909,0.0114624555025461,0.20276200296535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39023,-0.0156857059741739,0.0123145143677518,-0.0398221541349674,0.00845074218661952,0.202768868449192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,36430,-0.00522526206266336,0.00410270794365751,-0.0132665696322321,0.00281604550690536,0.202824162073959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36469,0.00555969403527662,0.00437164700309972,-0.00300873409079883,0.0141281221613521,0.203481190937996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,38863,-0.00480942693691351,0.00379642572571133,-0.0122504213593077,0.00263156748548069,0.205235660115883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,36538,-0.00520138459562065,0.00410669804955757,-0.0132505127727535,0.00284774358151219,0.20533548600285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,36731,0.00625730068367904,0.00494234731520268,-0.00342970005411822,0.0159443014214763,0.205515063591706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39283,0.00363091740560299,0.00286812532676154,-0.00199060823484964,0.00925244304605561,0.205548339315404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,39030,-0.00515598448939319,0.00407395988900272,-0.0131409458718385,0.00282897689305213,0.205677446665105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,36538,-0.00314864852022267,0.00248787114156415,-0.00802487595768842,0.00172757891724307,0.205679756079414
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,38727,-0.00555535929135555,0.00439460668927315,-0.0141687884023309,0.00305806981961983,0.206202769717873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,36767,0.00746406041843887,0.00590591987014411,-0.0041115425270436,0.0190396633639213,0.20631498763656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,36806,0.00231131265832809,0.00183254377847975,-0.00128047314749222,0.0059030984641484,0.207238210720044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,36538,-0.00671733721335287,0.00532950488580186,-0.0171631667895245,0.00372849236281877,0.207546319580041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,36339,-0.00339461983761493,0.0026958849912492,-0.00867855442046337,0.0018893147452335,0.207986816836254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,36747,0.00302684357900783,0.00240398993223408,-0.00168497668817095,0.00773866384618662,0.208020046500167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,36391,-0.0035067610723531,0.00278771374843111,-0.00897068001927808,0.00195715787457188,0.208438914732857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,39099,-0.00631286042577077,0.00503316283244249,-0.016177859577358,0.0035521387258165,0.209769238409933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,36792,0.00337334586150715,0.00268986595408177,-0.0018987914084931,0.00864548313150742,0.209830359374245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,36767,-0.00814552408598844,0.00650434669723827,-0.0208940436125754,0.00460299544059857,0.21047593977575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,36363,-0.00536655037695101,0.00428619491875236,-0.0137674924177056,0.00303439166380361,0.210573363633687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,36767,0.00406166807582029,0.00325317907194513,-0.00231456290519216,0.0104378990568327,0.211862328872284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,36791,0.0100730039374995,0.00808479379661314,-0.00577319190386229,0.0259191997788612,0.21281644609333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,38692,-0.00484559850872808,0.00389183715178791,-0.0124735993262324,0.00278240230877622,0.213126746395396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,36792,0.00380472556068399,0.0030565455802843,-0.00218610377667324,0.00979555489804122,0.213235336885499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36363,-0.00651825803104133,0.00524285170508593,-0.0167942473730097,0.00375773131092708,0.213793227881316
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36363,0.0085798880915675,0.00690611556020912,-0.00495609840644237,0.0221158745895774,0.214126727941602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,36792,0.00762916870321746,0.00614133869054392,-0.00440785513024862,0.0196661925366835,0.21416141544032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,38926,0.00404061991282628,0.00325707089910963,-0.00234323904942858,0.0104244788750812,0.214784472746987
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,38727,-0.00379011325185517,0.00305637997082992,-0.00978061799468182,0.00220039149097149,0.214970510507782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,38987,-0.0104888603479934,0.00845970466106441,-0.0270698814836797,0.00609216078769279,0.215045936210554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36391,-0.00441089807627898,0.00356148211070798,-0.0113914030132666,0.00256960686070866,0.21555366388896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,38677,-0.00510777174672998,0.00412429177783523,-0.013191383631287,0.00297584013782707,0.215565043860239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36391,-0.00441070687122167,0.00356616219251589,-0.0114003847685528,0.00257897102610948,0.216176453852495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,36743,-0.00236488869526886,0.00191273219040672,-0.00611384378846603,0.00138406639792831,0.216335056145022
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,36767,-0.00426285723121015,0.00345010365923333,-0.0110250604033075,0.00249934594088719,0.216639565873837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,39049,-0.0044636919710768,0.00361712926091484,-0.0115532653224699,0.00262588138031629,0.217206085486278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36391,-0.00527291789659996,0.00427880608493302,-0.0136593778230687,0.00311354202986876,0.217847493337085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,36747,-0.0053419881378157,0.00433586936095896,-0.0138402920852953,0.00315631580966387,0.21795458393393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",38741,0.00558104587054605,0.0045310518590516,-0.00329981577319509,0.0144619075142872,0.218068320726647
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36421,-0.00679053922581197,0.00551717774167186,-0.0176042075994888,0.00402312914786488,0.218420934597486
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,39291,-0.00372339456203268,0.00302700911035778,-0.00965633241833392,0.00220954329426856,0.218694411859052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,38841,0.00668214210925185,0.00543687129517006,-0.00397412562928148,0.0173384098477852,0.219075436837453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,38681,-0.00993741720479437,0.00812329940784555,-0.0258590840441716,0.0059842496345829,0.221227256271023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36420,-0.00658968992459746,0.00538897052413603,-0.0171520721519041,0.00397269230270916,0.221424209562504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,36731,-0.00655111305253459,0.00536282185992828,-0.017062243897994,0.00396001779292484,0.221889072005583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,36747,-0.0118557989530686,0.00971880720515057,-0.0309046610751637,0.00719306316902654,0.222531895760446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",36806,0.00177846055993161,0.00145949765278431,-0.00108215483952565,0.00463907595938886,0.22303992237545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,36391,-0.00420043118885513,0.00344823431965094,-0.010958970455371,0.00255810807766072,0.223193816703744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,36421,-0.00382201514531819,0.00314718559421863,-0.00999049890998671,0.00234646861935033,0.224608997322184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36430,-0.00307644176923148,0.00253798463948719,-0.00805089166262637,0.00189800812416342,0.2254741780236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,36747,-0.00427394355600163,0.00352704557747792,-0.0111869528878584,0.0026390657758551,0.225625308332364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,36767,-0.00350656178625674,0.00289660994966927,-0.0091839172876085,0.00217079371509503,0.226080736541186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,38992,-0.00289964967419172,0.00239756013188964,-0.00759886753269541,0.00179956818431198,0.22652162486113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,38987,-0.0155158316765586,0.0128704883101564,-0.0407419887644652,0.00971032541134804,0.228015465415858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39023,-0.00241686230576352,0.00200692874724256,-0.00635044265035895,0.00151671803883191,0.228508228079666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,36767,-0.012854993977902,0.0107001077439506,-0.0338272051560452,0.00811721720024111,0.229622304372076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,36791,-0.00274083557979825,0.00228463836980212,-0.0072187267846104,0.0017370556250139,0.230285518123086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,36420,0.00191127465494775,0.00159841874152629,-0.00122162607844378,0.00504417538833929,0.231825146001222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36391,-0.00659635767325263,0.0055194994534326,-0.0174145766019805,0.00422186125547526,0.232070304989887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36430,-0.00439869707077863,0.00368478716373883,-0.0116208799117067,0.00282348577014947,0.232600173111248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36339,0.0052920897377923,0.00443616234795176,-0.00340278846419314,0.0139869679397777,0.232914297010573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39093,0.00322697561584889,0.00270865884954928,-0.0020819957292677,0.00853594696096547,0.233532616704126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,38727,0.00722448737689486,0.00607080282874209,-0.00467428616743964,0.0191232609212294,0.234050374222032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36363,-0.00406937319808046,0.0034198689454451,-0.0107723163311529,0.00263356993499193,0.234100115660105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,36767,0.00556338708731452,0.00467544591508849,-0.00360048690625891,0.0147272610808879,0.234101364384628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,36767,0.0113599671883552,0.00955236599746188,-0.00736267016667005,0.0300826045433805,0.234370762356894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39099,0.00582393199150315,0.00491349425777084,-0.0038065167537277,0.015454380736734,0.23591997090747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,38741,0.00648775444700165,0.005482527221239,-0.00425799890662679,0.0172335078006301,0.236688944790166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,36421,0.00437200133096838,0.00369920538702234,-0.0028784412275954,0.0116224438895322,0.237277358719524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36391,0.00545160774592898,0.00461826295043379,-0.00360018763692124,0.0145034031287792,0.237845478374919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,36500,-0.00611714654198827,0.00518242691560174,-0.0162747032965677,0.00404041021259113,0.23787796344642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,36806,-0.002881440755062,0.00244229024776299,-0.00766832964067746,0.00190544813055346,0.238097096203308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36391,-0.00595336724381719,0.0050503806032552,-0.0158521132261974,0.003945378738563,0.23850189510171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,36743,0.0179573625686705,0.0152451114195107,-0.0119230558135706,0.0478377809509115,0.238854419202257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,36698,-0.00499510226263331,0.00424076849751269,-0.0133070085177582,0.00331680399249156,0.238867612215194
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,36806,-0.00333647928450533,0.0028346950373844,-0.00889248155777875,0.0022195229887681,0.239211059356071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,39117,0.00249371293648512,0.00212362769558351,-0.00166859734685855,0.0066560232198288,0.240305102838752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,36767,0.00504283250442416,0.00429478570511881,-0.00337494747760871,0.013460612486457,0.240346368402406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,36731,0.00532624844375488,0.00454404236397089,-0.00358007458962807,0.0142325714771378,0.241163022473422
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,39145,-0.00190900274477918,0.00163038820817012,-0.00510456363279261,0.00128655814323424,0.241661866171095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,36538,0.00298683051282678,0.00255397687084396,-0.00201896415402738,0.00799262517968093,0.242231391174624
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36398,-0.00406966639662261,0.00348285227373603,-0.0108960568531452,0.00275672405990001,0.242632736555941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,36747,0.0037524473754445,0.00321217978752749,-0.00254342500810939,0.0100483197589984,0.242750354295125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39243,-0.00858887870290001,0.00735251710375426,-0.0229998122262584,0.00582205482045834,0.242762402351649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,36430,0.00397722068100892,0.00340579424925577,-0.00269813604753239,0.0106525774095502,0.242917397814702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,36743,0.00530874024856715,0.0045482845742429,-0.00360589751694892,0.0142233780140832,0.243152767829179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",36792,-0.00774563521259615,0.00664114708645836,-0.0207622835020545,0.00527101307686224,0.243510703259487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,36391,-0.00367694422785616,0.00315340829089792,-0.00985762447801609,0.00250373602230377,0.243627642010248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,38667,-0.00700640823281167,0.00602118522879887,-0.0188079312812575,0.00479511481563411,0.244594323269596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,38987,0.00330010727977793,0.00283974674214049,-0.00226579633481744,0.0088660108943733,0.245207805684465
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36363,-0.00339181580378709,0.00292292871930326,-0.00912075609362148,0.00233712448604731,0.245901276852177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36430,-0.00701261128526231,0.00604448300951369,-0.0188597979839091,0.00483457541338452,0.246002748969963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36430,-0.00308724270930234,0.00266433225808611,-0.00830933393515111,0.00213484851654642,0.246588119208616
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,36430,-0.0122445229860263,0.0105741962069009,-0.032969947551552,0.00848090157949936,0.246901328959822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,36747,0.0113544857569652,0.00981159701674244,-0.00787624439585004,0.0305852159097803,0.24719105520977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,39162,-0.00407290069263072,0.00351951010125188,-0.0109711404910844,0.00282533910582296,0.247194376756751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,36747,0.00583506679451158,0.00504268956780078,-0.00404860475837795,0.0157187383474011,0.24723912612186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,36538,0.00738889672864569,0.00639089899031785,-0.00513726529237731,0.0199150587496687,0.247637826898081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36339,-0.00270794574106216,0.00234631978163615,-0.00730673251306901,0.00189084103094469,0.248471128063114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,36747,-0.00991166023022175,0.00861772940315634,-0.0268024098604082,0.00697908939996468,0.250104453110751
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36363,-0.00291349332577409,0.00253418513992753,-0.00788049620003206,0.00205350954848388,0.250299090846608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,36456,-0.00854256388736806,0.00743655235659267,-0.0231182065062897,0.00603307873155357,0.250690636812517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,39083,-0.00399286339506236,0.00348738627319039,-0.0108281404905155,0.0028424137003908,0.252250188979708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,39023,0.00605972398386712,0.00529776424962751,-0.00432389394540279,0.016443341913137,0.252713588364915
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,36408,-0.00712699649200554,0.00624139176551232,-0.0193601243524097,0.00510613136839861,0.253520626151613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39106,-0.00581183626811119,0.00509455721305948,-0.0157971684057078,0.00417349586948539,0.25397390683121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,36747,0.00260101560359794,0.00228010258094671,-0.00186798545505761,0.00707001666225348,0.253997255678831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,36571,0.00280712771336196,0.0024626242561582,-0.00201961582870811,0.00763387125543203,0.254352434590768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39054,0.00259847951226824,0.00227984705124785,-0.00187002070817755,0.00706697973271404,0.25440408002944
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36420,0.00757681069060318,0.00666451530839868,-0.00548563931385822,0.0206392606950646,0.255606597094874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36339,-0.00648406187608925,0.00570692822668274,-0.0176696412003874,0.00470151744820893,0.255905685192009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,39124,-0.00393223933972136,0.0034685339980453,-0.0107305659758902,0.00286608729644742,0.256942769953061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,38741,0.00652883186145144,0.00577785140609933,-0.00479575689450326,0.0178534206174061,0.258504664135154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39291,-0.00685410246899781,0.00607587774632949,-0.0187628228518036,0.00505461791380799,0.259301845705534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,36747,-0.0138272531003549,0.0122764187701756,-0.0378890338898991,0.0102345276891892,0.260048410838271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,39035,-0.00356790482358681,0.00317118784582418,-0.00978343300140221,0.00264762335422859,0.260564271865512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,36792,0.00294154009757169,0.00261868899604699,-0.00219109033468042,0.00807417052982379,0.261336347244688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,36430,-0.00298963933352939,0.0026615467908182,-0.00820627104353306,0.00222699237647427,0.261343708123891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36339,-0.00600890924845279,0.00535080568555595,-0.0164964883921425,0.00447866989523688,0.26146271323093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36430,0.00590264265528145,0.00526072919086731,-0.00440838655881848,0.0162136718693814,0.261875425971909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36421,-0.00532995918855477,0.00475608694047318,-0.0146518895918822,0.00399197121477266,0.262453789509041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36391,-0.00638028969098477,0.00569572238059611,-0.0175439055569531,0.00478332617498361,0.262654390104439
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39197,0.00298378443881555,0.00266577120147115,-0.00224112711606791,0.008208695993699,0.263031827284979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,36421,0.00485880791373041,0.00434241490460995,-0.00365232529930509,0.0133699411267659,0.263196351408646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36430,-0.00807586934865118,0.0072219895020693,-0.022230968772707,0.00607923007540465,0.263488724070989
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36430,-0.00895564340439375,0.00801234354940785,-0.0246598367612331,0.00674854995244564,0.263703333164766
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39023,0.00441159104776459,0.00395881394883499,-0.00334768429195199,0.0121708663874812,0.265137333195721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39095,-0.00515189916798041,0.00463617366922649,-0.0142387995596643,0.00393500122370351,0.266482822749282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36339,-0.00541687133001818,0.0048814096558068,-0.0149844342553995,0.00415069159536315,0.267152264085661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36066,-0.00484476585793694,0.00437431446665458,-0.0134184222125799,0.00372889049670604,0.268078637435082
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36421,0.00679151328793024,0.00613268906124751,-0.00522855727211488,0.0188115838479754,0.26813001127452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,39089,0.00608255445124738,0.0055205072305343,-0.00473763972059985,0.0169027486230946,0.270561349857387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36421,-0.00991511520731297,0.00899894493969724,-0.0275530472891196,0.00772281687449362,0.270565988410605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36421,-0.00416703936804694,0.00378272406297246,-0.011581178531473,0.00324709979537908,0.270657803703887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,36339,-0.00352836449982122,0.00320427932478966,-0.00980875197640894,0.00275202297676651,0.270856376282997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,36420,-0.00300611243495219,0.00273140689423595,-0.00835966994765465,0.00234744507775027,0.271103673028381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,39099,-0.0087292239212747,0.00795431586432381,-0.0243196830153494,0.00686123517279998,0.272475251092419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,38832,-0.00720297201046798,0.00657171638230111,-0.0200835361197782,0.0056775920988422,0.273071709021756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,39023,-0.00412941049570304,0.0037679732279389,-0.0115146380224633,0.00325581703105721,0.273129649527996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,39023,-0.00693923902931704,0.00633220794571026,-0.0193503666029091,0.00547188854427507,0.273155679628567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,36767,0.00763933873816272,0.00697801442115577,-0.00603756952730258,0.021316247003628,0.273636717995773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,36731,-0.0047816696160678,0.00437512219706057,-0.0133569091223065,0.00379356989017092,0.274448270855365
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,36748,-0.00232630476245433,0.00213016203977134,-0.00650142236040616,0.0018488128354975,0.27481888944182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39241,0.00639736017191155,0.005858175823903,-0.00508466444293834,0.0178793847867614,0.274832786339399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36430,-0.00324991279593009,0.0029824240070093,-0.00909546384966832,0.00259563825780813,0.275871324166173
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,38727,-0.00460176812225798,0.00422325903718476,-0.0128793558351401,0.00367581959062415,0.275896079735397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,36339,-0.00435597710477787,0.00400370549252337,-0.0122032398701237,0.00349128566056794,0.276622125876216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36421,-0.00417659006358838,0.00383929626439212,-0.0117016107417969,0.00334843061462016,0.276680868282043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,38705,-0.00336339919651937,0.00309188913287851,-0.00942350189696125,0.00269670350392252,0.27669504399333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,38882,-0.0166774397586357,0.0153354427786277,-0.046734907604746,0.0133800280874746,0.276829149239976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,36391,-0.00382318890011165,0.00352087385066928,-0.0107241016474234,0.00307772384720013,0.277560213020437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,36792,-0.00689105053920618,0.00636260459550274,-0.0193617555463915,0.00557965446797919,0.278804216893948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,36430,-0.0026522737542715,0.00245389865376784,-0.00746191511565646,0.00215736760711346,0.279788677449964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,36538,-0.00408420027481316,0.00378033420554491,-0.0114936553176812,0.00332525476805488,0.27999321926929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,36743,0.0100904545130588,0.00935428782268664,-0.00824394961940697,0.0284248586455247,0.28074243274927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36391,-0.004462262125982,0.00413696261926802,-0.0125707088597473,0.00364618460778332,0.280772371300952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,38832,-0.0104082015151614,0.0096524166845247,-0.0293269382168298,0.008510535186507,0.280917241198848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,39227,0.00405769270560734,0.00377153458638699,-0.00333451508371116,0.0114499004949258,0.28200089295313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,36743,0.0102554556590051,0.00953765470133071,-0.00843834755560305,0.0289492588736133,0.282278613912195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",36767,0.00378433393530009,0.00352649352340938,-0.00312759337058229,0.0106962612411825,0.283239477673128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,36421,0.00654854252210682,0.00611942122535742,-0.00544552307959373,0.0185426081238074,0.284583839044946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,38941,-0.00458786295417413,0.00428780140326435,-0.0129919537045723,0.003816227796224,0.284645308662711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36363,-0.00795688429162416,0.0074386310532559,-0.0225366011560057,0.00662283257275741,0.284788293322645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,36339,-0.00473401094486562,0.00443215997499808,-0.0134210444958618,0.00395302260613061,0.285493942859498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,39099,0.00780868612776749,0.00731156182325584,-0.00652197504581396,0.0221393473013489,0.285541248369936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,38727,-0.00842831999948318,0.00789793873676071,-0.0239082799235342,0.00705163992456781,0.285919452715996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,36538,-0.00328251336441104,0.00307739138346852,-0.00931420047600934,0.00274917374718725,0.286148192357574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36339,-0.00309446441670436,0.00290681059378673,-0.00879181318052635,0.00260288434711762,0.287097223925888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,38841,0.0067164590701796,0.0063161130249665,-0.00566312245875474,0.0190960405991139,0.287624588393869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,36767,-0.00338478386537718,0.00318393183485907,-0.00962529026170094,0.00285572253094659,0.287764193822507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36420,-0.00696195837970924,0.0065502727406992,-0.0198004929514797,0.00587657619206119,0.287870346003582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,36339,-0.00508296294288935,0.00479112400800039,-0.0144735659985701,0.00430764011279142,0.288750238593992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,38841,-0.00287065590799927,0.00270611784155629,-0.0081746468774496,0.00243333506145106,0.288796878672561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,36743,-0.00668050705010061,0.00630600470730863,-0.0190402762764255,0.00567926217622431,0.289442877569235
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,38841,0.00357292940684455,0.00337307173629016,-0.00303829119628418,0.0101841500099733,0.289502589480508
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,36791,0.00405952911211786,0.00383662284051203,-0.00346025165528571,0.0115793098795214,0.290029799724051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36391,-0.00827713233819932,0.00784413370245633,-0.0236516343950137,0.00709736971861508,0.291354064729471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,36391,0.00646215892837123,0.00612954829263974,-0.00555175572520265,0.0184760735819451,0.291782629482071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,38727,0.004811927905962,0.00457639882518914,-0.00415781379140872,0.0137816696033327,0.293061693137601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39291,-0.00491893240651547,0.00468362184506454,-0.014098831222842,0.00426096640981103,0.293623700539407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,36747,0.00713942147133771,0.00679965064719384,-0.00618789379716221,0.0204667367398376,0.293752117010274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,36339,-0.00393516935908546,0.00374918785502513,-0.0112835775549347,0.00341323883676379,0.293919710549167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36420,0.00430948021786783,0.00411075664747173,-0.00374760281117676,0.0123665632469124,0.294501083865763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,36711,0.00380428981583865,0.00362975987332484,-0.00331003953587803,0.0109186191675553,0.29462005351588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,36421,-0.00567660124485862,0.00541799488345708,-0.0162958712164345,0.00494266872671726,0.294782716019775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,36765,-0.00453821906140383,0.00433443051944894,-0.0130337028795238,0.0039572647567161,0.295111706365702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,36731,-0.00490957750515565,0.00469190192125602,-0.0141057052708175,0.00428655026050615,0.295398862332389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,36767,-0.00273544981554778,0.00261569235493894,-0.0078622068312281,0.00239130720013254,0.295680248010628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39093,-0.00482228414189175,0.00461411834100843,-0.0138659560902683,0.00422138780648478,0.295986420869697
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36391,-0.00626740875895436,0.00600191056027132,-0.0180311534570862,0.00549633593917743,0.29639653703212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39099,0.00405259388911746,0.00388207768084815,-0.00355627836534492,0.0116614661435798,0.296537133123929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36339,0.00522199852732663,0.00500453139159777,-0.00458688300020501,0.0150308800548583,0.296758266762315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36421,-0.00342611784354126,0.00328547917984834,-0.00986565703604401,0.00301342134896149,0.297058158797019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,39255,0.00190985976326474,0.00183389096031876,-0.00168456651896003,0.00550428604548951,0.297694731748026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,38741,-0.00456632060152508,0.0043896864161767,-0.0131701059772314,0.00403746477418125,0.298246031628849
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39106,-0.00805251284273029,0.00777855069867595,-0.0232984722121351,0.00719344652667457,0.300582504770814
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,36796,-0.0132978465946691,0.0128505513512378,-0.0384849272430951,0.011889234053757,0.300778175441319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,36500,-0.00688641273086883,0.00666009623543217,-0.0199402013523159,0.00616737589057822,0.301164843988183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",38741,-0.0045874557282245,0.00444045073248505,-0.0132907391638952,0.00411582770744621,0.3015711445689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,38939,-0.00620597694122392,0.00601360095502925,-0.0179926348130812,0.0055806809306334,0.302093284043249
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,39151,-0.00359342461112051,0.00348522932623181,-0.0104244740905349,0.00323762486829384,0.302536517611884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39110,-0.00362877109859686,0.00352198172785895,-0.0105318552852004,0.00327431308800668,0.302875769327136
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,39099,0.00880621469062428,0.00854787790043993,-0.00794762599423799,0.0255600553754866,0.302921999965448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,38832,-0.00897122231366909,0.0087084631448886,-0.0260398100776507,0.00809736545031257,0.302945512613122
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,36538,-0.00386708757811807,0.00375927664711097,-0.0112352698064556,0.00350109465021943,0.303650336466034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,39140,-0.00266435152980263,0.00259832743206062,-0.00775707329664144,0.00242837023703618,0.305185895818187
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,38987,0.0081790607862067,0.00797861163526418,-0.00745901801891108,0.0238171395913245,0.305321399380848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,38998,0.00221359465924891,0.0021605602539905,-0.00202110343857246,0.00644829275707028,0.305593544200932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,36731,-0.00767714570633379,0.00751326962813155,-0.0224031541774716,0.00704886276480405,0.306889305078599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39283,0.0044236418267155,0.00433747465793836,-0.00407780850284368,0.0129250921562747,0.307808134232707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36517,-0.00478542304882019,0.00471100197271542,-0.0140189869153424,0.00444814081770204,0.309745342333832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,36731,0.00354074140247432,0.00348624702687163,-0.00329230277019408,0.0103737855751427,0.30982411184268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,36339,-0.00282558928356726,0.00278254507979406,-0.00827937763996361,0.00262819907282909,0.309901830256777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36339,0.00730447655617633,0.00720061720214368,-0.00680873316002529,0.021417686272378,0.310400300120599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,38705,0.00410280096383021,0.00404452433994162,-0.00382446674245537,0.0120300686701158,0.310404273605097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",36747,0.00543594879347039,0.00536538552777648,-0.0050802068409715,0.0159521044279123,0.311006788258306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36430,-0.00665445270250993,0.0065754802080931,-0.0195423939103724,0.00623348850535255,0.311552680305719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,38951,0.00582185071425403,0.00575613057799949,-0.00546016521862498,0.017103866647133,0.311832904943852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36421,-0.00569662804061076,0.00563604165717619,-0.0167432696886761,0.00535001360745457,0.312155659114022
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36421,0.0046856049747863,0.00463618345816583,-0.00440131460321872,0.0137725245527913,0.312198676041206
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36430,0.00887059593922226,0.00877795528699115,-0.00833419642328039,0.0260753883017249,0.312249496206671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,38741,-0.00350223040805736,0.00347371218776807,-0.0103107062960828,0.00330624547996806,0.313370183444118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,38727,0.00517512188575148,0.00514345354962773,-0.00490604707151887,0.0152562908430218,0.314356419740831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39147,-0.0082057272261656,0.00817810854579377,-0.0242348199759214,0.00782336552359019,0.315694807451811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36339,-0.00436686165550365,0.00435841452281047,-0.0129093541202122,0.00417563080920488,0.31639290730679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36403,0.00515897336730614,0.00515276354964884,-0.00494044319000558,0.0152583899246179,0.316746954720485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36363,0.00287283266365546,0.00287046824373629,-0.00275328509406767,0.00849895042137859,0.31693141545935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36339,-0.0047142144025861,0.00473923066262641,-0.0140031065013339,0.00457467769616166,0.319891045634246
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,36538,0.00461707265400546,0.00466333166560884,-0.00452305741058787,0.0137572027185988,0.322153783562133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,36747,0.00334764726210382,0.00338703306125744,-0.00329093753796077,0.00998623206216841,0.322989250927034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39023,0.00292711598754056,0.00296252596955072,-0.00287943491277886,0.00873366688785998,0.323145216072492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39147,-0.00837454082843182,0.00849165658371712,-0.0250181877325174,0.00826910607565374,0.324046595119606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36391,0.00664619278420735,0.00674074460497664,-0.00656566664154686,0.0198580522099616,0.324165355087088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,36731,0.00286869542269416,0.00291882279797018,-0.00285219726132739,0.00858958810671571,0.325711474701644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36391,-0.00567447749044664,0.00578301841595637,-0.0170091935857211,0.00566023860482785,0.326497737232887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36339,-0.00499474302683606,0.00510732080984493,-0.0150050918141321,0.00501560576045999,0.328114269790658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,38727,0.0068238464310713,0.00700217012126291,-0.00690040700660401,0.0205480998687466,0.329807777184785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,36792,0.00656352251954464,0.00673871214121795,-0.00664435327724254,0.0197713983163318,0.330073512560928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,36538,0.00511953464284944,0.00525996459207137,-0.00518999595761043,0.0154290652433093,0.330421742841874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39099,-0.00637206510246186,0.00656304738690932,-0.0192356379808041,0.00649150777588041,0.331613306094879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,38741,-0.00333768566335798,0.00343951486365173,-0.0100791347961154,0.00340376346939941,0.331865754158587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36500,-0.00591408529927809,0.00609982651685352,-0.017869745272311,0.00604157467375481,0.332289520071744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39093,0.00287063836841198,0.00297867261907235,-0.00296755996496984,0.00870883670179379,0.335196236600876
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,36430,-0.00543680801941382,0.00564170897997285,-0.0164945576201606,0.00562094158133297,0.335224397419594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,36767,-0.00844688583855658,0.00877242865949198,-0.0256408460111609,0.0087470743340477,0.335620652616496
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36430,0.00368466278130352,0.00383117879239517,-0.00382444765179101,0.0111937732143981,0.336190214035156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,36747,0.00307118497726993,0.0031999694084959,-0.00320075506338203,0.0093431250179219,0.337196802633812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,36538,0.00387554788326696,0.00404393841970897,-0.00405057141936261,0.0118016671858965,0.337899650506487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,36791,0.00190276477062287,0.00198989595814127,-0.00199743130733402,0.00580296084857976,0.338982411061477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39283,0.00290522173289105,0.00304072994294557,-0.00305460895528227,0.00886505242106437,0.33937241717698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36363,-0.00644189191315708,0.00674835736529321,-0.0196686723491318,0.00678488852281761,0.339805221266511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,36430,-0.0050460068772746,0.00529391965430662,-0.0154220893997156,0.00533007564516637,0.340522130417674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36363,-0.0048206105737696,0.00505779004257288,-0.0147338790572124,0.00509265790967324,0.340554737763373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,38741,-0.00675126063427963,0.00709564076014465,-0.0206587165241631,0.00715619525560389,0.341383344497299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,38841,0.00499983433981427,0.0052551129368925,-0.00530018701649503,0.0152998556961236,0.341405132697254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,36430,0.00464105777166265,0.00487873104261312,-0.00492125507185907,0.0142033706151844,0.341478622275275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,38727,-0.0140090755347558,0.0147370750868407,-0.0428937427049635,0.014875591635452,0.3418225094952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36363,-0.00524571196075028,0.00553945767029336,-0.0161030489945253,0.0056116250730247,0.343671288148956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39241,-0.00386015004918044,0.00409342419783318,-0.0118832614769335,0.0041629613785726,0.345689337857994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39229,0.0027772564583378,0.00294602158996516,-0.00299694585799392,0.00855145877466952,0.345841913715835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,38909,0.0039127782930148,0.00415309303489229,-0.00422728405537409,0.0120528406414037,0.346138159267283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",36767,-0.00395158372159479,0.00420305671289825,-0.0121895748788754,0.00428640743568579,0.347148463080159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36363,-0.00270699789416609,0.00288574948074056,-0.0083630668764176,0.00294907108808541,0.348233167970999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36420,0.00346516259707309,0.00369612295915656,-0.00377923840287376,0.0107095635970199,0.3485128675272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,38813,0.00354302194641578,0.00379370785429562,-0.00389264544800364,0.0109786893408352,0.350359927913701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36339,-0.00726115838911987,0.00777573872175286,-0.0225016062837555,0.00797928950551574,0.350413620989036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,36747,-0.00177070486793585,0.0018963695957644,-0.00548758927563407,0.00194617953976236,0.350458589082011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36420,-0.00261752196972419,0.00280589155480915,-0.00811706941715012,0.00288202547770174,0.350906881520021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36430,-0.00378300685800023,0.00405716997002937,-0.0117350599992578,0.00416904628325733,0.351134819629484
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,36740,-0.00227719747912487,0.00244806347188865,-0.00707540188402663,0.00252100692577689,0.352283106641428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39283,-0.00581021510602354,0.00625864738671204,-0.0180771639839791,0.00645673377193206,0.353240590118239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,38994,0.00216041359904962,0.00232792232484342,-0.00240231415764348,0.00672314135574271,0.353399713119534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,36391,-0.00559224377451215,0.00603144172438104,-0.017413869554299,0.00622938200527468,0.353849940724764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,39093,-0.00260522010375433,0.00281246043745515,-0.00811764256116642,0.00290720235365776,0.354297751250683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,36737,0.0015494507727349,0.00167395010260875,-0.00173149142837824,0.00483039297384805,0.35465802262291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39093,-0.00330693995265237,0.00357985717568692,-0.0103234600169987,0.00370958011169399,0.355624304389176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,36538,-0.00362846310082033,0.0039281085677318,-0.0113275558935747,0.00407062969193401,0.355650935136546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,36731,0.00327610008878023,0.00355156661685588,-0.00368497048025729,0.0102371706578177,0.356317434767162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39093,0.00301222415285756,0.00326624590150327,-0.00338961781408885,0.00941406611980397,0.356424150719939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,36538,-0.00539341189235123,0.00585724125770102,-0.0168736047574452,0.00608678097274277,0.357166657260664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,38832,-0.00263327235905106,0.00286291969362658,-0.00824459495855916,0.00297805024045703,0.357699619087367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,36767,0.00631277880267888,0.00686464991669201,-0.00714193503403746,0.0197674926393952,0.357795453138101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36421,-0.00336233497481593,0.00365778387863912,-0.0105315913769486,0.00380692142731674,0.357994320746265
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,39135,0.00295223064641212,0.00321497353696168,-0.00334911748603278,0.00925357877885701,0.358489277455061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,36538,-0.00602507768156201,0.00656255850016864,-0.0188876923418925,0.00683753697876853,0.358584560803472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,38727,-0.0030997175409527,0.00338395781933001,-0.00973227486683952,0.00353283978493412,0.359679864737562
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36391,0.0037705190588686,0.00411732805814151,-0.00429944393508876,0.011840482052826,0.359805986369731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,38727,0.00304646498497357,0.00332741527080726,-0.00347526894580866,0.00956819891575579,0.359909941919447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,38741,0.00505048249561144,0.00552361574348298,-0.0057758043616152,0.0158767693528381,0.360551161828913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36500,-0.00225832375035289,0.00247351554935329,-0.00710641422708534,0.00258976672637956,0.361259093117744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36430,-0.00557019900242892,0.00611744902338935,-0.017560399088272,0.0064200010834142,0.362553794278203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36339,-0.00211483470354686,0.00232446280060082,-0.00667078179272447,0.00244111238563075,0.362936841992662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,38741,-0.00603559130533654,0.006664983688836,-0.0190989593354551,0.00702777672478201,0.365179582893026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,36430,0.00371123458974847,0.00410015654124618,-0.00432507223109404,0.011747541410591,0.365406130020864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36421,-0.00684968232531084,0.007584896968756,-0.0217160803840726,0.00801671573345092,0.366506802438708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,38841,0.00265720711052918,0.00295370908879814,-0.00313206270351518,0.00844647692457354,0.368338530712347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,36619,0.00887809011109238,0.0098848172072891,-0.0104961516151943,0.028252331837379,0.369120293738582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,39099,0.00272627140579788,0.00304209371240774,-0.00323623227052128,0.00868877508211704,0.370169411511526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39093,0.00374497648775603,0.00418030402356354,-0.00444841939842851,0.0119383723739406,0.370340504493288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36363,-0.00739073588228069,0.00825602872701806,-0.0235725521872361,0.0087910804226747,0.370701368955984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,36806,-0.00186053130785059,0.00208218793770915,-0.00594161966576053,0.00222055705005935,0.371581304222232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,38741,-0.00541784607833348,0.00607877873111842,-0.0173322523913256,0.00649656023465862,0.372797605669798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36363,-0.00354176981167201,0.00398237228317107,-0.0113472194866873,0.00426367986334328,0.37382577464028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36391,-0.00554925670652657,0.00624098262149737,-0.0177815826446614,0.00668306923160828,0.373932047025653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,39099,-0.00645281405394756,0.0072624970327043,-0.020687308238048,0.00778168013015287,0.37427955442021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,36731,-0.0035169643108365,0.00396512139897511,-0.0112886022528277,0.00425467363115472,0.375108830141232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,38974,-0.00223144408129101,0.00251926702270469,-0.00716920744579221,0.00270631928321019,0.375765641038256
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39216,0.00491163345334268,0.00556052578411862,-0.00598699708352981,0.0158102639902152,0.37708598903213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,38951,-0.00884429114231619,0.0100160981370363,-0.0284758434909074,0.010787261206275,0.377246211142084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,36743,0.00213321842367651,0.00241826954004338,-0.00260658987480852,0.00687302672216154,0.377725134473355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36430,-0.00731273478177998,0.00830174265310441,-0.0235841503818646,0.00895868081830467,0.378406415072067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,36785,-0.00379319748743293,0.00431756898307994,-0.0122556326942696,0.00466923771940376,0.379661992366559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39099,-0.00434656231153016,0.00496376973731387,-0.0140755509966653,0.00538242637360503,0.381230045548965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36339,-0.00328248531045111,0.00374891355728794,-0.0106303558827355,0.00406538526183326,0.38127357493909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,36743,0.00805146509929588,0.0091991706370039,-0.00997890934923177,0.0260818395478235,0.381460655795757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36421,-0.00952668230399712,0.0108912933262812,-0.0308736172235083,0.0118202526155141,0.381750484524856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,39147,0.00444626315164999,0.00508381282483375,-0.00551800998502415,0.0144105362883241,0.381809561534663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,39093,-0.00193140352162799,0.00222098434525012,-0.00628453283831823,0.00242172579506224,0.384523993166361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,36421,-0.00360163218351608,0.00414210041199778,-0.0117201489910317,0.00451688462399958,0.384580307770152
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,36767,0.00453317860183323,0.00522367345117079,-0.00570522136246152,0.014771578566128,0.385512125904446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,39255,0.00310035576873422,0.0035783600739324,-0.00391322997617328,0.0101139415136417,0.386274449989189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36339,-0.00358011044664735,0.00413331844115933,-0.0116814145913196,0.00452119369802493,0.386419695291106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,36731,0.00338343605523808,0.00391071392268975,-0.00428156323323384,0.01104843534371,0.386961095559972
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,36743,0.00351816743453627,0.00406762742562598,-0.00445438231969065,0.0114907171887632,0.38709946233227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,36430,-0.00128743052254322,0.00149229245836008,-0.00421232374092898,0.00163746269584254,0.38830790242997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39260,0.00275104035311603,0.0031897051278266,-0.00350078169742412,0.00900286240365617,0.388439714260726
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,38832,0.0024818681573114,0.00287824365314911,-0.00315948940286085,0.00812322571748365,0.388544166230525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,36421,-0.00379068788750303,0.00442817023220978,-0.0124699015426342,0.00488852576762813,0.391992353248792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36339,0.00303510064168566,0.00355172678988757,-0.00392628386649398,0.0099964851498653,0.39282100839721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,36391,-0.00467331911647426,0.00547129631007379,-0.0153970598842189,0.00605042165127037,0.393037059468606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36363,-0.00261489452867703,0.00306315305872841,-0.00861867452378472,0.00338888546643067,0.393309162516406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,39252,0.00159029488909202,0.00186322625262259,-0.00206162856604825,0.00524221834423229,0.393386063243472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36363,0.00404130360918208,0.00473887350950162,-0.0052468884694411,0.0133294956878053,0.393787463246762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,39147,0.00421328373247531,0.00494645043114331,-0.00548175911256557,0.0139083265775162,0.394349980102599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,39283,0.00396220760268318,0.0046584576331729,-0.0051683693583357,0.0130927845637021,0.395037771857801
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36420,-0.00356488064312735,0.00419149474343834,-0.0117802103402665,0.0046504490540118,0.395061468834082
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,39099,-0.00653825653552278,0.00769832209508309,-0.0216269678418856,0.00855045477084007,0.395722550048306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,38841,-0.00609446768976855,0.00720463349909577,-0.0202155493479963,0.00802661396845916,0.397616761121219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39165,0.00321868815584862,0.00380640989892985,-0.00424187524605388,0.0106792515577511,0.397790912177034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,38832,0.00232155547201795,0.00274634589783264,-0.00306128248773403,0.00770439343176992,0.397942787739403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,36767,-0.00585222875605813,0.00692318039808168,-0.0194216623362982,0.00771720482418197,0.397953840875228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,36747,-0.00344375410754139,0.00407490627003856,-0.011430570396817,0.00454306218173418,0.398063735499009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,36767,-0.00252153896837502,0.0029975584345163,-0.00839675350002697,0.00335367556327693,0.400252827428691
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36339,-0.00249582168551097,0.00296835315002866,-0.00831379385956715,0.00332215048854521,0.400470367100883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,36747,-0.00681521329565666,0.00812006932560598,-0.0227305491738444,0.00910012258253105,0.401313849865555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36420,0.00242815997466451,0.0029009012062867,-0.00325760638965741,0.00811392633898644,0.402588019579511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,39106,0.00495334053493015,0.00592079147309934,-0.00665141075234455,0.0165580918222048,0.402829951175852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,36538,0.00400513477725055,0.00479156529866539,-0.00538633320813361,0.0133966027626347,0.403242726439304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39023,0.0033551343828006,0.0040217930925949,-0.00452758007868541,0.0112378488442866,0.404159777769546
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,36731,0.00441364891942271,0.00529836714671277,-0.00597115068813432,0.0147984485269797,0.404848574828644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,36743,0.00397194657774684,0.00478427401463018,-0.00540523049092832,0.013349123646422,0.406436102277295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36363,0.00401398583168425,0.00484268588113984,-0.00547767849534985,0.0135056501587183,0.407190431713358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,38741,0.00294157653611555,0.00354897474338343,-0.00401441396091596,0.00989756703314707,0.407201178697268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36363,-0.00545888633451568,0.00659844979510949,-0.0183918479329303,0.00747407526389892,0.408083792839039
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36430,-0.00368447792578169,0.00445519746504989,-0.0124166649572795,0.00504770910571609,0.408248991386074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,36538,-0.00290058185552962,0.00351571163979567,-0.00979137666952913,0.0039902129584699,0.409367775593284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,36796,-0.00196109195568017,0.00238157911046694,-0.00662898701219537,0.00270680310083503,0.410271941354201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,38832,-0.0035496945479816,0.0043166247996323,-0.0120102791552609,0.00491089005929771,0.410901612794702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36430,0.00634521268550016,0.00772538193389792,-0.00879653590493976,0.0214869612759401,0.41146470624874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36339,0.00266861916616323,0.00325798740905602,-0.00371703615558658,0.00905427448791303,0.412744710029045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,36363,-0.00458367192222234,0.0056035595272508,-0.0155666485956339,0.00639930475118923,0.413376828249762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,36731,0.00262455572180995,0.00320956132049384,-0.00366618446635797,0.00891529590997787,0.413526309901115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36363,-0.00707467291634169,0.00866502854864636,-0.0240581288716885,0.00990878303900517,0.414251083194151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,36339,0.00335284607496582,0.00411255680300238,-0.00470776525891885,0.0114134574088505,0.414933073336129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,36806,0.00141575456693661,0.00173703824134483,-0.00198884038609926,0.00482034951997249,0.415064763717928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,36743,0.00244433604051255,0.0029999814896928,-0.00343562767928533,0.00832429976031043,0.415211189715791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,36421,-0.00429696252616256,0.00527580103366878,-0.0146375325521534,0.00604360749982825,0.415393269858697
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,36430,-0.00745281348800454,0.00916524773309742,-0.0254166990448755,0.0105110720688664,0.41614169092491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,36420,0.00633626824373137,0.00779773125233376,-0.0089472850108428,0.0216198214983055,0.416475201907999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,38733,-0.00207848354102471,0.00256153783980353,-0.00709909770703963,0.0029421306249902,0.417137388851899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,36157,0.00314206082421568,0.00387947497921458,-0.0044617101350449,0.0107458317834763,0.41800235439205
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,36538,-0.00377732451872389,0.00466479608223858,-0.0129203248399115,0.00536567580246373,0.418098346247136
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,38832,-0.00387962907961879,0.0047921399526744,-0.0132722233868606,0.00551296522762303,0.41819346279332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36339,-0.00288814640075383,0.00357045728808773,-0.00988624268540578,0.00410994988389812,0.418587526365615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36430,-0.00347224330802803,0.00430356548802736,-0.0119072316645617,0.00496274504850559,0.419780023740477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36391,-0.00367671725673907,0.00456408943394013,-0.0126223325472617,0.00526889803378358,0.42050311585612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,39023,0.0132412950651835,0.0166197476926167,-0.0193334104123451,0.0458160005427121,0.425625801553255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,36538,-0.00285600860577193,0.0035892167445198,-0.00989087342503073,0.00417885621348687,0.426210173828943
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,36538,-0.00611722840319304,0.00768862973227822,-0.0211869426784583,0.00895248587207227,0.426267772286232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",36767,-0.00462588169246282,0.00581762704220425,-0.0160284306951832,0.00677666731025751,0.426541319077671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,38727,-0.00229755904100387,0.00288971521929776,-0.00796140087082747,0.00336628278881974,0.426578802083441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,36339,0.00405144710043727,0.00509601478819818,-0.00593674188443117,0.0140396360853057,0.426615456282721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,38705,0.00472256943314457,0.00594057597025802,-0.00692095946856115,0.0163660983348503,0.426644666010783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,36791,0.00420615966977887,0.00529449687733098,-0.00617105420978986,0.0145833735493476,0.42695395224677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,39106,-0.0049345858050022,0.00621772369547588,-0.0171213242481349,0.00725215263813052,0.42742192604045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36339,0.003556593416272,0.00448414103697158,-0.00523232301619229,0.0123455098487363,0.427705910007704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,39291,0.00670742333484879,0.00847234984669716,-0.00989838236467764,0.0233132290343752,0.428557156123007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36391,-0.0032947219343429,0.00416422312785175,-0.0114565992649323,0.00486715539624653,0.428843864081825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,36743,0.00535158493280764,0.00679938232585864,-0.0079752044258753,0.0186783742914906,0.431255791608687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,36610,0.00221791870718004,0.00282283553133118,-0.00331483893422908,0.00775067634858915,0.432054370060633
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39106,0.00215176235738324,0.00275155133464311,-0.00324127825851726,0.00754480297328374,0.434216206913378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,38727,0.00246650053683593,0.00315742195381921,-0.00372204649264973,0.00865504756632158,0.434711745540783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,39023,0.00222467314875493,0.00284861123646123,-0.00335860487470909,0.00780795117221895,0.434833729215929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,36339,0.0028607486429548,0.00366581020415665,-0.00432423935719224,0.0100457366431018,0.435178237927958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36430,-0.0015263100352795,0.00195622163383028,-0.00536050443758685,0.00230788436702785,0.435268023381065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,38727,-0.00212942496866375,0.00273152286874154,-0.00748320979139716,0.00322435985406966,0.435653910447226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,39093,0.00370178959191704,0.00475784386626321,-0.00562358438595884,0.0130271635697929,0.436557919097471
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,36743,0.00384879069614322,0.00495561641753052,-0.0058642174822166,0.0135617988745031,0.43737821813645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,36538,0.00281691007582806,0.00362845156007999,-0.00429485498192872,0.00992867513358483,0.43756307065708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36421,0.00450363508993457,0.00580364599359304,-0.00687151105750778,0.0158787812373769,0.437763006249391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,36737,0.00219955012673725,0.00283656334250506,-0.00336011402457267,0.00775921427804717,0.438101141670239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,39209,-0.00177012706029764,0.00228367826465451,-0.00624613645902049,0.0027058823384252,0.438280083943406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36363,-0.00277679241609922,0.00359060720934675,-0.00981438254641885,0.00426079771422042,0.439330497371946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,36743,0.00348650552924318,0.00450963693483634,-0.00535238286303605,0.0123253939215224,0.439463578962375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39241,-0.00440677468909875,0.0057068937527493,-0.0155922864444874,0.00677873706628987,0.440017046437297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,36743,-0.00468707854086034,0.00608273587924768,-0.0166092408641858,0.00723508378246511,0.440985263432801
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,38990,0.00454860247960227,0.00590442605543349,-0.00702407258904737,0.0161212775482519,0.441091490074789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,38841,-0.00428032388914746,0.00555709782273943,-0.0151722356217167,0.00661158784342181,0.441167032715923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,38741,0.00363369490917836,0.00472457269001654,-0.00562646756325406,0.0128938573816108,0.441842881404159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,38841,0.00357810499067485,0.00466344315938652,-0.00556224360172274,0.0127184535830724,0.442935010384955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,36311,-0.00243500138179195,0.00317454505608653,-0.00865710969172155,0.00378710692813765,0.443072587737325
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36430,0.00410942758591308,0.00536072714490151,-0.00639759761809388,0.01461645278992,0.443345514316375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,36743,0.00177241991854153,0.00231432749921489,-0.00276366197991965,0.00630850181700271,0.443781595076976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36507,-0.00349320770882527,0.00456268841336005,-0.012436076999011,0.00544966158136042,0.443926876076261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,38741,0.00346334071162784,0.00452714410587505,-0.00540986173588725,0.0123365431591429,0.444273749587258
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,36767,0.00183664794198649,0.00240395606195116,-0.00287510593943779,0.00654840182341078,0.444874884694585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,36363,-0.00659585782431926,0.00863510122060457,-0.0235206562167042,0.0103289405680657,0.44497548424104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,36538,-0.00288657820056945,0.00378015619256567,-0.0102956843379982,0.00452252793685928,0.445111827405709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,38832,-0.00418745393170364,0.00548547916392071,-0.0149389930929882,0.00656408522958096,0.445254391848516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36430,0.00313180264657997,0.0041039655653421,-0.00491196986149055,0.0111755751546505,0.445408414810656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36363,-0.00338655426535674,0.00444232361097466,-0.0120935085428671,0.00532040001215359,0.445872389276196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,38987,0.00266631753803247,0.00350913222136385,-0.00421158161584067,0.00954421669190561,0.447372546293559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,39093,-0.00307991012370381,0.00405380858696619,-0.0110253749541575,0.00486555470674992,0.447411508504794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,36791,-0.00538418142638639,0.00709552402101447,-0.0192914085075748,0.00852304565480198,0.447977790035031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,36538,-0.0059922255039894,0.00789724456400887,-0.0214708248494468,0.00948637384146798,0.448001741644831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,36767,0.00423005904151026,0.0055864482437105,-0.00671937951616232,0.0151794975991828,0.448943826344363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,39145,0.00179964475649665,0.00237906461035814,-0.00286332187980531,0.0064626113927986,0.449390762674961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,36339,-0.00359975646896953,0.00478653967327394,-0.0129813742285865,0.00578186129064739,0.452030236729179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,38721,0.00397916357736016,0.0052930812300109,-0.00639527563346121,0.0143536027881815,0.452203120875445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,36363,0.00256649297528541,0.00341553799528821,-0.00412796149547948,0.00926094744605029,0.452415937576317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36311,0.0059186053001881,0.00787799863567602,-0.00952227202573689,0.0213594826261131,0.452496644910348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39239,0.0063056647726907,0.00840331964027869,-0.0101648417222555,0.0227761712676369,0.453038658153799
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,39079,0.0030372509893014,0.0040477253163721,-0.00489629063078792,0.0109707926093907,0.453049541913885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,38741,0.00203543366297559,0.00272067430534807,-0.00329708797550663,0.00736795530145782,0.454390114148094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39023,0.00219353582844427,0.00293318956305851,-0.00355551571515041,0.00794258737203896,0.454572517278909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,36731,0.00242316664196953,0.00324976377685405,-0.00394637036066441,0.00879270364460346,0.455896153318923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,36792,0.00697107183457935,0.00942903590449673,-0.0115098385382342,0.0254519822073929,0.459726319232159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39147,0.00197064581413643,0.00266830522175569,-0.00325923242050472,0.00720052404877758,0.460198691886504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,38575,0.00167992015141848,0.00227756184123888,-0.00278410105740973,0.00614394136024668,0.460771842192594
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,38754,-0.00521807272106521,0.00708901231663466,-0.0191125368616691,0.00867639141953873,0.461694246436665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39241,-0.00351958329168603,0.00478384245676137,-0.0128959145069383,0.00585674792356625,0.461910461591135
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,36791,-0.0088946538347461,0.0121343874542782,-0.0326780532451314,0.0148887455756392,0.463564286311045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,36538,-0.00546056883933315,0.00745085174719151,-0.0200642382638285,0.0091431005851622,0.463646104416328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,38841,-0.00432183835007648,0.0058976036314566,-0.0158811414677314,0.00723746476757846,0.463684190548045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39023,0.00153228219252533,0.00209125213953265,-0.00256657200095866,0.00563113638600932,0.463746405294188
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,36339,-0.00392393430813452,0.0053709849063712,-0.0144510647246221,0.00660319610835303,0.465049429762156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,39099,0.00550629218973649,0.00755727731316426,-0.00930597134406547,0.0203185557235385,0.466252721767313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36373,0.00333374202031899,0.00457571291338967,-0.00563465528992476,0.0123021393305627,0.466276382137011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,38841,-0.00379179967810366,0.00521381193795932,-0.0140108710765039,0.00642727172029661,0.467077731557507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39283,0.00204539256395437,0.00281323192620194,-0.00346854201140144,0.00755932713931018,0.467199330663491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,36430,-0.00277405164801918,0.0038214118569069,-0.0102640188875567,0.00471591559151834,0.467899348586841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,39032,0.00282445872092403,0.00389565383655965,-0.00481102279873288,0.0104599402405809,0.468445938334516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,36733,0.00384926485093275,0.00531765393503052,-0.00657333686172707,0.0142718665635926,0.469161624623532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,36421,0.00252682115810153,0.00350278636076133,-0.00433864010899067,0.00939228242519373,0.470692487863091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,36391,-0.00333023145648272,0.00462495992749687,-0.0123951529143766,0.00573469000141113,0.471503772422639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39162,-0.00264367270689591,0.00367278421425947,-0.00984232976684447,0.00455498435305266,0.471658697561731
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,38773,0.00301611274192439,0.00420739952661857,-0.005230390330248,0.0112626158140968,0.473472252071455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,36538,-0.00429155448146099,0.00599704700770587,-0.0160457666165645,0.00746265765364251,0.474244585867565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,36500,-0.00325030855885319,0.00454466367117711,-0.0121578493543603,0.00565723223665395,0.474503422904767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36391,0.00213413525850639,0.00298708084975353,-0.00372054320701054,0.00798881372402332,0.474959096291495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,36421,0.00592836706096393,0.00830699686676366,-0.0103533467978928,0.0222100809198207,0.47545102760262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,36767,0.00426481567326194,0.00598285976809602,-0.00746158947220625,0.0159912208187301,0.475958286483855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,39099,0.0025218948464904,0.00354283751087626,-0.00442206667482707,0.00946585636780787,0.476581505408636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39023,-0.00153198527839966,0.00215330067823043,-0.00575245460773131,0.00268848405093199,0.476810755914675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39140,0.00490672608834038,0.00691032657893832,-0.00863751400637872,0.0184509661830595,0.477679596381725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39147,-0.00391544735536407,0.00551624079360848,-0.0147272793108367,0.00689638460010855,0.47783678728911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,36806,-0.00263178210666585,0.00370871823848066,-0.00990086985408795,0.00463730564075625,0.477952348096346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39106,-0.00589041376007756,0.00831037720092236,-0.0221787530738854,0.0103979255537303,0.478458061236367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,36767,-0.00265452169765661,0.00376795941775471,-0.0100397221564558,0.00473067876114262,0.481135104775413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36339,-0.00212054019219149,0.00301660257634299,-0.00803308124182375,0.00379200085744078,0.482096012846118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,36767,0.00371830774678808,0.00532110461425683,-0.00671105729715531,0.0141476727907315,0.484699034831436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,36767,0.00159790641900248,0.00229213228394364,-0.00289467285752705,0.00609048569553202,0.485736115505488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,36421,0.00308486822266448,0.00442785613243067,-0.00559372979689963,0.0117634662422286,0.486006157565828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,36747,-0.0148984756501931,0.0213863809130409,-0.0568157822397533,0.0270188309393672,0.486044566957372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36391,-0.00201812219472011,0.00289896461595707,-0.00770009284199596,0.00366384845255574,0.486346084860938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36363,0.00367064415753943,0.00527786669068859,-0.00667397455621022,0.0140152628712891,0.486768246102843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,36747,0.00366627757327738,0.00528600012024523,-0.00669428266240327,0.014026837808958,0.487956525307379
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36363,-0.00299890848438062,0.00433237845431446,-0.011490370254837,0.00549255328607573,0.488819358685182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36363,-0.00363771759683485,0.00525610089275738,-0.0139396753466393,0.00666424015296961,0.488890947870822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,36652,0.00267250780890526,0.0038752894288747,-0.00492305947168914,0.0102680750894997,0.490440711061577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,38741,-0.00426372931790854,0.00618559706835393,-0.0163874995718822,0.00786004093606516,0.490645524301961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39162,-0.00173616344135961,0.00252649966452115,-0.00668810278382107,0.00321577590110185,0.49197887187458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,38960,-0.00191491906659684,0.00278898504956057,-0.00738132976373556,0.00355149163054187,0.492344935100354
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,36363,-0.00393197020877166,0.00574375307741755,-0.0151897262405101,0.00732578582296673,0.493631380898328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36430,0.00159827825152309,0.00233536762126085,-0.00297904228614817,0.00617559878919434,0.493748032463649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36420,0.00307296254475178,0.00452077379020148,-0.00578775408404312,0.0119336791735467,0.496679982465706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,39106,0.00700621636357753,0.0103185692848005,-0.0132181794346314,0.0272306121617865,0.497153829328041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39106,-0.00183248959239715,0.00270123176287098,-0.00712690384762428,0.00346192466282998,0.497534514944918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36339,-0.00564224810693939,0.00831779795039307,-0.0219451320897098,0.010660635875831,0.497572298830544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,36743,0.00522968564506524,0.00772109290099361,-0.00990365644088223,0.0203630277310127,0.498212230871966
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,36421,-0.00494012000534211,0.00729976737162011,-0.0192476640537175,0.0093674240430333,0.498576836779938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39291,-0.00601457153427888,0.00889302814596501,-0.0234449067003703,0.0114157636318125,0.498844868844547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,36430,-0.00176135016067146,0.00260990959244667,-0.00687677296186693,0.00335407264052401,0.499770659047403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,36391,-0.00286382271232869,0.00427111644116012,-0.0112352109370025,0.00550756551234515,0.502545623818704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",36538,-0.00299602547784013,0.00447134144198498,-0.0117598547041307,0.00576780374845044,0.50283767256129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39023,0.00228155674407312,0.0034097154213986,-0.00440148548186814,0.00896459897001437,0.503420148395075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,38841,-0.00234079373003009,0.00350827038540723,-0.00921700368542825,0.00453541622536807,0.504640881824308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,39147,0.00226571287239436,0.00341193396726907,-0.00442167770345302,0.00895310344824173,0.506664926008701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,36500,-0.00172931470929769,0.00260966640859917,-0.00684426087015206,0.00338563145155669,0.507562093309286
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39023,0.00736723366309529,0.0111527893637813,-0.0144922334899161,0.0292267008161067,0.50889610122757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36420,-0.00162402358154773,0.00247865417082129,-0.00648218575635746,0.00323413859326199,0.512348560539861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,36731,-0.00213628084326955,0.00326246277535025,-0.00853070788295604,0.00425814619641694,0.512604241359764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39093,0.00137242490017389,0.00210201627823763,-0.00274752700517186,0.00549237680551964,0.513824936569667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,38987,0.00337486603960097,0.00517302628960988,-0.00676426548803439,0.0135139975672363,0.514155111226071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36420,0.00354165283248712,0.005453866563797,-0.007147925632555,0.0142312312975292,0.516102178874016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,36538,0.0025581853333945,0.00395420205351361,-0.00519205069149217,0.0103084213582812,0.51767367369179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39076,0.00377547505120026,0.00584996303397638,-0.00769045249539344,0.015241402597794,0.518687822877539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39241,0.00300297431462685,0.0046756794314189,-0.00616135737095419,0.0121673060002079,0.520717779562879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39099,0.002510810565553,0.00391012412259153,-0.0051530327147264,0.0101746538458324,0.520798012318467
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,39139,-0.0022109322880601,0.00344649849491943,-0.00896606933810217,0.00454420476198198,0.52120684350799
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39106,-0.00161671856550521,0.00252404536604401,-0.00656384748295147,0.00333041035194106,0.521839833046815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,38832,-0.00302156362945758,0.0047269729691688,-0.0122864306490284,0.00624330339011327,0.522691257929758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36420,-0.00584990518772507,0.0091567852028696,-0.0237972041853495,0.0120973938098993,0.522925562209807
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,38841,0.00246378086872493,0.00386227964677662,-0.00510628723895725,0.0100338489764071,0.523543019045524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39023,0.00607074104808966,0.00953490853758454,-0.012617679685576,0.0247591617817554,0.524339123966623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36430,-0.00128573108924636,0.00202838064355248,-0.00526135715060922,0.00268989497211649,0.526176732509409
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36363,0.00328919614700737,0.00520290448297231,-0.00690849663961836,0.0134868889336331,0.527277811405803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36430,-0.00257283295165224,0.00408394546493133,-0.0105773660629176,0.00543170015961315,0.528714476767455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36320,-0.00143380415792443,0.00227639562241336,-0.00589553957785462,0.00302793126200575,0.528799571329017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,36538,0.0033136497192288,0.00528357580521584,-0.00704215885899425,0.0136694582974519,0.530565366785253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,38841,0.00317762212043395,0.00510016539626082,-0.00681870205623725,0.0131739462971052,0.533265778895096
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36421,0.00197462686282978,0.0031718789797767,-0.00424225593753255,0.00819150966319211,0.533597048064692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39099,-0.00205171653718147,0.00330689882623795,-0.00853323823660785,0.0044298051622449,0.534980561533477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39283,-0.00151429563448045,0.00244973480905906,-0.00631577586023621,0.0032871845912753,0.536487729192649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36421,0.00172316464588931,0.00278983721351219,-0.00374491629259459,0.00719124558437321,0.536812148681723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,38677,-0.00380065923333659,0.00615604904034521,-0.0158665153524132,0.00826519688574001,0.536989562149431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39274,-0.00211488055535906,0.00343599042229304,-0.00884942178305342,0.0046196606723353,0.538228190287505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,36538,0.00203241245214672,0.00330578435985743,-0.00444692489317385,0.00851174979746728,0.538694600907993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36391,0.00152823795949147,0.00249242344223186,-0.00335691198728298,0.00641338790626591,0.539786028556952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,36806,-0.00108891902205686,0.00177981735824639,-0.00457736104421979,0.00239952300010607,0.540670884033884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,36731,-0.00155217620173138,0.00253809469316813,-0.00652684180034091,0.00342248939687815,0.540845183592336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,36731,-0.00279828029511348,0.0045791105659226,-0.0117733370043218,0.00617677641409482,0.54114622029391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,36363,-0.00263645438579961,0.00432019275117597,-0.0111040321781045,0.00583112340650528,0.54169860271126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39023,0.00622257558841092,0.0102066526688513,-0.0137824636425377,0.0262276148193595,0.542096989166494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36421,-0.00158655462767726,0.00260609012185524,-0.00669449126651352,0.00352138201115901,0.542676426837671
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39241,0.00145789668682806,0.00239590321044379,-0.00323807360564176,0.00615386697929788,0.542867774339995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,36702,0.00523347139257317,0.00862260459794971,-0.0116668336194083,0.0221337764045546,0.543896246271752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39162,-0.00686765223495577,0.0113228250143149,-0.0290603892630129,0.0153250847931014,0.544170740848759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,38832,0.00512276174633979,0.008450640634824,-0.0114404938979152,0.0216860173905948,0.54439244792921
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,39023,0.0022753303313869,0.00375407653258588,-0.00508265967248142,0.00963332033525522,0.54446015741886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,36796,-0.00258300531776343,0.00426733506782577,-0.0109469820507019,0.00578097141517507,0.544992261098112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,38832,0.00287260514889962,0.00474653708403644,-0.0064306075358118,0.012175817833611,0.54505516174487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36363,-0.00377231620088193,0.00625082880942451,-0.016023940667354,0.00847930826559011,0.54619333893526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,38741,-0.00255180143756555,0.00423102128429376,-0.0108446031547813,0.00574100027965022,0.546439959410785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39093,-0.00309393966755727,0.00515838653928595,-0.0132043772845577,0.00701649794944319,0.548656282195329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,38741,-0.00450351631785819,0.00753773357579205,-0.0192774741264106,0.0102704414906942,0.550207446667907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36420,-0.00409456474729835,0.00690107433094141,-0.0176206704359435,0.00943154094134683,0.552975826412737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36391,-0.00644580443443171,0.0108758982620231,-0.0277625650279969,0.0148709561591335,0.553413590160454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,36339,0.00380372513862908,0.00642606160030674,-0.00879135559797214,0.0163988058752303,0.553913762835669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,36747,-0.00203518314015369,0.00344578166462188,-0.00878891520281259,0.0047185489225052,0.554778499790644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,39093,0.00474532716972475,0.00803723643823707,-0.0110076562492199,0.0204983105886694,0.554919362343717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,36472,-0.00737518016234864,0.0125348263613769,-0.0319434398306473,0.01719307950595,0.556291059239157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36391,-0.00316647686589419,0.00538396131592541,-0.013719041045108,0.00738608731331962,0.556454677455445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,36391,0.00250038302552525,0.00426977889867647,-0.00586838361588063,0.0108691496669311,0.558154815007236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39140,0.00455289888363517,0.00778705809627407,-0.010709734985062,0.0198155327523323,0.558774839940579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,38391,0.00146634393184871,0.00250988167582473,-0.00345302415276775,0.00638571201646518,0.559075786016612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36391,-0.00328002345505686,0.00562041454678725,-0.0142960359667599,0.00773598905664615,0.559506007151412
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,36500,-0.00406867184439533,0.00699066342143502,-0.017770372150408,0.00963302846161731,0.560566873234334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36339,-0.00331991388377036,0.00571074889954026,-0.0145129817268693,0.00787315395932854,0.561018626941825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,39046,-0.00241460943769844,0.00415984612483083,-0.0105679078423669,0.00573868896696998,0.561615472218639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39023,-0.0031854623663682,0.00549309122332798,-0.013951921164091,0.00758099643135465,0.56198836812616
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36430,-0.00151737748978016,0.00261913727127328,-0.00665088654147578,0.00361613156191547,0.562368487467542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,36311,-0.0021143177596723,0.00365009840025437,-0.00926851062417085,0.00503987510482626,0.562431298291798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,36731,-0.00218396776189668,0.00377469511765809,-0.00958237019250655,0.00521443466871319,0.562881893272372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,36421,0.00117822557734548,0.00203919756881754,-0.0028186016575369,0.00517505281222786,0.563417054454411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,36421,-0.00163031035097588,0.0028243753358045,-0.00716608600915271,0.00390546530720095,0.563795353373457
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39064,0.00335073841533572,0.00580560506039035,-0.00802824750302937,0.0147297243337008,0.56384278341876
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,39283,0.00279586976050831,0.00486186598319632,-0.00673338756655647,0.0123251270875731,0.565258397147107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,38727,-0.00174492394293863,0.00303964802556575,-0.0077026340730475,0.00421278618717023,0.565939536111465
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,39023,-0.000966997668290741,0.0016853699411401,-0.00427032275292533,0.00233632741634385,0.566138805995076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,36339,0.00172618100787439,0.0030101374445511,-0.00417368838344576,0.00762605039919454,0.566346399921239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,36421,0.00178370894016075,0.0031133727494992,-0.00431850164885768,0.00788591952917918,0.56671011243376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,38727,-0.0029746090427926,0.00519311298208764,-0.0131531104876844,0.00720389240209917,0.566789573441649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,39283,-0.00266748380680819,0.00465992931480142,-0.011800945263819,0.00646597765020259,0.567038972122118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,38841,-0.00233616107998162,0.00408207187809328,-0.0103370219610444,0.0056646998010812,0.567128773774723
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,36538,-0.00379029284551707,0.00664342577574417,-0.0168114073659757,0.0092308216749415,0.568326438613476
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36421,0.00362183760109147,0.00637470535872476,-0.00887258490200906,0.016116260104192,0.569938082577435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,38832,-0.00236688800976966,0.0041706455742972,-0.0105413533353922,0.00580757731585286,0.570375439168857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36391,-0.00208619543698037,0.00367807282465094,-0.00929521817329621,0.00512282729933547,0.570589847761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36339,0.00217932360863751,0.00384973919293034,-0.00536616520950596,0.00972481242678098,0.571338410329976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,39046,0.00139010197812815,0.00245588413213775,-0.00342343092086184,0.00620363487711813,0.57138233672904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,39147,0.00109578500605633,0.00193849755981239,-0.00270367021117595,0.00489524022328861,0.57189474601591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,36767,-0.00276643500790588,0.00492433478393112,-0.0124181311844109,0.00688526116859911,0.574269833714094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,36731,0.00189733115369444,0.00338759285201783,-0.0047423508362605,0.00853701314364939,0.575432978277434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,36767,0.00176588276615508,0.00315408407139334,-0.00441612201377585,0.00794788754608602,0.575576592375541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,36538,-0.0036147273898009,0.00646992070659313,-0.0162957719747234,0.00906631719512163,0.576378172818554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36391,-0.00235086752774384,0.00420842529360292,-0.0105993811032056,0.00589764604771788,0.57643804518554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,39095,0.00110848670766839,0.00198812480113139,-0.00278823790254914,0.00500521131788592,0.577157245138635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",36767,-0.00386773624919352,0.00694648829773986,-0.0174828533127636,0.00974738081437661,0.577680469499496
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,36391,-0.00201728249723392,0.00362520077740385,-0.00912267602094547,0.00508811102647763,0.577905751417457
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,39241,0.00288504142462779,0.00519101747893749,-0.0072893528340897,0.0130594356833453,0.578372276401601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,38841,-0.00139650097523025,0.00251552988047828,-0.00632693954096767,0.00353393759050717,0.578799113875999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,36782,0.0027911754205168,0.00502971957890498,-0.00706707495413695,0.0126494257951705,0.578947640163278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,39283,0.00214258623322557,0.0038732362911019,-0.00544895689733414,0.00973412936378529,0.580150055673502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36430,-0.00229603668828752,0.00415242947178079,-0.0104347984529779,0.00584272507640282,0.580315592830267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,36792,0.0037814672166366,0.00684038684275849,-0.00962569099517004,0.0171886254284432,0.58039977501866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36339,0.00405427663274651,0.0073367386883024,-0.0103257311963262,0.0184342844618192,0.580547721847949
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36403,0.00391692918203954,0.0071399765582536,-0.0100774248721375,0.0179112832362166,0.583295706397545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,39106,-0.0011711167855444,0.00213924145178059,-0.00536403003103436,0.00302179645994555,0.584081140775994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39283,0.00110573757053472,0.00203335416254091,-0.00287963658804546,0.00509111172911489,0.586587112371211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36420,-0.00229471234410036,0.00422161294779865,-0.0105690737217857,0.005979649033585,0.5867519155541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36391,0.00177017575304233,0.00327003965357758,-0.00463910196796974,0.00817945347405439,0.588288676366044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36391,-0.00221833306368388,0.00409891910005257,-0.0102522144997869,0.00581554837241915,0.588379686655717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39162,0.00135945530087254,0.00251279942484061,-0.00356563157181505,0.00628454217356014,0.588507006366049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",36747,0.00186177048975346,0.00344240070157451,-0.00488533488533259,0.00860887586483951,0.588630722707453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,36731,-0.00166996712336823,0.00308793528419262,-0.00772232028038576,0.0043823860336493,0.588652184797038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,36430,-0.00277845214444471,0.0051444829126236,-0.012861638653187,0.00730473436429755,0.589148774813764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,36452,0.00317906195023986,0.00588859590272796,-0.00836258601910695,0.0147207099195867,0.589297912221922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36391,0.00229147163318249,0.00428450795422422,-0.00610616395709697,0.010689107223462,0.592778803279526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36391,-0.00161458107481672,0.00302782852279035,-0.0075491249794858,0.00431996282985236,0.593871930778238
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,36500,0.00319492941927973,0.00600829444328143,-0.00858132768955187,0.0149711865281113,0.594906328873837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,36538,0.00250386940310011,0.00471719505602992,-0.00674183290671854,0.0117495717129188,0.595569282965204
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,36391,-0.0021889278744191,0.00413151315342275,-0.0102866936551277,0.00590883790628948,0.596251229891018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39089,0.00268053872585988,0.00508236919821076,-0.0072809049026332,0.012641982354353,0.597910247132772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,38987,-0.00169286085172671,0.00321191073570519,-0.00798820589370888,0.00460248419025546,0.598161558932971
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,38951,0.002221394381195,0.00421937594060653,-0.00604858246239381,0.0104913712247838,0.598566213027958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,36791,0.00186362157342973,0.00355625917937244,-0.00510664641814026,0.00883388956499972,0.600259795751759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,36743,-0.00119979124672879,0.0022903124986811,-0.00568880374414376,0.00328922125068617,0.600388530812481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,38658,-0.00397398515601446,0.00761307763925441,-0.0188956173289531,0.0109476470169242,0.601681927319431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,36767,-0.00128663481101147,0.00246485125278947,-0.00611774326647883,0.00354447364445589,0.601684243734581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,38987,-0.00057521351975873,0.00110197297129837,-0.00273508054350353,0.00158465350398607,0.601688317440434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,38741,0.0022003759477601,0.00421610423058826,-0.00606318834419289,0.0104639402397131,0.601749187751854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39099,-0.00166312200137849,0.00319176227190446,-0.00791897605431123,0.00459273205155425,0.602327667760065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,38841,0.0014456672524961,0.00277929335951911,-0.00400174773216137,0.00689308223715356,0.60296225125451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39066,-0.00166350637176031,0.00320468033412023,-0.00794467982663597,0.00461766708311535,0.603707960577873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,36767,0.00434138001331297,0.00840073679025357,-0.012124064095584,0.02080682412221,0.605314670373578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39153,-0.00152254198444629,0.00296503668387879,-0.00733401388484872,0.00428892991595613,0.607610055678969
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39023,-0.003879641067843,0.00757188697218858,-0.0187205395333326,0.0109612573976466,0.608396464846862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36430,0.00197643582384171,0.00385770749055614,-0.00558467085764833,0.00953754250533175,0.608426073099962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,36743,-0.0027410668459642,0.00535356759453729,-0.0132340593312573,0.00775192563932889,0.608654525824565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36421,-0.00198642683219117,0.00388527848557238,-0.00960157266391302,0.00562871899953069,0.609170904995125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,36670,-0.00114771700586944,0.00224573943962236,-0.00554936630752927,0.00325393229579038,0.60931491828936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,36747,-0.00328689037195104,0.00643260230292083,-0.0158947908856759,0.00932101014177379,0.609378250926506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,38741,-0.00294345903833543,0.00579418534918975,-0.0143000623227473,0.00841314424607649,0.611459313811764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,38645,-0.00294574919895591,0.00579995482914184,-0.0143136606640739,0.0084221622661621,0.611536838469633
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,36767,0.00277386357257277,0.00548435722709556,-0.00797547659253454,0.0135232037376801,0.613021609958803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",38939,-0.00180785871139271,0.00358962820487084,-0.00884352999293956,0.00522781257015413,0.614525972356453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,36792,-0.00180365298410305,0.00358698683673514,-0.00883414718410392,0.00522684121589781,0.615090717276385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,36538,0.00230247220850456,0.00458065788390628,-0.00667561724395175,0.0112805616609609,0.615218405578041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,39255,0.00148906132885188,0.0029653141585144,-0.00432295442183635,0.00730107707954011,0.615562356010159
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39023,0.00119100667982299,0.00237181696544649,-0.00345775457245214,0.00583976793209811,0.6155696614429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39241,-0.00119469545445231,0.00242088484335986,-0.00593962974743763,0.00355023883853301,0.621669658679368
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,38664,0.00519520941562167,0.0105427247844995,-0.0154685311619974,0.0258589499932407,0.622177665056038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,36743,-0.00338599345672892,0.00689566860174236,-0.016901503916144,0.0101295170026861,0.62341222905729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,38987,0.00194567020229731,0.00396337320714599,-0.00582254128370883,0.00971388168830345,0.62349532275373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36363,-0.00180746398078997,0.00368993102667663,-0.00903972879307616,0.00542480083149622,0.624257987003176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39241,-0.00244831985574964,0.00501454952884867,-0.012276836932293,0.00738019722079376,0.625384527913656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,38841,-0.00136565780491695,0.00279889539647301,-0.00685149278200404,0.00412017717217014,0.625608393515393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,38832,-0.00116587560547055,0.00241086950986031,-0.00589117984479676,0.00355942863385566,0.62868299754514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,39206,0.00257418337517663,0.00532798302188895,-0.0078686633477257,0.013017030098079,0.629000340691695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,36767,-0.00208037437653255,0.00431107066856182,-0.0105300728869137,0.00636932413384862,0.629412397683713
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",38741,-0.00189260359758209,0.00392293948331067,-0.009581564984871,0.00579635778970682,0.62949676503964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,36430,-0.00274460773306887,0.00568925675462158,-0.0138955509721272,0.00840633550598943,0.629516454868764
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,36712,0.00250156018967573,0.00519481054213973,-0.00768026847291813,0.0126833888522696,0.630133964676761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36339,0.00292450973857859,0.00608468549946119,-0.00900147384036535,0.0148504933175225,0.630784720710569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,38741,-0.0029713053121592,0.00620549100281606,-0.0151340676776787,0.00919145705336027,0.632074627044046
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",36747,0.00108116632592392,0.00226452331171448,-0.00335729936503646,0.0055196320168843,0.633059349141692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,36791,0.00168719881609244,0.00353722037287105,-0.00524575311473483,0.0086201507469197,0.633381315252798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,39092,-0.00168101263700315,0.00352491044985734,-0.00858983711872353,0.00522781184471722,0.633443639562329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36466,-0.00368970897203425,0.00774441060378942,-0.0188687537554615,0.011489335811393,0.633772697354975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36430,-0.00159140667082221,0.00334303470782555,-0.00814375469816028,0.00496094135651586,0.634056620363934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,38841,-0.0061118646892958,0.0128530792179221,-0.0313038999564232,0.0190801705778316,0.634425063215888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,36667,-0.00121024177933272,0.00254870999923017,-0.00620571337782385,0.00378522981915841,0.634905670395759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,38741,0.00236971606449592,0.00501682852451011,-0.00746326784354389,0.0122026999725357,0.636681479608904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,39057,0.00169805318251985,0.00359610068957589,-0.00535030416904889,0.00874641053408859,0.636795893287479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36363,-0.00197501089180061,0.00419046485048165,-0.0101883219987446,0.00623830021514343,0.637427104277448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,39093,-0.00794681437170249,0.0169409731923241,-0.0411511218286577,0.0252574930852527,0.639013148277793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,36743,-0.00105027514886053,0.00224136079289351,-0.00544334230293182,0.00334279200521076,0.639371964164887
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36430,-0.00134203357874412,0.00287257440597573,-0.00697227941445656,0.00428821225696831,0.640373155782018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36339,0.00107317919511657,0.00230060756096183,-0.00343601162436861,0.00558237001460174,0.640882659881577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39283,-0.00162895720382546,0.00349417170187489,-0.00847753373950025,0.00521961933184934,0.641084186010437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,36102,0.00291665604672463,0.00626237430838793,-0.00935759759771572,0.015190909691165,0.64140786376877
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,36430,0.00194760439995892,0.00418347736085049,-0.00625201122730804,0.0101472200272259,0.641548012926424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,39099,0.00382802183754832,0.0082333097302653,-0.0123092652337717,0.0199653089088683,0.641978735589788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36363,-0.00126382037369378,0.002720662450148,-0.00659631877598386,0.0040686780285963,0.642278516984317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36421,-0.00325729497514802,0.00704084465531837,-0.017057350499572,0.010542760549276,0.643638733730216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36391,0.00157244654145779,0.00340536747350978,-0.00510207370662138,0.00824696678953697,0.644264812002963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39255,0.00103450193142136,0.00225678398080447,-0.0033887946709554,0.00545779853379812,0.64667405930183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36500,-0.00284799153779468,0.00622834004340266,-0.0150555380228639,0.00935955494727454,0.647489638878476
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,38727,-0.00185024312258915,0.00405076551717823,-0.00978974353625847,0.00608925729108018,0.647847488219007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,36538,-0.00280038156663962,0.00613960231462593,-0.0148340021033064,0.0092332389700272,0.648313122825123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,38741,0.00325271919057912,0.00713725563836768,-0.0107363018606215,0.0172417402417798,0.648584984245107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36421,-0.00252187820368743,0.00554498965319423,-0.0133900579239481,0.00834630151657325,0.649258795950714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36414,-0.00242754300268437,0.00536808945025183,-0.012948998325178,0.00809391231980922,0.651120248330799
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,36791,-0.00179587405591329,0.00398502114300889,-0.00960651549621072,0.00601476738438414,0.652244988431383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,36767,0.00198217747600878,0.00440147965338406,-0.00664472264462397,0.0106090775966415,0.652470386940982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,36391,-0.00219494346797235,0.00488280542932609,-0.0117652421094515,0.00737535517350679,0.653060699893779
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39099,-0.00265897933145831,0.00592436319301018,-0.0142707311897583,0.00895277252684164,0.653567082919346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,36363,-0.00259704159764085,0.00579576499117069,-0.0139567409803354,0.00876265778505369,0.654093859414134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36391,-0.00401139952135218,0.00896671047875169,-0.0215861520597055,0.0135633530170011,0.654618704270649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,39106,-0.00172300759339853,0.00385700554237535,-0.00928273845645421,0.00583672326965716,0.655082446829154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,38741,0.00255262258826673,0.00574595727757806,-0.00870945367578626,0.0138146988523197,0.656870688306758
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,36531,-0.00390961230229243,0.00880246585019439,-0.0211624453686734,0.0133432207640886,0.656941962438609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,36339,-0.00239437688774171,0.00539604554928458,-0.0129706261643395,0.00818187238885606,0.657246890447213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,36743,0.00283377581549451,0.00639721870487742,-0.00970477284606523,0.0153723244770543,0.657794889259268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,38987,-0.00195446845422176,0.0044176973759439,-0.0106131553110718,0.00670421840262828,0.658193144204155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,38727,0.00174992282636981,0.00395828564041253,-0.00600831702883876,0.00950816268157837,0.658429719923327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,36421,0.0024200937336012,0.00547808496113946,-0.00831695279023213,0.0131571402574345,0.658657951742339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,36792,0.00253045703806703,0.00573149525298636,-0.00870327365778623,0.0137641877339203,0.658858205262332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36420,-0.0040563532324014,0.00921154011120888,-0.0221109718503708,0.013998265385568,0.659687158293173
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,36538,0.0025448296678687,0.00579879194947628,-0.00882080255310481,0.0139104618888422,0.660773980164152
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,36743,0.00166632047013037,0.00379936095726352,-0.00578042700610613,0.00911306794636687,0.660973867263008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,38841,0.00192813692155118,0.00442298943960145,-0.00674092238006767,0.01059719622317,0.662890004302327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,36743,-0.0099097305472923,0.0227421465502588,-0.0544843377857995,0.0346648766912149,0.66303052402906
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,39211,-0.00240662607677223,0.0055296470744857,-0.0132447343427642,0.00843148218921974,0.663407149010081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,36538,0.00223059426324287,0.00514735291152562,-0.00785821744334735,0.0123194059698331,0.664769460926917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,36731,0.00236369979528552,0.00545907621155877,-0.00833608957936966,0.0130634891699407,0.665032698563899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,36731,-0.00417806316175603,0.00966771789713404,-0.0231267902401387,0.0147706639166267,0.665627693471334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39182,-0.000776643110716995,0.001806656264993,-0.00431768939010328,0.00276440316866929,0.667289899929016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,36747,0.00415814385435379,0.00968169920600365,-0.0148179865894134,0.023134274298121,0.667577542656946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,38841,-0.00110336555138198,0.00257134374272909,-0.00614319928713099,0.00393646818436703,0.667856070380561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36363,-0.00187249752473639,0.00437112827118847,-0.0104399089362658,0.006694913886793,0.668382929004899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,36629,0.00113024700493972,0.00267336869279958,-0.00410955563294747,0.0063700496428269,0.672462848737274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36339,-0.00191775649706033,0.00454134487389084,-0.0108187924498864,0.00698327945576572,0.672821922017568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36421,0.0029074301788364,0.00688669529997314,-0.0105904926091109,0.0164053529667838,0.67290031766929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36339,0.00233175813451821,0.00552412348975134,-0.00849552390539441,0.0131590401744308,0.672955915941799
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39093,0.00106368022822201,0.00253079526809293,-0.00389667849724014,0.00602403895368416,0.67427599689904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36421,-0.00176308294017225,0.00422637670159364,-0.0100467812752958,0.00652061539495129,0.676567188638968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,38741,0.00195700910603574,0.00469176623598464,-0.00723885271649416,0.0111528709285656,0.67659983806601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,38741,-0.00528660271032237,0.012698246740926,-0.0301751663225374,0.0196019609018926,0.677177909580195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39291,-0.0012045926156811,0.00291161555121033,-0.00691135909605336,0.00450217386469115,0.679085171888675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,36430,0.000955464542743259,0.00231209450094257,-0.00357624067910418,0.0054871697645907,0.679433204105862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,39023,0.00055492601998067,0.00134422315937163,-0.00207975137238773,0.00318960341234907,0.679742254474565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,38705,-0.00153980923974789,0.0037322027921034,-0.00885492671227055,0.00577530823277478,0.679924828460735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36421,-0.00214873654125136,0.00520953031030002,-0.0123594159494394,0.00806194286693667,0.680007409683821
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39180,0.000885730690181873,0.0021498250352226,-0.00332792637885443,0.00509938775921817,0.680344241204529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36339,-0.00200175303685303,0.00487528598805411,-0.0115573135734391,0.00755380749973304,0.68137883858018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36391,0.00185855699799919,0.00454275354039584,-0.00704523994117665,0.010762353937175,0.682454445233375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39234,-0.00116865814848775,0.00285851618059973,-0.00677134986246323,0.00443403356548773,0.682667298300897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,38841,0.0024456398961075,0.00602468737751803,-0.00936274736382784,0.0142540271560428,0.684795130655965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,39023,0.00197044444643171,0.00485779923835793,-0.00755084206074983,0.0114917309536133,0.685023936056537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36339,0.00157576491407345,0.00389847699161932,-0.00606524998950043,0.00921677981764732,0.68607248363118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,36737,-0.00273033108883328,0.00675882396145839,-0.0159776260532917,0.0105169638756252,0.686244864168103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,36286,-0.00124340985856849,0.00308257239465172,-0.00728525175208586,0.00479843203494889,0.686684751490167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36339,-0.00317425869680641,0.00787251238267549,-0.0186043829668504,0.0122558655732376,0.686802242019898
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36391,0.00203678173556461,0.00505320949709943,-0.00786750887875027,0.0119410723498795,0.6869058502448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,38841,0.00103325287449002,0.0025659073426528,-0.00399592551710947,0.0060624312660895,0.687185579385726
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,39099,0.0012117873127498,0.00301733356086635,-0.00470218646654824,0.00712576109204785,0.687977681222498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,36731,-0.00165635554416792,0.00412640506681564,-0.00974410947512657,0.00643139838679072,0.688129360920342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,36391,0.00173862397060784,0.00438761840834824,-0.00686110810975471,0.0103383560509704,0.691922282710565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,36806,-0.000937276178000449,0.00238301885740262,-0.00560799313850959,0.00373344078250869,0.694093591411745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,36363,0.00227260138427756,0.00577913145567835,-0.009054496268852,0.0135996990374071,0.694146923390878
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,38741,0.00300410375522973,0.00765099312904857,-0.0119918427777055,0.0180000502881649,0.694589295666763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,36363,0.00194131526408457,0.00495184449382515,-0.00776429994381272,0.0116469304719819,0.695036214010326
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,36430,0.00153585873141147,0.00392033365123912,-0.0061479952250172,0.00921971268784014,0.695236761632369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,38832,-0.00441572225256399,0.0112962938660413,-0.0265564582300048,0.0177250137248769,0.695876651887329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39023,0.00072881798139025,0.0018701650509758,-0.00293670551852232,0.00439434148130282,0.696758072317727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,38741,-0.00129897237204864,0.00333657863315178,-0.00783866649302613,0.00524072174892885,0.697050427772168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,39291,-0.00139371835535531,0.00358177171279767,-0.00841399091243873,0.00562655420172811,0.69719701383986
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,38727,0.00210271171323404,0.00541026891557753,-0.00850141536129793,0.012706838787766,0.697539176661081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,38741,-0.00164743165803471,0.00423926683752671,-0.00995639465958707,0.00666153134351764,0.697568452570233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,38832,0.000946897229527385,0.00244615519215334,-0.00384756694709316,0.00574136140614793,0.698690538036859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39093,0.00147923881468177,0.00383972489782031,-0.00604662198504604,0.00900509961440958,0.700060514102281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39106,-0.00235011874055631,0.00610576960918707,-0.014317427174563,0.00961718969345035,0.700315901995106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39237,-0.00197450309262738,0.00516143357094139,-0.0120909128916725,0.00814190670641773,0.702059213462848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,36731,-0.00154061442630018,0.00403547783833019,-0.00945015098942736,0.006368922136827,0.702640103872959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36391,0.00170023972805706,0.00445799801358413,-0.00703743637856784,0.010437915834682,0.702919703077989
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36391,-0.00117662712799466,0.00308618867491561,-0.00722555693082926,0.00487230267483993,0.703019960516989
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36339,-0.00204879925039491,0.00537934044917523,-0.0125923065307784,0.00849470802998853,0.703310356106893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36420,-0.00145451425981352,0.00381957930332031,-0.00894088969432133,0.00603186117469429,0.703354512920075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,38727,0.00182109346672974,0.00478682576017767,-0.00756108502321851,0.011203271956678,0.703625273978252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,36743,0.00113168222356834,0.00297924993786119,-0.00470764765463959,0.00697101210177626,0.704059504026032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39095,0.00101303423197765,0.00267279859379495,-0.00422565101186045,0.00625171947581576,0.704681042062015
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,36792,-0.00247687110456212,0.00656124552234235,-0.0153369123283531,0.0103831701192289,0.705808155203582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,36339,-0.00122327906714761,0.00324053182557761,-0.00757472144527973,0.0051281633109845,0.705813458968135
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36430,-0.00218411500176426,0.00578789065153723,-0.0135283806787772,0.00916015067524871,0.705912897786062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,36686,0.00205231727420055,0.00548191200931076,-0.00869223026404854,0.0127968648124496,0.708127937719287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,36767,-0.00526834016176045,0.0140974623637645,-0.0328993663947389,0.022362686071218,0.708627410143183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39099,-0.00137126376324482,0.00367275239602615,-0.00856985845945608,0.00582733093296644,0.708884720742468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,36430,0.00158005734699751,0.00423930322199341,-0.00672897696810958,0.00988909166210459,0.709365899039684
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,38727,-0.00328929111182944,0.00882800985332448,-0.0205921904243454,0.0140136082006865,0.709453622495998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,36363,0.00257274390862583,0.00693796647685841,-0.0110256703860167,0.0161711582032683,0.71077711540369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",36792,-0.00290791532550786,0.00786950329370301,-0.0183321417811658,0.01251631113015,0.711748447278993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39136,0.0010941914754242,0.00297733706644294,-0.00474138917480397,0.00692977212565237,0.713246147411579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,36731,-0.00273500796466685,0.00744828929612868,-0.0173336549850791,0.0118636390557454,0.713476263314069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,38727,-0.00115504549249859,0.00315095763898912,-0.00733092246491726,0.00502083147992008,0.713945254254428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39224,0.0015198593889959,0.00414763356858845,-0.00660950240543746,0.00964922118342927,0.714041724553889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36391,0.0016765683264463,0.00457993405303781,-0.00730010241750782,0.0106532390704004,0.714320347295984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,36731,0.00156959389384245,0.00432393996405218,-0.00690532843569982,0.0100445162233847,0.716610208323903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,36747,-0.00281503779175191,0.00777289703090456,-0.0180499159723248,0.012419840388821,0.717237887832377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,36538,-0.00217516527025357,0.00603016087716821,-0.0139942805895033,0.00964395004899612,0.718319042034137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,38841,0.00180026963052802,0.00502766920136069,-0.00805396200413892,0.011654501265195,0.72029417013651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36421,0.00106451095828431,0.00301441630242562,-0.0048437449944699,0.00697276691103852,0.72398941618301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",38841,-0.00383722178202778,0.0108744381122718,-0.0251511204820804,0.0174766769180249,0.724193707014683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36420,0.00220623374611982,0.00625540421907672,-0.0100543585232706,0.0144668260155102,0.724324949528381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,36743,0.00187499904698342,0.00538963497711908,-0.00868868550816998,0.0124386836021368,0.727928627785728
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,36703,-0.00138764873777049,0.00402139045466181,-0.00926957402890763,0.00649427655336665,0.730049727715829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36499,0.00162595288347222,0.00471412427075458,-0.00761373068720676,0.0108656364541512,0.730167088949558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,38727,-0.00202102933308447,0.00588530585427503,-0.0135562288074635,0.00951417014129459,0.731300459502765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,36500,0.00114024050357508,0.00332980249302068,-0.00538617238274546,0.00766665338989562,0.732029339727722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,36430,0.00177075442361668,0.00519405037962581,-0.00840958432044991,0.0119510931676833,0.733169684323557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,39140,0.00251107530734309,0.00737431916697665,-0.0119425902599311,0.0169647408746173,0.733472489239403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,38841,0.00144346240977953,0.00424584002361703,-0.00687838403650985,0.00976530885606891,0.733883145695201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,36538,0.00158722966520051,0.00474322907669184,-0.0077094993251155,0.0108839586555165,0.737909282956804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,38987,-0.00167311211816373,0.00500162081311417,-0.0114762889118675,0.00813006467554004,0.737996376059814
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36430,-0.000885517915844619,0.00265802574884664,-0.00609524838358403,0.00432421255189479,0.739027569589226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36500,-0.00199645836658016,0.00599564291368068,-0.0137479184773943,0.00975500174423397,0.739151227862886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36421,0.00203246425188736,0.00617948695723573,-0.0100793301842947,0.0141442586880694,0.742232966699269
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,36731,-0.00121418148228313,0.00371272366635555,-0.00849111986834,0.00606275690377373,0.74364858556831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39023,0.00190132815999624,0.0058344031481165,-0.00953410201031209,0.0133367583303046,0.744517977126403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,36339,0.00209231970406568,0.0065044339509202,-0.0106563708397379,0.0148410102478693,0.747703618115528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39255,-0.00161027499426213,0.00500674647468694,-0.0114234980846485,0.00820294809612426,0.747744171025056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,36743,-0.000950857986771706,0.00295926125528271,-0.00675101004712581,0.0048492940735824,0.747976145688901
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,36792,0.00207582588569823,0.00648501104497675,-0.0106347957624562,0.0147864475338527,0.748900753682019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36391,0.00109955014098443,0.00347410653178512,-0.00570969866131441,0.00790879894328328,0.751629296785381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,38727,-0.00220894845352285,0.00700999475784424,-0.0159485381788976,0.0115306412718519,0.752679417158886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36421,-0.00101701917953377,0.00323016097946522,-0.0073481346992856,0.00531409634021806,0.752880072046156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36466,-0.0010892990751069,0.0034682359037169,-0.00788704144639201,0.00570844329617821,0.753466452562511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',36391,-0.00120399949918186,0.0038366577691725,-0.00872384872675995,0.00631584972839623,0.753667023915109
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36500,-0.000592817729883768,0.00189661805322243,-0.00431018911419973,0.00312455365443219,0.754615804817377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,38727,-0.00258162194622594,0.00829019852531873,-0.0188304110558506,0.0136671671633988,0.755495957543549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,39108,-0.000760031201485245,0.00244298924455594,-0.0055482901208149,0.00402822771784441,0.755723487029899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,36421,-0.00222768085866599,0.00716121691457419,-0.0162636660112314,0.0118083042938994,0.75574820470311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36421,-0.00101495610437154,0.00326490529694948,-0.00741417048639251,0.00538425827764943,0.755905775595284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36430,-0.00167760570781554,0.00541209736259179,-0.0122853165384954,0.00893010512286437,0.756586395123176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36430,0.0014807557304568,0.0047778468530305,-0.00788382410148299,0.0108453355623966,0.756626066110219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36421,-0.00146642961388292,0.00476701105102817,-0.0108097712738981,0.00787691204613228,0.758376332799455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,38727,-0.00086568268640839,0.00281848988033059,-0.00638992285185635,0.00465855747903957,0.758737953685277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,38987,0.000798985923644647,0.00260738358500994,-0.00431148590297483,0.00590945775026412,0.759279918562499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,38727,-0.0012953974959091,0.00424348565222382,-0.00961262937426779,0.00702183438244959,0.760166836590408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,39068,0.000719434928429903,0.00235712864424977,-0.00390053721429965,0.00533940707115946,0.760205322741929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,38972,0.00158633627895861,0.00520919816376507,-0.00862369212202093,0.0117963646799382,0.760731381073347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36420,0.00209687181557596,0.00689062611392251,-0.0114087553677121,0.0156024989988641,0.760898384713669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36339,-0.0015046750358247,0.00496230735410499,-0.0112307974498705,0.00822144737822109,0.761726617937003
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36430,0.0014771151846907,0.00493139286576845,-0.00818841483221546,0.0111426452015969,0.764538305046627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36430,-0.000738352770698057,0.00248012600758417,-0.00559939974556304,0.00412269420416692,0.765931136386995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,39093,-0.000628459279456481,0.00211461541211622,-0.00477310548720428,0.00351618692829132,0.766319470374021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39162,0.000533968315131407,0.00180671825418496,-0.00300719946307112,0.00407513609333393,0.767580844017735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,39114,0.00164914911049382,0.00560191389969276,-0.009330602132904,0.0126289003538916,0.768463684409497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,38832,-0.0015785175204953,0.00537081667703875,-0.0121053182074913,0.00894828316650065,0.768833483670584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,36747,0.00200094093509099,0.00686414178539824,-0.0114527769642896,0.0154546588344715,0.770668777931183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36430,0.000770273838336177,0.00265815344582363,-0.00443970691547814,0.00598025459215049,0.7719910176666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36420,0.00207468108742241,0.00720909568545865,-0.0120551464560765,0.0162045086309214,0.773514848691431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,39237,-0.00136080408261881,0.00476023511227242,-0.0106908649026728,0.00796925673743514,0.774982239088314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39283,-0.0008882949957462,0.00312230536546814,-0.00700801351206375,0.00523142352057135,0.776031269747307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39291,0.00091542994640761,0.00322596325983581,-0.00540745804287057,0.00723831793568579,0.776590844962107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,36743,0.00165222138503175,0.00584939027621033,-0.0098125835563405,0.013117026326404,0.777595009525376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,38841,-0.00208978647710414,0.00747317149331334,-0.0167372026039983,0.01255762964979,0.779758725754081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39162,-0.00259733990383398,0.00932933837793868,-0.0208828431245938,0.0156881633169258,0.780704794926717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,38987,0.00103598898840251,0.00373981566595344,-0.00629404971686622,0.00836602769367125,0.781771562086752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36320,-0.00118403367755135,0.00427695382760487,-0.0095668631796569,0.0071987958245542,0.781907238059403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36430,0.00188837686631095,0.00684841056291724,-0.0115345078370069,0.0153112615696287,0.782752736477435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,36792,0.00264509700429397,0.00964217694641805,-0.0162535698106854,0.0215437638192733,0.783838712685899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,39255,-0.000711482375105545,0.00260131287000605,-0.00581005560031741,0.00438709085010632,0.784465675573718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36430,0.000679825856325383,0.00249393898662292,-0.00420829455745554,0.00556794627010631,0.785171943969382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36339,0.000982939157154785,0.00365342611596746,-0.00617777603014145,0.00814365434445102,0.787898842994623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,36363,0.00204407952765118,0.00762590616972279,-0.0129026965650055,0.0169908556203078,0.788669757711529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,38841,-0.00216001188557596,0.00809608619701131,-0.0180283408317181,0.0137083170605662,0.789629100576557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39271,-0.00124184845750108,0.00467916859221312,-0.0104130188982388,0.00792932198323664,0.790705361251288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36430,-0.00153016202682869,0.00579218382139424,-0.0128828423167614,0.00982251826310403,0.791647826505284
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,36538,-0.00102103606370398,0.00387567036566066,-0.00861734998039887,0.00657527785299092,0.792209886387859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,36796,0.00162873615351733,0.00618386825173778,-0.0104916456198887,0.0137491179269234,0.7922582933345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,38832,0.00141142420289866,0.00537130951458561,-0.00911634244568913,0.0119391908514865,0.792730728798547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,38841,0.00155137458751115,0.00592326558978195,-0.0100582259684615,0.0131609751434838,0.793392856118622
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,38841,0.00146221743318117,0.0055865671706187,-0.00948745422123149,0.0124118890875938,0.793526969001918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39291,0.00179732776443457,0.00686916130784516,-0.011666228398942,0.0152608839278111,0.793593470017122
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,36731,0.00187524229372751,0.00717004114040243,-0.0121780383414612,0.0159285229289163,0.793681395938875
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,36420,-0.00164051341506152,0.00635220087730965,-0.0140908271345884,0.0108098003044654,0.79621121316498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39033,0.000600237764897212,0.00232730103728924,-0.0039612722681897,0.00516174779798413,0.796478686138382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,36538,-0.00136208641385859,0.00532015774312334,-0.0117895955903803,0.00906542276266315,0.797936699036839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39099,0.00339737160884252,0.0133074849510852,-0.0226852988952845,0.0294800421129695,0.798496545693274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,36731,0.00121050041172589,0.0047659545559741,-0.00813077051798335,0.0105517713414351,0.799508051780891
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36430,-0.00195678024351872,0.00772425638967721,-0.0170963227672861,0.0131827622802486,0.800017921215575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,38832,-0.00101801191201397,0.00404171347901611,-0.00893977033088554,0.00690374650685759,0.801140121754448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36339,0.0018012632659961,0.00719669033623803,-0.0123042497930304,0.0159067763250227,0.802366818221673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36363,0.000773941413756941,0.00309730883028555,-0.00529678389360275,0.00684466672111663,0.802687780314586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36391,0.00156949031207626,0.0063114780976501,-0.0108010067593179,0.0139399873834705,0.803618286624181
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39023,-0.00102254853146252,0.00413739830212874,-0.00913184920363484,0.00708675214070981,0.804797254585738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,36430,0.000902465941085328,0.00365482411234783,-0.00626098931911642,0.00806592120128708,0.804970618767761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,38987,0.00243371394624467,0.00985685399660795,-0.0168857198871069,0.0217531477795963,0.804984515396702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,36792,-0.00100436709638003,0.00408245201452571,-0.00900597304485042,0.00699723885209036,0.805670227940724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,36743,-0.00109764764846509,0.00446370901376412,-0.00984651731544276,0.00765122201851257,0.805759814845378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,38741,-0.00154386779358751,0.00628390851022563,-0.0138603284736298,0.0107725928864547,0.805928766768956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,36767,0.00149238012638833,0.00609754787983979,-0.0104588137180977,0.0134435739708743,0.806653230615059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36430,0.000911561842781943,0.00372640445472274,-0.00639219088847462,0.00821531457403851,0.80675284396956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,36363,0.0016137503739804,0.00666187819008876,-0.0114435308785936,0.0146710316265544,0.808600850248144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36430,-0.00195543855276691,0.00817243370331603,-0.0179734086112663,0.0140625315057325,0.810898197585691
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,39106,-0.00231298900043709,0.00967573738102747,-0.0212774342672509,0.0166514562663767,0.811069706295093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",36767,0.00100667244340937,0.00422671568531099,-0.00727769029980016,0.00929103518661891,0.811753838099589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,38727,-0.00136070276457571,0.00572667537249798,-0.0125849864946717,0.00986358096552032,0.812188570647608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,38741,-0.00140935982215831,0.0060499452533593,-0.0132672525187425,0.0104485328744259,0.815800217305153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36421,-0.00106630983808043,0.00460682991952398,-0.0100956964803474,0.00796307680418658,0.816959037820465
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36391,0.00107575711815705,0.00466533532564229,-0.00806830012010184,0.0102198143564159,0.817640857505235
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,36339,0.00239088410946507,0.0103875099005202,-0.0179686352955546,0.0227504035144847,0.817964121882796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39255,-0.000667170365053049,0.00290062256211102,-0.00635239058679065,0.00501804985668456,0.818087545447462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,36747,0.000460337965067828,0.00200831981711007,-0.00347596887646791,0.00439664480660357,0.818705088987131
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,36747,-0.00167297960051323,0.0073831762454887,-0.0161440050416711,0.0127980458406446,0.820743456383366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,36679,0.000562643052349297,0.00254293215784478,-0.00442150397702647,0.00554679008172506,0.8248953904312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36420,0.000525566317605843,0.00237790986607673,-0.00413513701990456,0.00518626965511624,0.825080230683861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,38841,0.00130646935858655,0.00591289131354362,-0.0102827976159589,0.012895736333132,0.825132266165782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36339,-0.00132475458898356,0.00600139999574497,-0.0130874985806437,0.0104379894026766,0.825297774753291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,36430,-0.00165803232823681,0.00758162887964434,-0.0165180249323397,0.0132019602758661,0.826894482550416
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36430,-0.000756819607449315,0.00346192776329467,-0.00754219802350687,0.00602855880860824,0.826955705844854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,36363,-0.000674347375712669,0.00309791571642011,-0.00674626217989608,0.00539756742847074,0.827683739769391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,36767,-0.00155772962277696,0.00718039799592259,-0.0156313096947852,0.0125158504492313,0.82825700482893
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,38987,-0.00152514468453517,0.00703093223884894,-0.0153057718726791,0.0122554825036088,0.828274185624631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,38844,0.000437433962179645,0.0020349056817024,-0.00355098117395707,0.00442584909831636,0.829797354960779
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39057,0.000776597234904192,0.0036380592725094,-0.00635399893921424,0.00790719340902262,0.830967382620074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,36743,-0.00279467481267902,0.0131139405069418,-0.0284979982062849,0.0229086485809269,0.831246740429801
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36391,-0.00122431513036663,0.00577477710707056,-0.0125428782602249,0.0100942479994917,0.832102054611797
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36430,-0.00172420300582016,0.00817352265935234,-0.0177443074181508,0.0142959014065104,0.832929859725373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,38727,-0.000668160647734401,0.00319214676415344,-0.00692476830547514,0.00558844701000634,0.834206079335431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,36500,0.000630996318062786,0.00301641061886809,-0.00528116849491867,0.00654316113104424,0.834305002619706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,38741,0.00133320731745252,0.0063840441080191,-0.0111795191342649,0.01384593376917,0.834580460407134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39165,0.000508005379463827,0.00244999353990721,-0.0042939819587543,0.00530999271768196,0.835739535741632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,39241,-0.00140611952498961,0.00678792719184682,-0.0147104568210094,0.0118982177710302,0.835895409899424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39093,-0.000811421406966671,0.00393430589007738,-0.00852266095151833,0.00689981813758499,0.836604183063685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,36591,-0.000629911977738402,0.00306547932510954,-0.0066382514549531,0.0053784274994763,0.837196002571905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",38741,0.000932176212557558,0.00454190189785218,-0.00796995150723272,0.00983430393234784,0.837388068426333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36363,-0.00132943228812567,0.00649356412571124,-0.0140568179745197,0.0113979533982684,0.837785822604312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,38977,-0.000864508656951572,0.00427900044754415,-0.0092513495341381,0.00752233222023496,0.839891934475946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39045,0.000624054173567541,0.0030911861637649,-0.00543467070741166,0.00668277905454675,0.840011848421678
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,36538,-0.00142804084871459,0.00707653134332575,-0.0152980422816331,0.0124419605842039,0.840076670174121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,36421,-0.00121936119957051,0.00606871372545106,-0.0131140401014546,0.0106753177023136,0.840759841722859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,36430,-0.000720704927859904,0.00360713896936501,-0.00779069730781531,0.00634928745209551,0.841640545130924
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39023,0.00122485605328206,0.0061387840932913,-0.0108071607695689,0.013256872876133,0.841852833600932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39079,-0.00109486628355899,0.00550515480549993,-0.0118849697023388,0.00969523713522087,0.842359115653506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,36748,-0.000348308818921424,0.00177472482982311,-0.00382676948537473,0.00313015184753188,0.844409178439375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,36391,0.000652512618541822,0.00335151799450337,-0.00591646265068478,0.00722148788776843,0.845637493635102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36420,-0.00071102198143822,0.0036569128333746,-0.00787857113485243,0.00645652717197599,0.845840543508161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,36806,-0.000382324114423038,0.00198895741373427,-0.00428068064534221,0.00351603241649613,0.8475702486639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36391,-0.000766980102075702,0.003992034490339,-0.00859136770314014,0.00705740749898873,0.847645350249076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36519,-0.000934282607893146,0.00489955275776512,-0.0105374060131128,0.00866884079732648,0.848773627681862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,38841,-0.000613014621741606,0.00322477544994042,-0.00693357450362483,0.00570754526014162,0.849237037047065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36363,-0.000578923859623666,0.00305031723794243,-0.00655754564599083,0.00539969792674349,0.849475706845461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,36698,-0.00080932412039106,0.00431893312540029,-0.00927443304617563,0.00765578480539351,0.851357961504523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",38741,-0.00091211408959582,0.00487924902323939,-0.010475442175145,0.00865121399595339,0.851712269406931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",36767,-0.00131879526474389,0.00721105808471821,-0.0154524691107916,0.0128148785813038,0.854891026439213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39216,-0.000638994392140308,0.00360357058478756,-0.00770199273832392,0.0064240039540433,0.859257363256711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,36430,0.000543845827003831,0.0030688962977975,-0.00547119091667926,0.00655888257068692,0.859344577958964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,36792,0.000848951443036406,0.00480555461845335,-0.00856993560913216,0.010267838495205,0.859777874661918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,38909,-0.000596724476508487,0.0034033807435519,-0.00726735073387022,0.00607390178085325,0.86082045268597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,36538,-0.00107688956337743,0.00616952751474347,-0.0131691634922746,0.0110153843655198,0.861436213181493
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",36721,0.00170522841179091,0.00980530723949359,-0.0175131737776165,0.0209236306011983,0.861939938177543
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36510,-0.00100440541075218,0.00577715741351348,-0.0123276339412386,0.0103188231197342,0.861979791645044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,36747,0.000683064219656131,0.00398310635030835,-0.00712382422694824,0.0084899526662605,0.863840926466027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39255,0.000820087970712057,0.00482932157012212,-0.00864538230672729,0.0102855582481514,0.865158394065703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,38992,-0.00034874796778054,0.00206200394684608,-0.00439027570359886,0.00369277976803778,0.865696175834911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,39283,0.000638071464136699,0.00379716992501391,-0.00680438158889057,0.00808052451716397,0.866555044052829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,36806,0.000324278989936489,0.00195229024892031,-0.00350220989794732,0.0041507678778203,0.868079405091138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39291,-0.000636645355189106,0.00384708378427342,-0.008176929572365,0.00690363886198679,0.868562235199857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39191,-0.000409288423985064,0.00248751708699431,-0.00528482191449392,0.00446624506652379,0.869310646374902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,38605,0.00125229313594176,0.00762128718063628,-0.0136854297381053,0.0161900160099889,0.869485288475383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,36538,0.00241821518363233,0.0148103174242081,-0.0266100069678155,0.0314464373350801,0.870301297534056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,38727,-0.00176311938165874,0.0108045626692218,-0.0229400622133335,0.019413823450016,0.870376683101062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39023,-0.000448409276245922,0.00275749037763857,-0.00585309041641753,0.00495627186392568,0.870823748983628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,38810,0.000719762090105601,0.00445416416269913,-0.0080103996687847,0.0094499238489959,0.871628493487645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,36538,-0.000981772951715252,0.00611481064212876,-0.0129668018102876,0.0110032559068571,0.872445230351031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,39093,-0.00081307777125953,0.00506981422940776,-0.0107499136608987,0.00912375811837967,0.872586827331075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,36363,-0.00135956753144149,0.00848080509710578,-0.0179819455217688,0.0152628104588858,0.872638573875283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36363,-0.000946523400736907,0.00592046283098796,-0.0125506305494733,0.0106575837479995,0.872983534479515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,36791,-0.000427240681445824,0.00270244022878588,-0.00572402352986614,0.00486954216697449,0.874384877535655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,36796,-0.00031453094726453,0.00199275652351021,-0.00422033373334454,0.00359127183881548,0.874587612577812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,36767,0.00128020247315583,0.00811930608081722,-0.0146336374452459,0.0171940423915576,0.874716252106907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,38832,-0.00110475434846351,0.00702487037307773,-0.0148735002796959,0.0126639915827688,0.875039457510829
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,36538,-0.000822390890903633,0.00525689706801818,-0.0111259091442193,0.00948112736241199,0.875688413867665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,36792,0.000449277055878683,0.00287307985840309,-0.00518195946659137,0.00608051357834873,0.875740104182942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,36792,0.000655443699995597,0.00419829848832186,-0.00757322133711524,0.00888410873710644,0.875939868269398
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36391,-0.000561393069683948,0.00362675059720059,-0.0076698242401971,0.0065470381008292,0.876987554038545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,38949,0.000627809858158015,0.00407328794471702,-0.00735583451348734,0.00861145422980337,0.877510459490677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38336,0.00039936839659739,0.00259521691153975,-0.00468725675002052,0.0054859935432153,0.877701510781866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36421,0.000517874975124866,0.00340078425813998,-0.00614766217082949,0.00718341212107922,0.878967721518866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,36796,0.000633859471689801,0.00416515489848679,-0.00752984412934431,0.00879756307272391,0.879046167347051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36355,-0.000465137003678154,0.00308504432893306,-0.00651182388838696,0.00558154988103065,0.880158340684548
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,39128,0.000372066262531361,0.00250585003453506,-0.00453939980515736,0.00528353233022009,0.881966669772934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39291,-0.00048075764863335,0.00328055695606209,-0.00691064928251506,0.00594913398524836,0.883491054543404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,39071,0.00119229629110187,0.00821777214449961,-0.0149145371121174,0.0172991296943211,0.884643683301704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,38741,-0.00069527236939273,0.00481044725382971,-0.010123748986899,0.0087332042481135,0.885080901095221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,39162,-0.000832024181773247,0.00578327428070911,-0.0121672417719631,0.0105031934084166,0.885607135143136
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36391,0.00056187833896906,0.00396487032165578,-0.00720926749147626,0.00833302416941438,0.887308053582217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39023,-0.000271398511978445,0.00192632392961634,-0.00404699341402647,0.00350419639006958,0.887959233103171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",38951,-0.000921971958718944,0.00655047423306265,-0.0137609014555217,0.0119169575380838,0.888070201644955
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,36731,-0.000418564282648081,0.0030471537033994,-0.0063909855413109,0.00555385697601474,0.890746514712269
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,38775,0.00109575232377603,0.00799004204104144,-0.0145647300766652,0.0167562347242173,0.890922188771928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36420,-0.000649980567901057,0.00479202663417104,-0.0100423527708763,0.00874239163507418,0.892109693247249
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39072,0.000346704819662547,0.00257690754358432,-0.00470403396576272,0.00539744360508781,0.892975006995316
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36500,0.000993136851389068,0.00741379249172598,-0.0135378964323939,0.015524170135172,0.893437914916241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",38832,0.000516250421438675,0.00386631572622445,-0.00706172840196124,0.00809422924483859,0.893779863127236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,38727,-0.00116380509823862,0.00873335436067913,-0.0182811796451697,0.0159535694486925,0.893989718664861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36421,0.000992271324479382,0.00746576296603892,-0.0136406240889569,0.0156251667379157,0.894267029525519
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,38841,-0.000636923316466952,0.00480584758698221,-0.0100563845869521,0.00878253795401818,0.894566162108569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36421,-0.000591610903305407,0.00450526657876964,-0.00942193339769391,0.00823871159108309,0.89552790930004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,38741,-0.000665087707701576,0.00509160900752676,-0.010644641362454,0.00931446594705088,0.896074308533141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,36391,-0.000469962150392357,0.00360218549812503,-0.00753024572671741,0.00659032142593269,0.896199974469114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,36466,0.00035926525013585,0.00275712682168215,-0.00504470332036116,0.00576323382063286,0.896327823405403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36420,-0.000341025290737919,0.00262466570803381,-0.00548537007848418,0.00480331949700835,0.8966231434212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,38741,0.000673043938766571,0.00518498224670202,-0.00948952126476938,0.0108356091423025,0.896721344689137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39093,-0.000313884721239684,0.00247968408576481,-0.0051740655293387,0.00454629608685934,0.899272483894584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39095,0.00333779316610108,0.0264031565954474,-0.0484123937609758,0.0550879800931779,0.89940395439805
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,38502,0.000330519603485068,0.00262838548607301,-0.00482111594921803,0.00548215515618817,0.89993150945229
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,38841,-0.00127013888708969,0.0102327022190432,-0.0213262352364144,0.0187859574622351,0.901217603848317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39051,0.000440333513263405,0.00354918675233326,-0.00651607252130978,0.00739673954783659,0.901264635211988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,39217,-0.000259920561698209,0.00211156483579576,-0.00439858763985789,0.00387874651646148,0.902034423354894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,39133,0.000329503506535944,0.00268041493170893,-0.00492410975961355,0.00558311677268544,0.902164117478435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,39160,0.000296903815023747,0.00242043448470719,-0.00444714777500234,0.00504095540504983,0.902373592760529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,38727,0.000327075213293756,0.00268044016719891,-0.00492658751441611,0.00558073794100362,0.902882492786905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36391,-0.000426917408272655,0.00355413176282819,-0.00739301566341591,0.0065391808468706,0.904391107005007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,36339,0.000468705130049541,0.00396479270178487,-0.0073022885654488,0.00823969882554788,0.905897776679483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36391,0.000466784166252635,0.00397277168706673,-0.00731984834039816,0.00825341667290343,0.9064690195532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36339,-0.000273258160247575,0.00235100764550744,-0.00488123314544215,0.004334716824947,0.907471949031871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,38841,-0.000410739816644301,0.00353592832316624,-0.00734115933005014,0.00651967969676153,0.907525863912616
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39023,-0.00028381150583166,0.00250612807140911,-0.00519582252579352,0.0046281995141302,0.909836227555814
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,36420,0.000690441896714689,0.00619881718971307,-0.0114592397951229,0.0128401235885523,0.911314542572391
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,36363,0.000418672753317698,0.00382650494705827,-0.00708127694291651,0.00791862244955191,0.912875981060095
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36421,0.000770568374403989,0.00706540833422859,-0.0130776319606841,0.014618768709492,0.913154965773483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,39099,-0.000835418821158194,0.00768234437955427,-0.0158928138050846,0.0142219761627682,0.913405944817179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,36731,-0.000433443025329408,0.00400586389841159,-0.00828493626621613,0.00741805021555731,0.913837038213708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,36731,0.000652139303725035,0.00603310247066905,-0.0111727415387863,0.0124770201462364,0.91392319043481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,38841,-0.000323725074060679,0.00301080906879433,-0.00622491084889757,0.00557746070077621,0.91437713980933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39266,0.000221651285526313,0.0020805108607974,-0.0038561500016366,0.00429945257268923,0.915157725990113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,36767,-0.000625986781135218,0.00607651273815094,-0.0125359517479111,0.0112839781856406,0.917950730614221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39023,-0.000708159431337551,0.00688465879228334,-0.0142020906642129,0.0127857718015378,0.918075049681151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,36538,0.000938138345594375,0.00952473016621148,-0.0177303327801801,0.0196066094713689,0.921540795219373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,36391,0.000322668300069759,0.00327685649940428,-0.00609997043876263,0.00674530703890215,0.921561578629851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,36538,-0.000198056196679341,0.0020392974714256,-0.00419507924067352,0.00379896684731484,0.922632778968549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,38741,-0.000409998216271599,0.00426105636242625,-0.00876166868662706,0.00794167225408386,0.923347259347895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39136,0.000608326972248861,0.00641074068400944,-0.0119567247684096,0.0131733787129074,0.924401983489538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,38741,0.000263773382422133,0.00286584045942899,-0.0053532739180587,0.00588082068290296,0.926667102494769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,39086,0.00031117439248233,0.00341936921902926,-0.00639078927681502,0.00701313806177969,0.92749104759526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36500,0.000474252036631269,0.00523168982652872,-0.00977986002336501,0.0107283640966276,0.927772235700307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,39106,-0.000412762897789299,0.004605782418197,-0.00944009643745542,0.00861457064187682,0.928591631289146
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36339,-0.000285122575173853,0.00332662190474881,-0.00680530150848153,0.00623505635813382,0.931698850481193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36339,-0.000366778478512034,0.004332908010074,-0.00885927817825708,0.00812572122123302,0.932541406161094
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36339,0.000556726610752803,0.00664855655702349,-0.0124744442410132,0.0135878974625188,0.933267308727746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,36538,-0.000218879582286199,0.00261936713292546,-0.0053528391628201,0.0049150799982477,0.933405992251358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36430,-0.000321428351259372,0.0038933106813258,-0.00795231728665794,0.00730946058413919,0.934203412610579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36391,0.000484031019153227,0.00587318172163506,-0.0110274051552515,0.0119954671935579,0.934319006570331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,39234,-0.000194850054431264,0.00241155032163156,-0.00492148868482911,0.00453178857596659,0.935603118907817
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,36339,0.000383744289591482,0.00486195708384658,-0.00914569159474782,0.00991318017393079,0.937091199847577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,36339,0.000507906179386365,0.00652880153548071,-0.0122885448301558,0.0133043571889286,0.9379926069567
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36421,-0.000373434240151394,0.00490668391437923,-0.00999053471233468,0.00924366623203189,0.939334980904038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39147,-0.000535284317995668,0.00703529707816368,-0.0143244665911965,0.0132538979552052,0.93935204654982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36421,0.000268446979645028,0.00353067385276381,-0.00665167377177204,0.00718856773106209,0.939394222816806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,38832,0.000224851259958596,0.00299086397780097,-0.0056372421365313,0.00608694465644849,0.9400730052384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39255,-0.000223835558803501,0.00299898602547827,-0.0061018481687409,0.0056541770511339,0.940504440845569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,38727,-0.000294757710246534,0.00396306816686664,-0.00806237131730514,0.00747285589681208,0.940712094892651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,36538,0.000567885896442552,0.00775397902531445,-0.0146299129931738,0.0157656847860589,0.941617885298919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,36731,0.000555381608336189,0.00763996637794419,-0.0144189524924344,0.0155297157091068,0.942050555655272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36230,-0.000206482687706884,0.00292645469578242,-0.00594233389144043,0.00552936851602666,0.943751250648962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,38727,-0.000341327990388098,0.00491906457196482,-0.00998269455143914,0.00930003857066294,0.944681076531392
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36430,0.000256758045125056,0.00398932214344042,-0.00756231335601818,0.00807582944626829,0.948683550535806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,38841,0.000248810910473728,0.00438944203072164,-0.00835449546974069,0.00885211729068815,0.954797715834009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39004,-0.000226104267209841,0.00416329997941054,-0.00838617222685449,0.00793396369243481,0.956689770452591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36430,-0.000276157577486082,0.00513135491760438,-0.0103336132159907,0.0097812980610185,0.95708128470136
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36421,0.000352541968973889,0.0065608359369606,-0.0125066964674689,0.0132117804054167,0.957147704191995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,38841,-0.000312264957632875,0.00583438825815707,-0.0117476659436207,0.011123136028355,0.957317148944477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36375,0.000400845356185509,0.00751034532123465,-0.0143194314734344,0.0151211221858054,0.957436025966174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,36743,0.000136906739785717,0.00260119589909318,-0.00496143722243692,0.00523525070200835,0.958025753084754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36391,-0.000316242290651033,0.00602075224249284,-0.012116916685937,0.0114844321046349,0.958110911341604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36430,-0.000192736287571127,0.00368482107416575,-0.00741498559293599,0.00702951301779374,0.958286128294322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36339,-0.000393504242148079,0.0082386607597207,-0.0165412793312007,0.0157542708469045,0.961905783663434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,36538,0.000129823719132274,0.00276085991876267,-0.00528146172164257,0.00554110915990712,0.962495693924418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,39291,3.75824688892323e-05,0.000806394597609736,-0.00154295094242585,0.00161811588020431,0.962828206590038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,36747,0.000156300195622341,0.00344323605534106,-0.00659244247284614,0.00690504286409082,0.963794443998727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36430,0.000273656340051196,0.00607499354933636,-0.0116333310166481,0.0121806436967505,0.964071072885011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36363,0.000460548403195224,0.0104418475796065,-0.0200054728528335,0.0209265696592239,0.964820593565161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,36391,-0.000186023242900893,0.00422433516627228,-0.00846572016879456,0.00809367368299277,0.964876330325226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36421,0.000160681182491751,0.00367657331969813,-0.00704540252411658,0.00736676488910008,0.965140997250458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,36421,9.99018460931494e-05,0.00243269447845017,-0.00466817933166919,0.00486798302385549,0.967243665516383
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39099,-0.000200057331928352,0.00500335319687432,-0.010006629597802,0.00960651493394532,0.968105886944965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,36538,0.000270410700152013,0.00689201389242944,-0.0132379365290097,0.0137787579293137,0.968703353669802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,36538,-0.000388844787551947,0.0101950859426369,-0.0203712132351203,0.0195935236600164,0.969576330408465
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36339,0.000103143516690405,0.00272754177667915,-0.00524283836560074,0.00544912539898154,0.969835343932359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36420,0.000869780942091885,0.0230720859356937,-0.0443515074918678,0.0460910693760516,0.969928743309782
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,36430,0.000295829067036648,0.00785856370980511,-0.0151069558041814,0.0156986139382547,0.969971992261709
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36421,0.000211428260892956,0.00581005705033546,-0.0111762835577646,0.0115991400795505,0.970971926911888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,38960,-0.00026909124717542,0.00799695612785881,-0.0159431252577787,0.0154049427634278,0.973157326204934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,38728,0.000207704713206205,0.00627685013267375,-0.0120949215468343,0.0125103309732468,0.973602785969792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36391,0.000173246204828196,0.00528397532844843,-0.0101833454389307,0.0105298378485871,0.973844890999241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,38960,-0.000143127269648614,0.00439491151094339,-0.00875715383109766,0.00847089929180043,0.974020645544742
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,38727,0.00020236302359163,0.00652388837381473,-0.0125844581890852,0.0129891842362685,0.975254983213272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,36767,8.14909474067674e-05,0.00266046953137348,-0.00513302933408525,0.00529601122889878,0.975564860905226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,39162,8.36558795591583e-05,0.00292355471454963,-0.00564651136095812,0.00581382312007643,0.977172468886468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,36791,8.56005863404962e-05,0.00301858766441195,-0.00583083123590693,0.00600203240858792,0.977377197568749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,36421,-0.000166872244775296,0.00594327368705806,-0.0118156886714091,0.0114819441818585,0.977600788419459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36430,9.68133790792991e-05,0.00350914062128874,-0.00678110223864663,0.00697472899680523,0.977990461553402
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36339,-0.00014304678835165,0.00520108971286367,-0.0103371826255644,0.0100510890488611,0.978058800112236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36421,8.3963083787075e-05,0.00330669500082524,-0.00639715911783039,0.00656508528540454,0.97974281986948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36420,-5.85248374733492e-05,0.0023274662353928,-0.00462035865884323,0.00450330898389654,0.979939466628176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39241,0.000102648175083614,0.00420520803265856,-0.00813955956892715,0.00834485591909438,0.98052606927538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,36726,7.16818735139434e-05,0.00331070061424937,-0.00641729133041482,0.0065606550774427,0.982726230215358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,39098,4.15346638401179e-05,0.00194857187850056,-0.00377766621802097,0.00386073554570121,0.982994307664737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,39099,-7.01160439428696e-05,0.00346003553643624,-0.0068517856953579,0.00671155360747216,0.983832604707225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39283,5.60417013668139e-05,0.00280360433508999,-0.00543902279540956,0.00555110619814319,0.984052276850508
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,36421,-0.000134166823530701,0.00673826903409673,-0.0133411741303603,0.0130728404832989,0.984114550404437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,39291,0.000147041012579903,0.00749853716886521,-0.0145500918383959,0.0148441738635557,0.984355304029195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36339,-5.17752837429981e-05,0.00265916451699092,-0.0052637377370452,0.0051601871695592,0.984466075149189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,39080,0.000201215143008623,0.0111796544364974,-0.0217109075525263,0.0221133378385436,0.985640419215614
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,36421,6.60887911479056e-05,0.003985618894145,-0.0077457242413763,0.00787790182367211,0.986770496252575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36363,8.14679187514097e-05,0.00495034031301477,-0.00962119909475753,0.00978413493226035,0.986870041943339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36391,-9.71018830469955e-05,0.00604434932328054,-0.0119440265566769,0.0117498227905829,0.98718286933765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,36767,4.82539849073855e-05,0.00315191214898744,-0.00612949382710799,0.00622600179692276,0.987785554294196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39255,4.51970825624271e-05,0.00295815703068938,-0.00575279069758877,0.00584318486271362,0.987809955555451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,38841,-6.1035582156259e-05,0.0042274607392485,-0.00834685863108332,0.0082247874667708,0.988480828790841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,36731,5.66157687472458e-05,0.00443320557640947,-0.00863246716101532,0.00874569869850981,0.989810817105564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,38727,-9.926776495198e-05,0.00785438863425341,-0.0154938694880887,0.0152953339581847,0.989916366476021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36420,-7.99155995522271e-05,0.00650138975871964,-0.0128226395266427,0.0126628083275383,0.990192781779228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,36731,-3.84336000444285e-05,0.00352670235222348,-0.00695077021040246,0.0068739030103136,0.991305086059703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,38987,3.19475645876026e-05,0.00326550841061734,-0.00636844892022238,0.00643234404939759,0.992194281129196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36391,7.96642055297354e-05,0.00882218376525523,-0.0172118159743705,0.01737114438543,0.992795354374195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,36806,-1.77963406974536e-05,0.00269879195291143,-0.00530742856840386,0.00527183588700896,0.994738739178429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39099,-2.45456001860585e-05,0.00392170986353874,-0.00771109693272199,0.00766200573234987,0.995006232754207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39147,-6.73283411635079e-06,0.00209516039022062,-0.00411324719894876,0.00409978153071606,0.99743603052132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36420,1.64692631714002e-05,0.00554150781602989,-0.0108448860562472,0.01087782458259,0.997628751893958
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,38945,6.47279175344144e-06,0.0024778775811117,-0.00485016726722549,0.00486311285073237,0.99791577712277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,38741,8.09913596138613e-06,0.00580246714457319,-0.0113647364674021,0.0113809347393248,0.998886324606986
